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ABSTRACT

Author: Horzmann, Katharine, A. PhD
Institution: Purdue University
Degree Received: May 2018
Title: Investigating the Developmental Toxicity of Legacy, Emergent, and Current Use
Environmental Toxicants Using the Zebrafish Model System.
Committee Chair: Jennifer Freeman
Environmental toxicants are chemical or physical agents that enter the environment and
can have adverse health effects on populations of humans. Chemical contamination of rivers,
lakes, and ground water is a significant public health concern; 23% of private wells are
contaminated with at least one significant environmental toxicant and chemical spill incidences
can have severe consequences to human health and the environment. Even low doses of
chemicals in the environment can have an effect on human health, and it is suggested by the
Developmental Origins of Health and Disease (DOHaD) hypothesis that embryonic exposure to
toxicants alters health status and disease prevalence later in life. Therefore, it is important to
study the legacy, emergent, and current-use chemicals that are found in low levels in drinking
water sources to assess the risk of early exposure. The first chapter of this dissertation introduces
the problem of drinking water contamination and provides a background on the zebrafish
biomedical model used in this dissertation as well as the zebrafish neurotransmitter systems and
methods used to evaluate neurotoxicity. The second chapter is focused on the legacy toxicant,
trichloroethylene (TCE). TCE, an industrial solvent and degreaser, is an environmental toxicant
that contaminates over half of Superfund sites. In the study described in Chapter 2, the zebrafish
model was used to evaluate the acute developmental toxicity of near regulatory concentrations of
TCE by monitoring survivability, percent hatching, morphological measurements, and
neurobehavior. The percent survival was not significantly different between treatments, but the
500 ppb treatment had increased hatching at 48 hpf. Morphological measurements indicated that
the 500 ppb treatment had significantly larger head length to body length ratios and significantly
shorter brains compared to the controls. No significant differences were observed during the
evaluation of neurobehavior. The expression of four cytochrome p450 enzymes was also
evaluated and the expression of cyp24a1 was significantly downregulated, suggesting altered
vitamin D3 metabolism. The reported alterations suggest that developmental TCE toxicity is still

xvii
a concern near regulatory concentrations and that TCE should remain a priority environmental
toxicant. The third chapter describes the acute toxicity of the emergent chemical mixtures in the
methylcyclohexanemethanol (MCHM) family. In January 2014, a chemical mixture containing
crude MCHM contaminated the water supply of Charleston, West Virginia. Although the
mixture was later identified as a mix of crude MCHM and stripped propylene glycol phenyl
ethers, initial risk assessment focused on 4-MCHM, the predominant component of crude
MCHM. The mixture’s exact composition and the toxicity differences between 4-MCHM, crude
MCHM, and the tank mixture were unknown. In the studies described in Chapter 3, the chemical
compositions of crude MCHM and the tank mixture were analyzed via GC/MS and found to be
different from each other and the reported composition of crude MCHM. The percent mortality
and percent hatch, larval morphology alterations, and larval visual motor response test were used
to establish toxicity profiles for each of the chemicals or mixtures. The acute toxicity differed
between 4-MCHM, crude MCHM and the tank mixture with significant differences in survival,
hatching, morphology, and locomotion. The acute toxicity increased as the complexity of the
mixture increased, but the developmental toxicity was greatest with the 4-MCHM parent
compound. Additionally, behavior was changed at levels as low as the short-term screening level
of 1 ppm, suggesting a need for further research into human health risks. The final toxicant of
interest is the current use herbicide, atrazine (ATZ). ATZ is the second most commonly used
pesticide and frequently contaminates rural and urban water sources. Exposure to ATZ is linked
to endocrine disruption, cancer, changes in genome methylation, and alterations in
neurochemistry and behavior. The studies described in Chapter 4 focus on ATZ related
developmental neurotoxicity while the studies described in Chapter 5 examine the later life
effects on the nervous system of embryonic ATZ exposure. In Chapter 4, the relative expression
of six genes was monitored throughout a developmental time course to determine normal
expression and to determine if developmental exposure to 0, 0.3, 3, or 30 ppb ATZ altered
expression. One gene, cyp17a1, had dynamic expression during development that was not related
to ATZ exposure, but ttc3 and tpd52l1 both had ATZ related changes in relative gene expression.
The brain lengths were measured and larval behavior was monitored to determine physical and
functional outcomes of developmental ATZ exposure. Increased brain length was observed in
larvae exposed to 0.3 ppb ATZ, while hypoactivity was observed larvae with developmental
exposure to 30 ppb ATZ. Proteomic analysis identified 28 proteins with a significant label-free

xviii
quantification intensity value and the proteins were associated with pathways related to organism
and organ system development, intracellular signaling, protein handling and degradation,
epigenetic regulation of gene expression, and cancer. The results suggest that the effects of
developmental ATZ exposure are broad, time sensitive, and involve the interaction of many
pathways. In Chapter 5, the studies use adult zebrafish aged 9 to 14 months to tests the
hypothesis that embryonic exposure to low levels of ATZ results in age and sex-specific changes
in behavior, the adult brain transcriptome, and adult body and brain pathology, according to the
DOHaD hypothesis. At age 9 months, a novel tank test, a light-dark box, and an open field test
evaluated adult behavior; microarray analysis investigated ATZ related differences in gene
expression; and brain histopathology investigated neuropathology. At 14 months, the body
length, weight, and brain weight was measured to evaluate effects of ATZ on mature body and
brain size. The 9 month adult behavioral tests found nonmonotonic, sex-specific behavior
changes, with male zebrafish having decreased activity and female zebrafish having increased
signs of anxiety. Microarray analysis identified sex-specific transcriptomic alterations, with
females having altered expression of genes in pathways related to cancer and organismal injury
and males having altered gene expression in organismal development and reproductive system
development and function pathways. Genes with persistant altered expression were also
identified. Adult zebrafish also had nonmonotonic, sex-specific alterations in body length, body
weight, and brain weight. This study suggests that developmental exposure to ATZ does cause
sex-specific alterations in adult neural function later in life. In summary, developmental exposure
to legacy, emergent, and current use environmental toxicants can alter neurodevelopment and
later life neural function in zebrafish, suggesting a greater need for human health risk
assessments.

1

CHAPTER 1.

1.1

INTRODUCTION1

Abstract

The health effects of many environmental contaminants are unknown, or understudied and
contamination of drinking water sources with environmental toxicants represents a possible route
for chronic, low-dose exposure. Exposure to contaminated water during development may cause
long lasting effects on growth and organ system development. Drinking water contaminants have
been linked to developmental neurotoxicity as well as nervous system abnormalities later in life.
Neurotransmission is the basis of neuronal communication and is critical for normal brain
development, behavior, learning, and memory. Exposure to drugs and chemicals can alter
neurotransmission, often through unknown pathways and mechanisms. The zebrafish (Danio
rerio) model system is increasingly being used to study the brain and chemical neurotoxicity.
The model has many advantages, including easy husbandry, high fecundity, a sequenced
genome, a short generational period, and the ease of genetic manipulation and ability for highthroughput assays. Further background on the model and its usefulness in toxicology research
will be provided in this chapter. The major modulatory neurotransmitters present in humans
(dopamine, norepinephrine, serotonin, acetylcholine, and histamine) are also present in zebrafish
and, although there are some significant differences, the systems are relatively conserved with
respect to neurotransmitter synthesis, transport, metabolism, and action. These neurotransmitter
systems will be reviewed, and differences in neurochemistry are highlighted. Methods of
evaluating neurotoxicity, including behavioral assays for larval and adult zebrafish, are also
discussed and toxicogenomic techniques used for transcriptomic and proteomic evaluations of
toxicity are extensively reviewed. Finally, examples of chemical toxicity studies evaluating
alterations in neurotransmitter systems in the zebrafish model are reviewed and emerging areas
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Sections of this chapter were originally published in:
Horzmann, K. A., and Freeman, J. L. (2016). Zebrafish get connected: investigating
neurotransmission targets and alterations in chemical toxicity. Toxics 4(3), 19.
Horzmann, K. A., and Freeman, J. L. (2017). Toxicogenomic evaluation using the zebrafish
model system. In Encyclopedia of analytical chemistry 1-19.
Horzmann, K. A., and Freeman, J. L. (2018). Making waves: new developments in toxicology
with the zebrafish. Toxicological sciences 163(1).

2
in toxicology that can take advantage of the zebrafish model are introduced. These areas include
the Developmental Origins of Health and Disease (DOHaD), epigenetic, and multi- and
transgenerational toxicity. The overall hypothesis and specific aims of this dissertation are
outlined at the end of the chapter.

1.2

Introduction to Environmental Toxicants and Developmental Neurotoxicity

The United States Environmental Protection Agency (US EPA) currently lists over 85,000
chemicals in the Toxic Substances Control Act (TSCA) Chemical Substance Inventory (US
EPA, 2017). Of these chemicals, around 24,600 were reported as being in current use on 5
January, 2018 (US EPA, 2018) and 700-1000 chemicals are added to the list every year
(Wambaugh et al., 2014). As a result of the widespread use of chemicals in today’s society,
people are exposed to chemicals at work, in their homes, and in the environment. During a nontargeted surveillance of chemical exposure, over 3,200 chemicals were detected in human serum
samples, suggesting prevalent exposure to chemicals and absorption of those chemicals into the
body (Park et al., 2012). The Centers for Disease Control and Prevention (CDC) defines an
environmental chemical as a chemical that is found in air, water, food, soil, dust, and other
environmental media (CDC, 2009) and an environmental toxicant can be defined as a chemical
or physical agent released into the general environment that can produce adverse health effects in
a large number of people (Lippmann et al., 2008). As of 2009, around a third (34%) of all
chemicals listed on the TSCA Inventory had no toxicity data (Judson et al., 2009). Therefore, the
health effects of many chemicals found in the environmental are unknown.
Contamination of water with environmental toxicants represents a significant ecological
and public health concern. Just under a quarter (23%) of private wells, which are largely
unregulated, have at least one contaminant at a level of potential health concern (DeSimone et
al., 2009). Significant groundwater contamination may come from industrial or agricultural
sources, and chemical incidents may also release chemicals with the potential to adversely affect
human health into groundwater and drinking water supplies (Bongers et al., 2008; Calderon,
2000). Superfund sites are places that have been identified by the US EPA as having hazardous
waste contamination and are candidates for clean up to reduce the risk to human health and the
environment (US National Library of Medicine, 2017). Superfund sites, represent a legacy of
chemical use and environmental contamination; however, current use chemicals, such as
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pesticides also can be found in drinking water sources. The US EPA regulates the concentrations
of many contaminants in public drinking water with maximum contaminant levels (MCLs);
however, fluctuations in environmental conditions can raise contaminant levels above the MCL.
Additionally, some contaminants persist in drinking water sources, and people can be exposed to
low-levels of contaminants for long periods of time which may result in toxicity, especially in
susceptible populations (Daughton, 2004).
Children, including developing fetuses, represent an important susceptible population.
They have a proportionally greater exposure to environmental toxicants due to factors such as
increased food and water consumption per body mass, increased hand to mouth events, and
closer contact with floors and ground surfaces (Landrigan et al., 2004). Additionally, children
have limited metabolism and biotransformation of xenobiotics, lack of a blood-brain-barrier,
have immature immune system, and have increased metabolic rate may contribute to greater
toxicity during development (Newbold et al., 2007). Finally children are in a dynamic state of
growth and any perturbation can have long lasting effects. Often toxic effects appear at much
lower exposure concentrations in developing organisms compared to the concentration of
toxicant required to cause adverse effects in adults (Landrigan et al., 2004; Newbold et al.,
2007).
The nervous system is particularly sensitive to toxicant exposure during development. In
humans, most specialized neuronal cell groups, such as the dentate gyrus granular cells in the
hippocampus, develop prenatally and the nature of neuronal differentiation and specialization
limit the ability of the brain to compensate for cell loss and disruptions in the developmental
period (Faustman et al., 2000). Developmental exposure to environmental toxicants is suggested
as a cause of lowered IQ, learning disabilities, attention disorders, and autism spectrum disorder
(reviewed by Grandjean et al. (2014)) and developmental neurotoxicity can manifest as physical
changes in nervous system development, alterations in gene expression or protein levels, and
abnormal neural function and behavior.
The zebrafish (Danio rerio) research model is increasingly being used in developmental
neurotoxicity studies (as reviewed by (de Esch et al., 2012; Fan et al., 2010; Nishimura et al.,
2015; Parng et al., 2007; Rico et al., 2011). The following section will provide a history and
overview of the zebrafish model. Later the use of the zebrafish in neurotoxicity studies will be
discussed.
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1.3

Introduction to Zebrafish

The zebrafish (Danio rerio) is now a well-recognized biological model system for toxicology
research and can be used to study and model toxicity from molecular initiating events to
alterations in organismal health and behavior (Figure 1.1). The small, freshwater cyprinid fills a
scientific niche between in vitro models and higher organisms. Zebrafish can be used for highthroughput chemical toxicity testing, allowing for quick, large scale screening similar to in vitro
assays. Yet zebrafish are complex organisms with highly conserved organ systems and metabolic
pathways that enable the evaluation of the toxicokinetics and toxicodynamics of xenobiotics
similar to mammalian models. Zebrafish are also being used to study emerging topics in
toxicological research such as the developmental neurotoxicity, the developmental origins of
health and disease, and the persistence of xenobiotic induced epigenetic alterations through
generations.

Figure 1.1 Zebrafish can be used to define and connect changes along the entire spectrum of toxicity research.
Zebrafish can be used to model toxicity from the initial intoxication (1), through the molecular initiating event (2),
and changes at the cellular (3), tissue (4), and organ (5) levels. Finally, changes in phenotype (6), including
alterations in growth and development or behavior and disease outcomes can be observed. In this example, the
methylation status of a gene is altered by xenobiotic exposure (2), resulting in altered gene transcription (3), altered
neurotransmission (4), and brain dysfunction (5).
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1.3.1 Zebrafish Ecology
The zebrafish (Danio rerio) is a small, robust, freshwater tropical fish. Zebrafish are in the
family Cyprinidae, which includes carps and minnows, in the order Cypriniformes. The family
Cyprinidae is the largest of all vertebrate families, with over 3,000 species. Zebrafish originate in
freshwater streams and rice paddies in Northeast India, Bangladesh, and Nepal. The natural
range appears to be the Ganges and Brahmaputra river basins although zebrafish have been
collected from other rivers in the Indian subcontinent. Wild zebrafish prefer shallow water with
silty bottoms and vegetation, such as the edges of streams and ditches and rice paddies. The
name “Danio” reportedly comes from the Bengali word dhani which has been translated as “of
the rice field”.
Adult zebrafish are up to 40 mm standard length (which is the length from the end of the
snout to the base of the caudal fin), torpedo-shaped, and compressed laterally. The lateral stripes
are the eponymous feature, although an incomplete lateral line and two pairs of barbels are other
identifying features. Males and females have similar coloration, although males tend to have
larger anal fins and more yellow pigment while mature females have a protruding silver belly
(Barman, 1991). Figure 1.2 demonstrates the phenotypic differences between sexes.

Figure 1.2. Photograph of adult zebrafish taken at 12 months post fertilization. (a) Male zebrafish are typically
smaller than female zebrafish with a more fusiform body and heavier yellow pigment on fins. (b) Female zebrafish
have a gravid, protruding silver belly and lighter pigmentation. The scale bar represents 1 cm.
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The mechanism of sex differentiation in zebrafish was largely unknown until recently and
many details are still uncertain. A polygenic sexual determination mechanism is currently
suspected with multiple chromosomes having sex-linked gene clusters (Liew et al., 2014;
Nagabhushana et al., 2016). Environmental and epigenetic factors are also suspected to have
secondary roles in sex determination, with availability of food, crowding and stress, and growth
rates being hypothesized to influence sex selection (Spence et al., 2008). All zebrafish initially
develop ovaries, however males begin to develop testes at 5-7 weeks post fertilization. Sexual
maturity occurs at 3-4 months of age. If males and females are kept together, small numbers of
embryos are produced daily, but a larger clutch of embryos can be obtained if males and females
are kept separate for 5-7 days and then reintroduced in a controlled breeding. Females typically
can produce 100-200 ova per breeding, although not all breeding pairs will breed on every
attempt. The ova are 0.7 mm in diameter, transparent, non-adhesive, and have a sequestered
yolk. Fertilization by males occurs almost simultaneously to the release of the ova from the
female genital opening.
Fertilized embryos develop ex vivo and development is rapid (Figure 1.3) and well
characterized (Kimmel et al., 1995). Given a standard incubation temperature of 28.5°C, the
precursors of all major body systems are formed by 36 hours post fertilization (hpf). Hatching
generally occurs between 48 and 72 hpf. 72 hpf is considered the end of embryogenesis and a
blood-brain-barrier forms at 72 hpf as well. At 120 hpf, the hatched larvae are free swimming,
have inflated swim bladders, and exhibit prey searching and capture behaviors. The yolk is
absorbed between 5 and 7 days post fertilization (dpf). The juvenile period is considered to be
between 30 and 90 dpf. Adult zebrafish in the wild rarely live beyond 2 years, but captive
zebrafish have been reported to live 5-7 years.
1.3.2 History of Use as a Model Organism
Zebrafish have been used in laboratory research since the late 1960s. George Streisinger
pioneered the genetic manipulation of zebrafish at the University of Oregon and promoted its use
as a tool to study the embryological development of the vertebrate nervous system (Grunwald et
al., 2002). Streisinger developed methods to produce gynogenetic zebrafish, where a diploid
embryo is created from only maternal chromosomes. This technique allowed for the
identification of genetic mutations associated with unique phenotypes. Charles Kimmel, Monte
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Figure 1.3. Timeline of zebrafish development and significant developmental milestones.
The scale bar represents 1 mm.

Westerfield, Judith Eisen, and others at the University of Oregon adopted the zebrafish model
and studied the patterning and development of the nervous system and later the embryology of
the entire organism, thus securing the zebrafish’s role in developmental biology. Westerfield
established protocols for zebrafish husbandry and helped organize The Zebrafish Information
Network (ZFIN; https://zfin.org/) and The Zebrafish International Resource Center (ZIRC;
http://zebrafish.org) (Westerfield, 2007).
Many features of zebrafish enable them to be aptly suited for use as a model organism.
Zebrafish can breed year round in laboratory conditions and have high fecundity with easy
husbandry. The external fertilization allows for selection of embryos for either manipulation of
ploidy and the genetic code or exposure to toxicants or xenobiotics. Furthermore, the rapid ex
vivo development and transparent embryos allows for early screening of genetic phenotypes or
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toxic effects. The zebrafish has many similarities to humans and rodent models in metabolism,
endocrine signaling, and disease pathways. Zebrafish are also a viable alternative to mammalian
models and may offer a more cost effective, ethical alternative for early screening tests.
Zebrafish are used in the study of developmental biology, genetics, as models of human diseases,
and in high-throughput screening of pharmaceuticals and potential toxicants (Fan et al., 2010;
McGrath et al., 2008). Zebrafish also are considered a prototypical fish species and are used as a
model of ecotoxicity.
1.3.3 Zebrafish Genetics
Zebrafish have 25 pairs of chromosomes which is similar to the 23 pairs in humans, although the
zebrafish genome is about half the size of the human genome, and zebrafish chromosomes are
mosaically orthologous to human chromosomes. The zebrafish genome was sequenced in 2013
and consists of approximately 1.68 billion base pairs as of the Genome Reference Consortium
Zebrafish Build 11, with over 26,000 protein-coding genes (Howe et al., 2013). The zebrafish
genome has approximately 70% similarity with the human genome with approximately 80%
similarity in genes linked to disease.
One unique feature of the zebrafish model when compared to mammalian models is that
approximately 250 million years ago, a whole genome duplication event occurred in teleost (rayfinned) fish. Greater than 20% of duplicated genes were retained, and so zebrafish often have
two paralogous genes for a single gene found in other vertebrate classes (Postlethwait et al.,
2000). The duplicated genes may have partially redundancy in function. The redundant
functionality can be both an advantage and a disadvantage in genetic research and studies of
toxicology. Obviously having two genes with redundant functions can complicate genetic studies
of a single human or mammalian gene and create twice the work in gene identification and
analysis. However, in cases where knock-out of the mammalian gene causes lethality, it may be
possible to knock-out one of the two zebrafish paralogs and study the effects of loss of
expression without causing a lethal condition due to partial redundancy in the other paralog.
Zebrafish are highly amenable to genetic manipulation. Historically the genome of
zebrafish have been modified by N-ethyl-N-nitrosourea (ENU) chemical mutagenesis, retroviral
mediated mutagenesis,

and then morpholinos.
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Morpholinos are able to knock-down gene expression in a targeted manner for reverse genetic
research. As techniques for genetic manipulation advanced, targeted induced local lesion in
genomes (TILLING), zinc finger nucleases (ZFNs), TAL effector nucleases (TALENs), and
most recently CRISPR/Cas9 techniques have successfully been used in zebrafish (Varshney et
al., 2015). The ease of genetic manipulation has aided the genomic evaluation of zebrafish and
was used to create the foundation of the zebrafish genome and zebrafish functional genomics.
Many transgenic zebrafish lines are available from ZIRC and can provide models of human
diseases. The sequenced genome with relatively high similarity to the human genome, ability for
genetic manipulation, and ability for high-throughput screening of drugs and toxicants are
advantages of the zebrafish model in toxicogenomic research.
1.3.4 Zebrafish in toxicology
Although zebrafish are also used for assaying organ system toxicology (Goessling et al., 2015),
investigating mechanisms of action (Peterson et al., 2012), and evaluating ecotoxicity and
environmental toxicants (Bambino et al., 2017), in recent years, zebrafish have become a
workhorse model in chemical toxicity screening (Rennekamp et al., 2015), drug development
(Gibert et al., 2013), and developmental neurotoxicity (Bailey et al., 2013; Nishimura et al.,
2015a). The zebrafish model performs comparably to mammalian models in developmental
toxicity assays. As reviewed by Sipes et al. (2011), the concordance between zebrafish and
mammalian models in evaluating chemicals for developmental toxicity is 55-100% (Brannen et
al., 2010; Padilla et al., 2011; Selderslaghs et al., 2009). However, in screens of known fetotoxic
substances, assays with rats identified 79%, rabbits 75%, and mice 75% of chemicals, though the
concordance between the rats, rabbits, and mice is only 56% (Hurtt et al., 2003). The percent
concordance across the mammalian species suggests that the response of zebrafish is on par with
mammalian models of toxicity and supports the utility of the zebrafish model in toxicology
research.

1.4

Zebrafish Neurotransmission

Neurotransmission is the basis of neuronal communication and is critical for normal brain
development, behavior, learning and memory, and even maintenance of life. The nervous system
is exceedingly complex, and many enzymes, transporters, and receptors all work in concert to
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maintain these functions. Neurotransmission can be altered by exposure to drugs,
pharmaceuticals, chemotherapeutic agents, radiation, food additives, and environmental toxicants
including pesticides and heavy metals ((Kaplan et al., 2016; Megha et al., 2015) and as reviewed
by (Andersen et al., 2000; Costa, 1988; Grandjean et al.; Parng et al., 2007). Alterations in
neurotransmission have been linked to a number of diseases including movement disorders,
neuropsychiatric disorders, and depression (reviewed by (Beitz, 2014; Sarter et al., 2006; Werner
et al., 2010).
Zebrafish share the common neurotransmitter pathways with mammals and have similar
neuroanatomy in many areas such as the spinal cord, hindbrain and retina, but as the brain
develops by eversion rather than inversion, some classical regions of the mammalian brain, such
as the hippocampus, amygdala, and substantia nigra, are not present as such in zebrafish. The
function of these areas appears to be maintained elsewhere in the brain, allowing functional
comparisons between zebrafish and mammals (Cheng et al., 2014). As an additional resource,
Mueller and Wullimann have recently published a second edition of their “Atlas of Early
Zebrafish Brain Development”, which characterizes neuronal development and provides
excellent figure panels for neuroanatomy (Mueller et al., 2016). Although the neurochemistry of
zebrafish has been reviewed previously (Panula et al., 2010; Rico et al., 2011), this section will
focus on the comparative anatomy and function of the major modulatory neurotransmitter
systems in zebrafish.
1.4.1 Neurotransmitters
Zebrafish share the common neurotransmitter systems with other vertebrates, and therefore can
serve as a model system for neurotoxicity. Although there are many more similarities than not,
there are some noteworthy differences between mammals and zebrafish within the
neurotransmitter systems, mainly in the number and name of genes encoding proteins, as a result
of the teleost gene duplication event. In general, the synthesis and metabolism pathways are
shared between the brain of mammals and teleosts. The major shared modulatory
neurotransmitter systems are reviewed and differences in relevant genes, anatomy, and
physiology are highlighted below.
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1.4.2 Catecholamines
Dopamine, norepinephrine, and epinephrine are the major catecholamine neurotransmitters.
Structurally, this group is characterized by a catechol group (benzene group with two adjacent
hydroxyl groups), with an ethylamine side chain and an amine group. Catecholamines are
considered modulatory neurotransmitters and have been linked to reward, movement, memory,
and neuropsychiatric disorders (Goldman-Rakic, 1998; Howes et al., 2012; Schultz, 2013).
Catecholamines are formed from the amino acid tyrosine and oxygen. Tyrosine
hydroxylase (tyrosine 3-monooxygenase; TH) is the first enzyme in the synthesis pathway and is
the rate limiting step. TH produces 3,4-dihydroxyl-l-phenylalanine (L-DOPA) with (6R)-Lerythro-tetrahydrobiopterin (BH4) and Fe2+ acting as cofactors in the hydroxylase step
(Daubner et al., 2011). L-DOPA is converted to dopamine (DA) by the enzyme aromatic amino
acid decarboxylase (AAAD), also known as DOPA decarboxylase (Cho et al., 1997). AAAD is
the preferred enzyme name as AAAD is also important in the monoamine serotonin synthesis
pathway (Scimemi, 2014). Although TH immunoreactivity is considered specific for
dopaminergic neurons, AAAD can be found in non-monoamine producing neurons and glial
cells. AAAD can also alternatively produce trace amines such as tryptamine, tyramine, and 2phenylethylamine (Gnegy, 2012).
In noradrenergic and adrenergic neurons DA is converted to norepinephrine (NE) by
dopamine-β-hydroxylase (dopamine β-monooxygenase; DBH) and NE can be further modified
by phenylethanolamine-N-methyltransferase (PNMT) to epinephrine (EP). Catecholamines are
transported into vesicles through members of the SLC18 family, namely SLC18A2 (also known
as VMAT2) in the brain (as reviewed by (Benarroch, 2013; Lawal et al., 2013)). SLC18A2 can
transport serotonin and histamine as well as catecholamines. Dopamine and norepinephrine
transporters belong to the SLC6 family of carriers, with, at least in mammals, SLC6A2
functioning as the norepinephrine transporter (NET), and SLC6A3 as the dopamine transporter
(DAT) (Rudnick et al., 2014).
Catecholamines are metabolized by a monoamine oxidase (MAO) enzyme. In humans,
there are two isoforms of MAO in mammals, MAO-A and MAO-B, with different substrate
specificity, pharmacology, and anatomic localization (Shih et al., 1999). The catecholamine
substrates are degraded into aldehydes, and aldehyde dehydrogenase and aldehyde reductase
further degrade the products into alcohols or glycols respectively. Catechol-O-methyltransferase
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(COMT) adds a methyl group to catecholamines and their metabolites, which assists in
elimination of the neurotransmitters and their metabolites. A major DA metabolite is 3,4dihydroxyphenylacetic acid (DOPAC), which is the product of MAO and aldehyde
dehydrogenase. DOPAC can be further metabolized by COMT to form homovanillic acid
(HVA). Norepinephrine is mostly metabolized by MAO and aldehyde reductase, forming 3,4dihydroxyphenylglycol (DHPG). Likewise, DHPG can be further metabolized to 3-methoxy-4hydroxyphenylgylcol (MHPG) (Gnegy, 2012).
Catecholamines bind to G-protein-coupled receptors to modulate neurotransmission. As
reviewed by Callier et al., there are five dopaminergic receptors in mammals: D1–D5, with D1
and D5 (D1-like) and D2–D4 (D2-like) sharing similar mechanisms (Callier et al., 2003). D1like receptors classically activate Gs G-proteins causing an increase in cAMP while D2-like
activate Gαi/Go G-proteins which inhibits adenylyl cyclase activity (Missale et al., 1998).
Beaulieu et al. extensively reviewed the mechanisms of dopamine receptor signaling (Beaulieu
et al., 2015). Norepinephrine has nine receptors organized into three families, α1, α2, and β, each
containing three receptors. α1 receptors activate Gq/G11 proteins and activate phospholipase C
and increase intra cellular calcium and protein kinase C activation. The α2 adrenergic receptors
are coupled to Gi/Go proteins and inhibit adenylyl cyclase and stimulate phospholipase A2. The β
adrenergic receptors are coupled to Gs and activate adenylyl cyclase (Gnegy, 2012).
Originally two Th encoding paralogs were identified in teleosts, th1 and th2 (Candy et
al., 2005). th1-negative, th2-positive neurons were identified in zebrafish brain (Filippi et al.,
2010; Yamamoto et al., 2010, 2011) and although these neurons appeared to be immunoreactive
for slc18a2 (vmat2), aaad, and slc6a3 (dat), consistent with a dopaminergic phenotype, it was
discovered that the gene encoded by th2 appears to function as a tryptophan hydroxylase when
isolated in vitro (Ren et al., 2013; Yamamoto et al., 2011). Therefore, th1 is referred to as th by
the Zebrafish Information Network (ZFIN) and is considered the only Th in zebrafish. Currently,
only one ortholog of AAAD (aaad), DBH (dbh), and of the transporters SLC18A2 (slc18a2),
SLC6a2 (slc6a2), and SLC6A3 (slc6a3) have been identified. Although mammals have two
isozymes, MAO-A and MAO-B, zebrafish have only one paralogous enzyme, Mao (also known
as Zmao) (Setini et al., 2005b). Zebrafish Mao may have a structure and function more similar to
MAO-A, but is inhibited by deprenyl, a MAO-B specific inhibitor (Anichtchik et al., 2006;
Sallinen et al., 2009). Two putative COMT genes have been identified, comta and comtb.
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However, the gene products have not been fully characterized, and some protein products may
not be functional (Alazizi et al., 2011; Panula et al., 2010). Table 1 outlines known paralogs of
dopamine and adrenergic receptors (Ruuskanen et al., 2005; Sprague et al., 2006). The receptor
genes drd1a and drd1b likely have D1-like activity and the other receptor genes likely have D2like functions (Ruuskanen et al., 2005).
In order to help compare neuroanatomy between species, dopaminergic populations have
been labeled numerically based on rostral to caudal location in the brain. As reviewed by
Schweitzer et al. (2012), Rink and Wullimann (2002) labeled the dopaminergic populations 1-8
in larvae and 0-8 in adults, with 0 representing the ventral thalamic area. Sallinen et al. (2009)
used a 17 population classification scheme. Both classification systems localize dopaminergic
neurons to the olfactory bulb, subpallium, posterior tuberculum, hypothalamus, and pretectum
(Schweitzer et al., 2012). Zebrafish brain lack a substantia nigra and ventral tegmental area,
however, the posterior tuberculum has populations of dopaminergic cells with projections that
extend to the subpallium and spinal cord (Becker et al., 1997; Rink et al., 2001). Figure 1.4
outlines the locations of the modulatory neurotransmitters in humans and zebrafish.
Neurons producing dopamine or norepinephrine also produce either glutamate or γaminobutyric acid (GABA) and therefore have two transmitter profiles. Dopaminergic neurons in
the dopaminergic posterior tubercular groups 2, 4, and 6 and hypothalamic group 5 and some
norepinephrine producing cells in the area postrema produce glutamate and all other dopamine or
norepinephrine producing neurons produce GABA (Filippi et al., 2014).
DBH, the enzyme that converts dopamine to epinephrine, is also present and is used as a
marker of adrenergic neurons. Dbh is only found in zebrafish hindbrain, specifically at the locus
coeruleus (Ma, 1997; McLean et al., 2004). The locus coeruleus projects to the pallium, the
subpallium and the thalamus (Kaslin et al., 2001; Ma, 1994).

Table 1.1 Zebrafish genes involved in catecholamine neurotransmission
Common Name
Tyrosine hydroxylase
Aromatic amino acid decarboxylase
Dopamine-β-hydroxylase
Phenylethanolamine-N-methyltransferase
Vesicular monoamine transporter 2 (VMAT2)
Dopamine transporter (DAT)
Norepinephrine transporter (NET)

Human
TH
AAAD
DBH
PNMT
SLC18A2
SLC6A3
SLC6A2

Catechol-O-methyltransferase

COMT
DRD1
DRD2

Dopamine Receptors

DRD3
DRD4
DRD5
ADRA1A
ADRA1B

Adrenergic Receptors

ADRA1D
ADRA2
ADRA2B
ADRA2C

ADRB1
ADRB2
ADRB3

Zebrafish
th
aaad
dbh
pnmt
slc18a2
slc6a3
slc6a2
comta
comtb
drd1a
drd1b
drd2a
drd2b
drd2l
drd3
drd4a
drd4b
drd5a
drd5b
adra1aa
adra1ab
adra1ba
adra1bb
adra1d
adra2a
adra2b
adra2c
adra2da
adra2db
adrb1
adrb2a
adrb2b
adrb3a
adrb3b

Gene ID
30384
406651
30505
100332609
553304
80787
565776
561372
565370
792634
568126
282557
378719
378718
282554
503564
503565
100536970
798498
557259
100149100
492486
568614
266750
266751
266752
266754
266755
557194
565838
100037315
558248
792519

RefSeq
NM_131149
NM_213342
NM_001109694
XM_002666341
NM_001256225
NM_131755
XM_689046
NM_001030157
NM_001083843
XM_017359120
NM_001135976
NM_183068
NM_197936
NM_197935
NM_183067
NM_001012616
NM_001012618
XM_003199767
NM_001324454
XM_680297
XM_001921978
NM_001007358
XM_691951
NM_207637
NM_207638
NM_207639
NM_194364
NM_194365
NM_001128689
NM_001102652
NM_001089471
NM_001128335
NM_001135134

ZFIN ID
ZDB-GENE-990621-5
ZDB-GENE-040426-2656
ZDB-GENE-990621-3
ZDB-GENE-080514-1
ZDB-GENE-010316-1
ZDB-GENE-110408-4
ZDB-GENE-050913-117
ZDB-GENE-040724-164
ZDB-GENE-130522-1
ZDB-GENE-070524-2
ZDB-GENE-021119-2
ZDB-GENE-030910-2
ZDB-GENE-030910-1
ZDB-GENE-021119-1
ZDB-GENE-070112-996
ZDB-GENE-070508-3
ZDB-GENE-130522-2
ZDB-GENE-130522-3
ZDB-GENE-030131-2831
ZDB-GENE-060503-384
ZDB-GENE-120510-1
ZDB-GENE-041114-51
ZDB-GENE-090312-203
ZDB-GENE-021010-1
ZDB-GENE-021010-2
ZDB-GENE-021010-3
ZDB-GENE-021010-4
ZDB-GENE-021010-5
ZDB-GENE-081022-145
ZDB-GENE-100414-3
ZDB-GENE-070410-32
ZDB-GENE-080917-21
ZDB-GENE-081022-154
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Figure 1.4. Distribution of Modulatory Neurotransmitters in the Zebrafish and Human Brain. (A) Distribution of DA
in the zebrafish (left) and human (right) brains (red); (B) Distribution of NE in zebrafish (left) and human (right)
brains (blue); (C) Distribution of 5-HT in zebrafish (left) and human (right) brains (green); (D) Distribution of ACh
in zebrafish (left) and human (right) brains (yellow); (E) Distribution of histamine in zebrafish (left) and human
(right) brains (purple). Brains are not to scale with some simplification of systems that are represented. DA,
dopamine; NE, norepinephrine; 5-HT, serotonin; ACh, acetylcholine. Neurotransmitter distributions synthesized
from (Barreiro-Iglesias et al., 2013; Dalley et al., 2012; Haas et al., 2008; Panula et al., 2010; Panula et al., 2014;
Parker et al., 2013; Perry et al.; Tomkins et al., 2001).
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1.4.3 Serotonin
The neurotransmitter serotonin (5-hydroxytrptamine; 5-HT) is a biologic amine. 5-HT has an
indole nucleus with a hydroxyl group and an amine group. L-tryptophan is the base of the
molecule, with dietary protein being the major source. 5-HT is a modulatory neurotransmitter
and has been associated with brain development, appetite, motor function, arousal and mood,
neuroendocrine function, circadian rhythms, and depression (Daubert et al., 2010; Gaspar et al.,
2003; Lucki, 1998; Parsey, 2010).
The first enzyme in the 5-HT synthesis pathway is tryptophan hydroxylase (Ltryptophan-5-monooxygenase; TPH), which converts tryptophan to 5-hydroxytryptophan (5HTP). The conversion of tryptophan to 5-HTP is considered the rate limiting step in the synthesis
pathway and is unique to serotonergic neurons. In mammals there are two genes that code for
TPH. TPH1 is expressed in the periphery and TPH2 is expressed exclusively in the brain and can
be used as a marker for serotonergic neurons (Walther et al., 2003). Once formed, 5-HTP is
quickly converted to 5-HT by AAAD.
5-HT is transported into synaptic vesicles by vesicular transporter SLC18A2 (VMAT2)
and released from the vesicle via exocytosis (Mohammad-Zadeh et al., 2008). The serotonin
transporter SLCl6A4 (also known as SERT) is responsible for the uptake/reuptake of 5-HT,
although glia and non-serotonergic neurons can take up serotonin through organic cation
transporter (OCT), plasma membrane monoamine transporter (PMAT), or through SLC6A2 or
SLC6A3 (NET and DAT, respectively) (Hensler, 2012).
5-HT is metabolized by MAO to 5-hydroxy-indolecetaldehyde which is rapidly
metabolized by an aldehyde dehydrogenase to form 5-hydroxyindoleacetic acid (5-HIAA), the
major metabolite of 5-HT (Hensler, 2012).
In mammals there are three families of 5-HT receptors (HTR) that act through Gproteins, the 5-HT1 family, the 5-HT2 family, and a family that includes the 5-HT4, 5-HT6, and 5HT7 receptors (Parsey, 2010). 5-HT3 is a cation specific ligand-gated ion channel and is
considered its own family (Hensler, 2012). The 5-HTR1 family generally acts to inhibit adenylyl
cyclase through the Gi/o family of G proteins while the 5-HTR2 family acts through Gq/11 family
G proteins by stimulating phospholipase C. The 5-HTR4, 5-HTR6, and 5-HTR7 family mainly act
through the Gs family G proteins to stimulate adenylyl cyclase (Nichols et al., 2008).
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As a result of the teleost gene duplication event, zebrafish have four paralogous genes
encoding TPH, although the nomenclature has not been standardized. Bellipanni et al. (2002)
first identified two paralogs of TPH in the developing zebrafish brain, tphD1, expressed in the
preoptic nuclei and the posterior tubercular in the diencephalon, and tphD2, expressed in the
pineal gland and transiently in the preoptic nuclei. Teraoka et al (2004) identified a third paralog
of Tph, tphR, expressed in the raphe nuclei and pineal gland. In later reviews of the serotonin
neurotransmitter system, these genes are referred to as tph1a, tph1b, and tph2, respectively
(Herculano et al., 2014; Lillesaar, 2011; Lillesaar et al., 2007). Further research found that
zebrafish th2 encodes for a fourth tph gene in the ventral diencephalon and caudal hypothalamus
(Ren et al., 2013). This gene has also been called tph3 to better reflect its function (Herculano et
al., 2014). As mentioned previously, zebrafish have only one ortholog of AAAD and MAO (Setini
et al., 2005a). There are two paralogs of the serotonin transporter gene SLC6A4, slc6a4a and
slc6a4b (Norton et al., 2008). In mammals, over 15 HTR genes have been identified. Table 2
outlines the critical genes in serotonin synthesis and metabolism as well as listing known
paralogous genes for the serotonin HTR receptor families (Sprague et al., 2006).
Table 1.2. Zebrafish genes involved in serotonin neurotransmission.
Common Name
Tryptophan
hydroxylase

Human
TPH1
TPH2

Zebrafish
tph1a
tph1b
tph2
tph3/th2

Gene ID
352943
415103
407712
414844

RefSeq
NM_178306
NM_001001843
NM_001310068
NM_001001829

ZFIN ID
ZDB-GENE-030317-1
ZDB-GENE-030805-6
ZDB-GENE-040624-4
ZDB-GENE-050201-1

Aromatic amino acid
decarboxylase

AAAD

aaad

406651

NM_212827

ZDB-GENE-040426-2656

Monoamine oxidase

MAO-A,
MAO-B

mao

404730

NM_001039972

ZDB-GENE-040329-3

Serotonin
Transporter (SERT)

SLC6A4

slc6a4a
slc6a4b
htr1aa
htr1ab
htr1b
htr1d
htr1fa
htr2a
htr2b
htr2cl1
htr2cl2
htr3a
htr3b
htr5a
htr5al
htr6
htr7

664719
664770
100001828
797538
561647
556429
100005344
560808
751784
100000981
798599
571641
571632
100038775
368475
568269
562111

NM_001177459
NM_001123321
NM_001145766
NM_001128709
NM_001145686
NM_001145686
XM_017357893
NM_001044743
NM_001044743
XM_001339004
XM_001339004
XM_009295409
NM_001126410
NM_001007121
XM_009297078
XM_685507
NM_178306

ZDB-GENE-060314-1
ZDB-GENE-060314-2
ZDB-GENE-071203-1
ZDB-GENE-090409-2
ZDB-GENE-081022-141
ZDB-GENE-090409-3
ZDB-GENE-081105-125
ZDB-GENE-070912-500
ZDB-GENE-081022-57
ZDB-GENE-081104-48
ZDB-GENE-120215-109
ZDB-GENE-071012-5
ZDB-GENE-071012-4
ZDB-GENE-060531-129
ZDB-GENE-030616-574
ZDB-GENE-030131-7839
ZDB-GENE-130530-666

HTR1a
HTR1b

HTR2
Serotonin Receptors

HTR2CL1
HTR2CL2
HTR3
HTR5
HTR5-like
HTR6
HTR7
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As reviewed by Lillesaar (2011), in larval zebrafish 5-HT positive cells are located in the
pineal gland, the pretectum, the posterior tuberculum, the hypothalamus, and the superior and
inferior raphe. Panula et al. (2010) outlined a labeling scheme for the adult zebrafish with
serotoninergic nuclei identified in the pretectal complex, the anterior, intermediate, and posterior
paraventricular organ nuclei, the dorsal, median, and ventrolateral raphe, the inferior raphe, and
the caudal raphe (Herculano et al., 2014; Panula et al., 2010). Adult zebrafish also have scattered
serotonergic neurons within the medulla oblongata (Kaslin et al., 2001). The distribution of 5-HT
in the zebrafish brain compared to humans is shown in Figure 1.4C.
When identifying serotonergic populations, the Ets-domain transcription factor pet1
(pheochromocytoma 12 ETS [E26 transformation-specific]) is a specific developmental marker
of the raphe serotonergic nuclei (Lillesaar et al., 2007). TPH is typically used as the serotonergic
specific marker in imaging studies (Lillesaar, 2011).
1.4.4 Acetylcholine
Acetylcholine (ACh) is the major neurotransmitter in the parasympathetic nervous system and is
the neurotransmitter at neuromuscular junctions (Picciotto et al., 2012). Additionally, ACh
neurotransmission is widespread in the CNS and can help modulate the release of other
neurotransmitters such as GABA, and has been implicated in arousal, reward, and learning and
memory (Alkondon et al., 1996; Kenney et al., 2010; Picciotto et al., 2012).
ACh is formed from acetyl-CoA and choline via choline acetyltransferase (ChAT). Two
SLC family transport systems, a high affinity (SLC5A7; HAChU) and a low affinity (SLC44
family; LAChU), concentrate choline in terminals to provide a reserve for ACh synthesis. SLC44
is present ubiquitously throughout the body, but SLC5A7 is only found in cholinergic nerve
termini (Fisher et al., 2012). The rate of SLC5A7 transport is regulated by the rate of ACh
release and SLC5A7 is the rate limiting step in ACh production. Once ACh has been synthesized
by ChAT it is packaged into vesicles by vesicular ACh transporter (VAChT) which is coded by
SLC18A3 (Lawal et al., 2013). ACh is then released in quanta into the synaptic cleft in a calcium
dependent manner. Unlike other neurotransmitters which have transporter mediated
uptake/reuptake to clear the synapse, ACh is metabolized by acetylcholinesterase (AChE) within
the synaptic space and broken into acetate and choline (Fisher et al., 2012).
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There are two major types of cholinergic receptors, nicotinic (nAChR) and muscarinic
receptors (mAChR). The receptors were respectively named after nicotine and muscarine, their
drug agonists. nAChRs are a member of the cys-loop family of ligand-gated ion channel
receptors and are formed by combinations of receptor subunits (Fisher et al., 2012; Yakel, 2013).
In mammals, there are 17 nicotinic receptor subunits including muscle and neural specific
subunits. nAChRs are located throughout the brain, though many subtypes of nAChR are located
on presynaptic termini or cell bodies and function to modulate neurotransmitter release
(Alkondon et al., 1996). mAChRs are G-protein-coupled receptors and are located throughout
the CNS and PNS. There are five subtypes of mAChR receptors in mammals, M1-M5. M1, M3,
and M5 couple to Gq/11 family proteins to increase phospholipase C. M2 and M4 receptors act to
decrease adenylyl cyclase through Gi/Go receptor activation. mAChR are expressed throughout
the brain, but are not uniformly distributed (reviewed by Brown (2010)).
The important genes in the cholinergic system are outlined in Table 3. Zebrafish have
two paralogs of the HAChU SLC5A7 (slc5a7a and slc5a7b), although slc5a7b has not been well
described. The gene that produces ChAT has two paralogs in zebrafish, chata and chatb.
slc18a3a and slc18a3b are two paralogs of SLC18A3 (VAChT). There is only one paralog of
ACHE (ache). Currently, there are 12 putative genes encoding nAChR subunits in zebrafish and
10 putative paralogs of mAChR (Papke et al., 2012; Williams et al., 2004; Zirger et al., 2003).
Cholinergic neurons have been identified through immunohistochemical staining against
choline-acetyltransferase (ChAT) (Kaslin et al., 2004; Mueller et al., 2016b). In zebrafish,
cholinergic neurons are found in both the brain and spinal cord, specifically in the octavolateralis
cells and modulatory or sensory neurons, the ventral telencephalic area, the central, dorsal, and
subcommissural nuclei of the ventral telencephalic areas, the preoptic area, dorsal thalamus,
pretectal nuclei, hypothalamus, optic tectum, and tegmentum (Arenzana et al., 2005; Clemente et
al., 2004; Kaslin et al., 2001; Mueller et al., 2004). The distribution of ACh in zebrafish and
human brains is shown in Figure 1.4D.
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Table 1.3. Zebrafish genes involved in cholinergic neurotransmission.
Common Name
High-affinity choline
transporter
Choline
acetyltransferase
Vesicular
ACh
transporter (VAChT)
Acetylcholinesterase

Human
SLC5A7
CHAT
SLC18A3
ACHE
CHRNA1
CHRNA2
CHRNA3

Nicotinic Cholinergic
Receptors

CHRNA4
CHRNA5
CHRNA6
CHRNA7
CHRNA9
CHRNA1
0
CHRM1
CHRM2

Muscarinic
Cholinergic Receptors

CHRM3
CHRM4
CHRM5

Zebrafish
slc5a7a
slc5a7b
chata
chatb
slc18a3a
slc18a3b
ache
chrna1
chrna2a
chrna2b
chrna3
chrna4a
chrna4b
chrna5
chrna6
chrna7
chrna9
chrna10a
chrna10b
chrm1a
chrm1b
chrm2a
chrm2b
chrm3a
chrm3b
chrm4a
chrm4b
chrm5a
chrm5b

Gene ID
100005589
100170938
103171573
559347
394082
114549
30725
678575
568849
568467
556619
550584
555747
394199
568807
556507
792708
794658
352938
555516
571679
100149598
100150701
553978
561491

RefSeq
XM_005159931
NM_001130719
NM_001291882
NM_001077550
NM_201107
NM_131846
NM_131445
NM_001040327
XM_692206
XM_001921279
NM_001048063
NM_001017885
NM_001042684
NM_201219
XM_001920859
NM_001044804
XM_001332257
NM_178301
NM_178301
XM_678041
XM_695289
XM_001919125
XM_001922407
NM_001020803
NM_001030160

ZFIN ID
ZDB-GENE-090313-273
ZDB-GENE-140429-1
ZDB-GENE-080102-2
ZDB-GENE-140429-2
ZDB-GENE-060929-990
ZDB-GENE-040426-1410
ZDB-GENE-010906-1
ZDB-GENE-980526-137
ZDB-GENE-040108-2
ZDB-GENE-041001-99
ZDB-GENE-070822-1
ZDB-GENE-130530-903
ZDB-GENE-090505-3
ZDB-GENE-050417-440
ZDB-GENE-090312-91
ZDB-GENE-040108-3
ZDB-GENE-090312-63
ZDB-GENE-060503-725
ZDB-GENE-130530-624
ZDB-GENE-090410-9
ZDB-GENE-070705-188
ZDB-GENE-030314-1
ZDB-GENE-090410-3
ZDB-GENE-090410-4
ZDB-GENE-090410-5
ZDB-GENE-090410-6
ZDB-GENE-090410-7
ZDB-GENE-080723-32
ZDB-GENE-041001-169

1.4.5 Histamine
Histamine is a signaling molecule present in many tissues, serving functions in the stomach,
skin, and immune systems. Histamine also has a role in neurotransmission (Haas et al., 2003).
Within the CNS, histamine is associated with wakefulness, feeding and drinking, and learning
and memory (Haas et al., 2008; Schwartz et al., 1991; Sundvik et al., 2011).
The structure of histamine, 2-(4-imidazolyl)ethylamine, is similar to 5-HT, NE, and EP,
but histamine has an imidazole nucleus and therefore has tautomeric properties that may be
associated with receptor affinity. In mammals, mast cells of bone marrow origin reside in
perivascular spaces, choroid plexus, and meninges and can produce significant amounts of
histamine within the brain although the only neurons that produce histamine are located within
hypothalamic tuberomamilary neurons within the posterior hypothalamus (Leurs et al., 2012).

21
Zebrafish, on the other hand, do not have stores of histamine outside of the brain, suggesting any
histamine is of importance to neurotransmission (Eriksson et al., 1998; Haas et al., 2008). The
periventricular cells of the caudal hypothalamus are the only cell group that contains
histaminergic neurons in zebrafish brain, similar to mammals, although the axons project
throughout the CNS (Eriksson et al., 1998; Kaslin et al., 2001). These histamine producing
neurons also contain other signaling molecules including GABA, neuropeptides, and thyrotropinreleasing hormone (Onodera et al., 1994).
Histamine is synthesized by L-histidine decarboxylase (HDC). The rate of biosynthesis is
controlled by the availability of L-histidine and the rate limiting enzyme, HDC. Once formed,
histamine is transported into vesicles by SLC18A2 (VMAT2) (Kukko-Lukjanov et al., 2003).
Most histamine in the brain is released via non-synaptic mechanisms and often acts on both
presynaptic and postsynaptic receptors. There is no evidence of a neuronal histamine transporter
(Leurs et al., 2012).
The metabolism of histamine can occur either by diamine oxidase (DAO; amine oxidase
AOC1), which oxidizes histamine to imidazole acetic acid (IAA), or by histamine Nmethyltransferase (HNMT), which methylates histamine and forms tele-methylhistamine (t-MH)
and is then further metabolized by MAO (MAO-B in mammals) to tele-methylimidazole acetic
acid (t-MIAA). The methylation metabolism pathway is more common in vertebrate brains and
HMT is widely distributed throughout the brain (Leurs et al., 2012; Schwartz et al., 1991).
Mammals have four histamine receptors that are found in the brain, H1, H2, H3, and H4.
H1 and H2 are considered excitatory while H3 is inhibitory and often acts as an autoreceptor. H4
is the most recently discovered but does appear to localize to the brain (Connelly et al., 2009).
Histamine receptors are linked to G proteins in both neurons and glia. H1 receptors are linked to
Gq and stimulate phospholipase C. H2 receptors may couple with Gq or Gs but act through the
stimulation of adenylyl cyclase. H3 receptors are linked to Gi/o and inhibit adenylyl cyclase. H3
receptors may also activate MAPK, Akt/GSK-3β, and phospholipase A2 pathways (Drutel et al.,
2001; Giovannini et al., 2003; Mariottini et al., 2009). The H4 receptor is similar to the H3
receptor and acts through Gi/o proteins to inhibit adenylyl cyclase (Connelly et al., 2009).
In zebrafish there is one ortholog each of HDC (L-histidine decarboxylase), AOC1
(diamine oxidase), and HNMT (histamine N-methyltransferase) (Table 4). To date, there are four
known genes in zebrafish that code for histamine receptors, hrh1, hrh2a, hrh2b, and hrh3
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(Peitsaro et al., 2007). In zebrafish, histamine containing neurons have been localized only to the
ventrocaudal hypothalamus, though the projections are widespread (Kaslin et al., 2001; Sundvik
et al., 2012). The distribution of histamine in the zebrafish brain compared to humans is shown
in Figure 1.4E.

Table 1.4. Zebrafish genes involved in histamine neurotransmission.
Common Name
L-Histidine decarboxylase
Amine oxidase
Histamine N-methyltransferase

Human
HDC
AOC1
HNMT
HRH1

Histamine Receptors

HRH2
HRH3

1.5

Zebrafish
hdc
aoc1
hnmt
hrh1
hrh2a
hrh2b
hrh3

Gene ID
793609
555401
445242
735302
735303
100005590
561773

RefSeq
NM_001102593
NM_001077598
NM_001003636
NM_001042731
NM_001045338
NM_001109738
NM_001025518

ZFIN ID
ZDB-GENE-080102-5
ZDB-GENE-061103-112
ZDB-GENE-040801-157
ZDB-GENE-070531-3
ZDB-GENE-070531-4
ZDB-GENE-070928-20
ZDB-GENE-040724-204

Evaluation of Neurotoxicity

The neurotransmitter systems can serve as targets of chemical toxicity. The individual enzymes,
transporters, and receptors may be altered by chemical toxicants through changes in gene
expression or changes in activity of the enzyme or receptor. Multiple methods can be used to
evaluate neurotransmitter systems in zebrafish, from the measuring of neurotransmitter levels in
the brain, to toxicogenomic evaluations of the epigenome, the transcriptome, and the proteome,
to the functional testing of behavioral assays. These methods are reviewed below.
1.5.1 Evaluation of Neurotransmitters
In the evaluation of chemical toxicants, measuring neurotransmitter levels can provide
information on the functional alterations in the brain resulting from chemical treatment. The
quantity of neurotransmitters can be measured in the zebrafish brain. Sallinen et al. (2009) and
Chattererjee et al. (2009) have both described methods for measuring neurotransmitter levels via
high performance liquid chromatography (HPLC) that have been modified and used in other
laboratories (Milanese et al., 2012; Wirbisky et al., 2014).
Experimental neurotransmitter results may be comparable within one laboratory, but not
comparable across multiple laboratories due to differences in experimental methods and
equipment used. Furthermore, one difficulty in comparing neurotransmitter levels across studies
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and laboratories is the lack of reference intervals and the tendency to normalize neurotransmitter
values to controls rather than reporting absolute values, which limits comparison. For example,
Pan et al. (2012) reported the difference in neurotransmitter levels between the AB and short-fin
wildtype strains of zebrafish as a ratio between zebrafish strains, rather than average
concentration. Table 5 lists reported neurotransmitter levels from control zebrafish. Comparison
of values in the table is difficult between studies in part to different methodologies used for
normalization. Neurotransmitter levels can be normalized to protein content or number of fish
pooled for the sample, and it is difficult to equate between the two methods.

Table 1.5 Reported neurotransmitter levels in control zebrafish brain
Reference
(age, sex, and strain if known)
Adult Zebrafish
Panula et al. (2010)
(Sex, age, and strain unknown)
López Patiño et al. (2008)
(Male and female 9±1 mpf AB
wildtype)
Chatterjee and Gerlai (2009)
(Male and female 90 dpf AB
wildtype)
Embryonic / Larval Zebrafish
Wirbisky et al. (2014)
(Embryos raised at 28.5°C)

Tufi et al. (2016)
(Embryos raised at 26°C)

Glutamate

GABA

DA

NE

2.09±0.42
nmol/g
1.5-2
pg/ug
protein
4.18±0.28
ng/mg
protein

4.53±0.97
nmol/g

5-HT

ACh

7.2±0.01
pg/embryo
(48 hpf)
7.1±0.1
pg/embryo
(72 hpf)

3.0±0.1
pg/embyro
(48 hpf)
4.0±0.1
pg/embyro
(72 hpf)

78.31±2.26
ng/fish
(48 hpf)
99.17±6.54
ng/fish
(72hpf)
9.1±0.5
ng/embryo
(48 hpf)
12±0.3
ng/embryo
(72 hpf)

1.8±0.03
ng/embryo
(48 hpf)
2.2±0.1
ng/embryo
(72 hpf)

Other methods for the measurement of neurotransmitters include an analytical method described
by Tufi et al. (2016) of hydrophilic interaction liquid chromatography (HILIC) coupled to
tandem mass spectrometry (MS/MS) that has been used to measure neurotransmitter levels in
zebrafish larvae. The levels of neurotransmitters and major metabolites were measured in 0-6 dpf
zebrafish larvae. Additionally, Jones et al. (2015) describe a technique to detect neurotransmitter
release and reuptake in brain tissue slices through fast scan cyclic voltammetry (FSCV).
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1.5.2 Evaluation of Toxicogenomics
Toxicogenomics has been defined as ‘the study of the structure and output of the entire genome
as it relates and responds to adverse xenobiotic exposure (Hamadeh et al., 2004). When
considering the genome, DNA nucleotides and the genetic code often first come to mind.
However, toxicogenomics encompasses the study and evaluation of the genome (genomics);
alterations in DNA methylation, histone modifications, and microRNA expression (epigenome);
gene expression (transcriptome); alterations in protein levels (proteome); and changes in
metabolites and small molecules (metabolome) as well as the up- and downregulation, feedback,
and interactions of the various ‘-omes’ with one another (Figure 1.5).

Figure 1.5. Components of toxicogenomics and the relationship between -omics.

The goal of toxicogenomics is to understand the effects of toxic exposures
comprehensively and not just in an isolated system or pathway. The advantage of
toxicogenomics is the ability to evaluate essentially the global state of the cell, tissue, or
organism and identify differences between treated and untreated samples. This whole genome
approach allows for the identification of pathways and genes altered after xenobiotic exposure
that can suggest the mechanisms of action of toxicity or unconsidered xenobiotic targets.
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1.5.3 Definitions
The suffix ‘-ome’ as used in molecular biology, such as found in genome or proteome, is a neosuffix added to a root word to imply totality. The suffix ‘-omics’ then is a study of a subject in
totality. Although these terms can be added to any subspecialty in biology or toxicology, as can
be found frequently in the literature, this section will focus on the defining the major fields of
genomics, epigenomics, transcriptomics, proteomics, and metabolomics.
Genomics, by definition, is the study of the genome. In the simplest form, this is the
study of the genetic code formed by DNA. The field of genomics then seeks to explain health
and disease by evaluating DNA for unique genetic variants, mutations caused by xenobiotics, or
genes associated with certain outcomes. In a broader sense, genomics is also an umbrella term
that describes further downstream products of DNA, such as messenger ribonucleic acid
(mRNA) and proteins, which are transcribed and translated from the genetic code.
Epigenomics is the study of the epigenome, which is the record of the reversible chemical
and biological alterations to DNA that effect the transcription or translation of a DNA sequence
without modifying the genetic code itself. DNA methylation, histone acetylation, and
microRNAs are systems for elucidating epigenomic alterations and are thus targets for
epigenomic evaluations. Another use of epigenomics is in multi- and transgenerational studies of
disease or toxicity as epigenetic alterations can be inherited.
The transcriptome is the sum of all RNAs in the cell, tissue, or organism. Although this
includes the collection of ribosomal ribonucleic acid (rRNA), transfer ribonucleic acid (tRNA),
small RNAs, and mRNA, mRNA is usually the target of transcriptomic analysis.
Transcriptomics studies the amount of mRNA transcripts to determine how genes are being
expressed and how this may be different in disease states or after xenobiotic exposure.
Proteomics studies the global amount, composition, and interaction of all proteins in a
given cell, tissue, or organism at a given time or circumstance. Proteomics techniques can
determine changes in protein levels associated with disease or toxicity as well as alterations in
protein modification states. Differences in protein modifications, such as glycosylation,
phosphorylation, and ubiquitination, can alter the fate and action of proteins and enzymes and
thus the action and health of the cells in tissues and organisms.
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Metabolomics is the comprehensive study of metabolites and small molecules in a cell,
tissue, or organism. Metabolites are intermediates and products of metabolism, and thus
metabolomics can determine alterations in metabolic function and the presence and quantity of
xenobiotic metabolites (Hasin et al., 2017).
Toxicology is the study of the adverse effects of chemical, physical, and biologic agents
on living organisms. The term xenobiotic is used to refer to a chemical substance that is foreign
to a biological system. Toxicology utilizes aspects of biology, chemistry, pharmacology, and
medicine to study the toxicokinetics and toxicodynamics of xenobiotic exposure.
Toxicogenomics is a portmanteau of toxicology and genomics, using the catch-all term of
genomics to imply the study of the alterations of the different ‘-omes’ that occur as a result of
xenobiotic exposure.
1.5.4 Transcriptomics
1.5.4.1 Introduction to the Transcriptome
The transcriptome is considered to be a snapshot of the complete population of mRNA
transcripts in a cell or population of cells, such as a tissue, organ, or organism (Morgan et al.,
2004). The transcriptome is dynamic, as mRNA is constantly being transcribed from DNA,
interacting with regulatory proteins, having post-transcriptional modifications, and being
translated to proteins. Some mRNA has a half-life of minutes while other mRNA may be stable
for over a day, with the median half-life of mRNA in mammals being 9 hours (Schwanhausser et
al., 2011). Therefore, mRNA profiles are time and condition dependent. Additional care should
be taken during sample collection, as stress due to handling during collection may alter the
transcriptome. Transcriptomics is the study of the transcriptome. The metric of transcriptomics is
typically referred to as gene expression, although technically most techniques used in
transcriptomic analysis measures the relative abundance of mRNA transcripts in a sample. Gene
expression refers to the fact that the rate of gene transcription or turnover may be altered in
different states, such as disease or after xenobiotic exposure.
Transcriptomics has been extensively incorporated into toxicologic research. In
toxicology, transcriptomics allows for the evaluation of differential gene expression between
treated and untreated groups. The differential gene expression can be used to determine possible
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pathways perturbed by xenobiotic exposure and thus the mechanisms of action of the xenobiotic.
Due to the dynamic nature of mRNA expression, the cellular response after an acute exposure to
a xenobiotic may be quite different from a chronic exposure and gene expression will reflect this.
1.5.4.2 Transcriptomic Techniques
The most commonly utilized zebrafish toxicogenomic method has been the cDNA microarray.
The ability to evaluate the transcriptome concurrently in control and treatment groups to find
differentially expressed genes is the main advantage of the technique. Other techniques to
evaluate mRNA abundance are qPCR, RNA-SAGE, and RNA-seq which uses next generation
technology.
1.5.4.2.1 cDNA Microarray
The cDNA microarray is a highly utilized tool in transcriptomic and toxicogenomic analyses.
The cDNA microarray, or just microarray, is a type of DNA microarray that uses probes
designed to hybridize with cDNA, or less commonly RNA. Numerous studies have combined the
zebrafish model with microarray technology in order to evaluate changes in gene expression
after xenobiotic exposure.
The term “microarray” refers to the technology, but also to physical “chip” used in the
technology. Multiple companies and laboratories have developed microarray technologies in
parallel, and as a result there are different methods used in the synthesis of microarray chips.
Microarrays can be assembled by spotting premade oligonucleotide probes onto a glass or nylon
substrate or by synthesizing the oligonucleotide probes on the surface of the substrate in situ. For
spotted microarrays, oligonucleotide sequences can be synthesized in the laboratory from
bacterial clone sets, amplified via PCR, or can be commercially purchased. The oligonucleotides
are then deposited by contact or through a piezoelectric, Inkjet method of delivery onto the
substrate surface, often with a robotic arm. For in situ synthesis, the basic principle is the
controlled, stepwise addition of nucleotides to form oligonucleotide probes. Competing array
manufacturers use physical methods, electrochemical methods, or photometric methods to add
monomers to the 5’ hydroxyl group of an elongating probe. Chains are capped by a protective
acetylene group to terminate elongation. Inkjet style printing allows selective addition of
monomers to specific substrate sites. Alternatively, all spots may be exposed to a certain
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monomer and a selective removal of the protecting acetylene through acid, electrochemical
methods, or UV light at desired locations can build the oligonucleotide probes (Hamadeh et al.,
2004).
Each chip can have tens of thousands to millions of probes that can interrogate thousands
of gene targets. In transcriptomics, the target is usually cDNA synthesized from an RNA sample.
A single cDNA target is represented by multiple oligonucleotide sequences, usually between 25
and 60 nucleotides long, on the array and each of the different oligonucleotide sequences has
multiple repetitions. The genes chosen for microarray analysis can represent a collection of genes
of interest or a wide selection of protein encoding genes from across the genome. Both Agilent
Technologies and ThermoFisher/Affymetrix, two of the main producers of commercial array
platforms make zebrafish specific arrays and custom zebrafish arrays are also available.
Samples for microarray analysis are collected from tissues of interest, or pooled whole
organisms in the case of embryonic or larval zebrafish samples. The RNA from the samples is
isolated and a reverse transcription step produces cDNA. Fluorescent dyes are commonly added
to the cDNA sample solutions to quantify the DNA target to array probe hybridization when
scanned. Fluorophores such as Cy3 or Cy5 are incorporated into the cDNA sample during the
process of reverse transcription from the original RNA sample. Microarrays can be run with one
or two added fluorophores, depending on the samples used and the goal of the analysis. Onecolor microarrays use only one fluorophore and determine relative expression of a gene target by
comparing the relative intensity of fluorescence across repeated oligonucleotide probes.
Comparison across treatment groups can made if multiple arrays are on a single substrate. Figure
1.6 provides an overview of the steps required for a one-color microarray analysis.
Two-color microarrays hybridize two separate samples on a single microarray. In
toxicogenomics, the samples are often a control and an exposed/treated sample. Each sample has
a different dye added (Cy3 vs. Cy5) and the two differentially labeled cDNA samples are
allowed to hybridize to the same microarray. The determination if a gene is up- or downregulation is made by the ratio of fluorescence levels between the two fluorophores. Figure 1.7
provides a summary of two-color microarray analysis.
Three types of controls are typically built into microarray platforms: positive controls,
spike-in labeled controls, and negative controls. Positive controls, usually using known
housekeeping genes, test for adequate hybridization and that sample labeling is sufficient to meet
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Figure 1.6. Visual summary of a one-color
microarray. The samples are collected, and RNA is
isolated. cDNA is prepared via reverse transcription,
and a reporter label is incorporated into the cDNA
targets, with one-color microarrays, the sample
reporter is added to both samples. The cDNA is
hybridized to two separate microarrays, one for each
sample. The arrays are scanned and the fluorescence
intensities recorded, the relative fluorescence
differences between the two microarrays will be used
to compare across treatment groups. The data is
normalized and analyzed

Figure 1.7. Visual summary of a two-color
microarray. The samples are collected, and RNA is
isolated. cDNA is prepared via reverse transcription,
and a reporter label is incorporated into the cDNA
targets, with two-color microarrays each sample is
labeled with a different reporter. The two cDNA
samples are allowed to hybridize to the same array.
The array is scanned and the fluorescence intensities
recorded. The relative fluorescence of the two reports
is used to determine changes in expression. The data
is normalized and analyzed.
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the minimum data quality requirement. Spike-in controls are important when comparing between
samples, fluorophores, and experiments. Spike-in controls, with targets and probes from an
unrelated species, are generally added to the sample and the relative intensity of the probe
labeling can be used to normalize between different arrays. Negative controls estimate the
amount of nonspecific hybridization and background labeling. Blank spots or probes derived
from the genome of unrelated species are common negative controls (Hamadeh et al., 2004).
The level of relative fluorescence can provide information on if a gene is up-regulated or downregulated after xenobiotic exposure; however, the volume of data produced can render analysis
quite the undertaking. After the microarray is scanned, the intensities are corrected for
background fluorescence, and the data are aggregated and normalized for differences in dye
properties (if needed). The magnitude of fold-changes in expression levels are used in
combination with p-values to determine if there is a significant change in the expression of a
gene. The MicroArray Quality Control (MAQC) project is a US Food and Drug Administration
(FDA) led community wide effort to determine the best practices in microarray technology and
analysis, while the Minimum Information About a Microarray Experiment (MIAME) describes
minimum information standards (Brazma et al., 2001; Shi et al., 2006). Principal component
analysis (PCA) is one technique that reduces the dimensionality of data to enable easier analysis,
mainly to help explain sources of variation within a sample. Gene ontology and pathway analysis
is a powerful tool to evaluate the possible biologic function of altered genes and suggest which
cellular pathways are possible targets of xenobiotic exposure.
1.5.4.2.2 Other Techniques – qPCR and RNA-SAGE
The technique of qPCR utilizes nucleotide amplification technologies to be able to quantify the
amount of target gene or transcript within a sample. For transcriptomic evaluations, qPCR can be
and is often used to validate significant differences in gene expression observed on a microarray.
qPCR can also be used when evaluating only a few specific genes or a smaller set of genes of
interest. The Minimum Information for publication of Quantitative Real-Time PCR Experiments
(MIQE) guidelines help promote consistency and transparency in data publication (Bustin et al.,
2009).
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In these applications of qPCR, RNA is first isolated from a sample and usually cDNA is
then created from the RNA via reverse transcriptase. This cDNA is used for analysis due to its
greater stability. Primers are designed to target the 5’ and 3’ ends of the gene of interest and a
fluorophore is added to the PCR solution to detect the amount of target amplified during the
reaction. DNA-binding dyes (such as SYBR green), hybridization probes, and hydrolysis probes
(such as Taqman) are commonly used to quantify the amount of PCR product; the greater the
fluorescent signal, the greater the amount of gene transcript. qPCR can determine relative
expression of a gene in multiple treatment groups as compared to a control or a reference
housekeeping gene. The quantity of a gene target can be determined if a standard of known
concentration is serially diluted to create a standard curve and then used for determining absolute
values of transcripts.
RNA-Serial Analysis of Gene Expression (RNA-SAGE) is a sequencing technique that
also provides genome level information about the identity and quantity of mRNA in a sample.
RNA-SAGE uses streptavidin beads and restriction endonucleases to produce small 10-14 bp
tags that correspond to short sections of a cDNA from a transcript. The tags have linkers added
and are then serially ligated to form larger sections of transcript that are amplified in bacterial
vectors before sequencing. RNA-SAGE allows for sequencing of transcripts without prior
knowledge of sequence and can provide more accurate quantification of gene expression
(Yamamoto et al., 2001). However the cost, which is more expensive than microarrays, and
technical steps required have limited widespread use especially with the advent of NGS
sequencing.
1.5.4.2.3 Next Generation Sequencing – RNA-seq
RNA-sequencing (RNA-seq) is a technology that takes advantage of NGS methods to determine
the quantity and identity of RNA in a sample through direct sequencing of cDNA. RNA-seq only
requires a small amount of RNA and, given sufficient depth of coverage, is able to find rare
transcripts. RNA-seq also has the advantage that no prior knowledge of sequence is required,
which allows RNA sequencing of species without a sequenced genome and allows for the
identification of splice variants.
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In RNA-seq, RNA from cells or tissues is isolated and usually fractionated to remove
rRNA. The RNA is then converted to a cDNA library through a combination of reverse
transcription and fragmentation. Sequencing adaptors are ligated onto both ends of a cDNA
fragment and the strands may be chemically modified in order to retain directional information.
The cDNA fragments are sequenced by a NGS platform and the resulting reads are reassembled
into a list of transcripts. RNA-seq can also be modified to analyze micro- and other small RNAs
through selecting for 22-23 nucleotide long sequences. Qian et al. (2014) review the use and
application of RNA-seq technology in fish.
For most applications RNA-seq technology is currently still more expensive than
microarrays, although the price points have become much more comparable in recent years. In
addition, RNA-has some limitations. First, the options and modifications available in the cDNA
library development allows for high customization in that individual experiments can be
modified in order to find answers to specific questions. However, the flexibility of the
experimental design means that it can be difficult to compare results across different
experiments. Additionally, there are no clear guidelines on best practice standards, although
ENCODE (www.encodeproject.org) and others have made progress on this front (Conesa et al.,
2016). The abundance of read data provides challenges in data storage and analysis; however, the
amount of information received and the flexibility of the techniques will lead to increased use of
this technique as it becomes assessable to more laboratories.
1.5.5 Proteomics
1.5.5.1 Introduction to Proteomics
Proteomics is the study of the identity, quantity, structure, and function of all proteins in a cell,
tissue, or organism at a given point of time. Proteomics takes into consideration the quantity of
protein in a sample, which is dependent on the rate of translation as well as the rate of
degradation. The structure is dependent on any post-translational modifications and this, along
with protein-protein interactions can help inform function. Post-translational modifications
include phosphorylation which can either activate or inactivate protein function; ubiquitination,
which marks the protein for degradation; glycosylation, which can promote protein folding; and
acetylation, which appears to have regulatory functions. The identity of proteins is based on the
primary peptide code as well as secondary, tertiary, and quaternary structure. Although proteins
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are encoded by genes, the complete genome is represented in all somatic cells and while the
transcriptome may vary between cells, the transcriptome does not always correlate with the
proteome. Due to all of these factors, the study of the proteome is complex and requires
separation techniques and identification techniques.
Proteomics in toxicology is not utilized as much as transcriptomics, although it has the
potential to identify key proteins and pathways that could be altered after xenobiotic exposure
and is closer to the functional change affecting the cell, tissue, or organ. Miller et al. (2014)
provide a review of common proteomics techniques and their application to toxicology. It is
likely that proteomics will be used more in toxicology as technologies become more
standardized and accessible.
1.5.5.2 Proteomic Technology and Techniques
One of the main problems with proteomic evaluations in toxicology is that proteins that have
altered levels due to xenobiotic exposure may be rare when compared to the other proteins
within a cell. Therefore sample preparation and separation are necessary to sufficiently
differentiate the wide range of proteins that are in a cell or tissue. Proteomic techniques for
separation were originally developed as early as the 1970s with two directional (2D)
electrophoresis which separates proteins based on isoelectric point and molecular mass. Affinity
based techniques, such as enzyme-linked immunosorbent assay (ELISA) or antibodies targeting
specific proteins or modifications have also been used to separate out proteins of interest;
however, this approach is limited by the knowledge requirement. Protein arrays are an
application of this technique that offer a wider coverage of proteins for evaluation. Proteins can
also be separated through chromatography methods such as gas chromatography (GC), liquid
chromatography (LC), or HPLC (high performance liquid chromatography).
Mass spectroscopy (MS) coupled techniques have become the mainstay of proteomic
technologies. With MS, separated, purified proteins are digested into peptides and these peptides
are ionized. The ionized peptides are then measured for mass and charge for identification.
Electrospray ionization (ESI), desorption electrospray ionization, and matrix-assisted laser
desorption ionization (MALDI) are techniques used for ionization of peptides. Tandem MS/MS
offers the ability to select specific products based on their mass and charge from the first MS
stage and submit them to additional fragmentation for further separation before being detected at
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the end of the second stage. The fragment ions are produced through collision, photodissociation,
electron capture and transfer, or other methods. Detection of fragment ions occurs at the end of
the second state. Time-of-flight (TOF) detectors detect mass to charge rations by measuring the
time it takes for the ions to travel a known distance. The peptides identified are then reassembled
to determine protein identities and relative abundance. These techniques can also be used to
determine post-translational protein modifications.
The Human Proteome Organization (www.hupo.org) has developed recommendations for
the minimum information about a proteomics experiment (MIAPE) to help promote data
standardization, verification, and comparability. Increased use of proteomics will likely follow
increased accessibility and acceptance of standards.
1.5.6 Evaluation of Neurobehavior
The significance of apparent alterations in neurotransmitter levels and toxicogenomic endpoints
is uncertain without having differences in phenotype. Zebrafish are an accepted model of
neurobehavior (Ahmad et al., 2012; Bailey et al., 2013; Blaser et al., 2010; Budick et al., 2000;
Buske et al., 2014; Champagne et al., 2010; Egan et al., 2009; Gerlai, 2014; Kalueff et al., 2013;
Kalueff et al., 2014) and have been used to study stress, anxiety-like behavior, and depression,
with decreased movement typically associated with anxiety (Maximino et al., 2010a; Nguyen et
al., 2014; Steenbergen et al., 2011). Changes in neurobehavior can substantiate changes
observed through neurotransmitter analysis or through transcriptomic or proteomic evaluation;
however, changes in neurobehavior cannot be localized to a specific neurotransmitter, pathway,
or protein. Please refer to Kalueff et al. (2016a) and Parker et al. (2016) for recent reviews of
neurobehavior in zebrafish toxicology research.
Zebrafish behavior is increasingly being incorporated into toxicological testing as a
measurable phenotype reflecting alterations in normal physiology and in neurobehavioral
research to evaluate learning and neuropsychiatric disorders (reviewed by (Bailey et al., 2013;
Blaser et al., 2010; Egan et al., 2009; Kalueff et al., 2016a)). Behavioral tests for both larval and
adult zebrafish take advantage of well-characterized behavioral responses (Kalueff, 2017;
Kalueff et al., 2013). The assays are largely modified from rodent behavioral methods and test
conserved behavioral endpoints, such as thigmotaxis (wall-hugging), scototaxis (light/dark
preference), geotaxis (diving preference), exploration, habituation, and stress and anxiety related
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parameters (reviewed by Ahmad et al. (2012)). Deviations from normal behavior can highlight
possible functional outcomes of chemical toxicity, provide information on drug efficacy, or
suggest mechanisms of action or including the direct disruption of neurotransmission or other
neural elements, indirection alterations in intracellular signaling, disruption of the
musculoskeletal system, and altered growth and development (Reif et al., 2016).
1.5.6.1 Larval Behavior
Larval zebrafish behavior is well characterized and is often incorporated into toxicological
assays. The utility of using larval zebrafish behavior for toxicity assessment was validated by
exposing larvae to compounds with known mechanisms of action and known behavioral
outcomes in rodents. For example, zebrafish larvae exposed to the drug valproate experienced
hyperactivity similar as to what has been described in rodent models and humans (MacPhail et
al., 2011). Endpoints such distance moved, velocity, time moving, angular velocity, and turn
angle can be used to link xenobiotic exposure to behavior outcomes which could suggest
developmental neurotoxicity or other adverse effects. Commercial zebrafish behavioral systems
have allowed for easier, high-throughput analysis of larval behavior through the integration of
infrared cameras with contained testing arenas, programmable stimuli control, and analysis
software.
Two of the most common assays for high-throughput analysis are an embryonic
photomotor response and a larval locomotor assay called either a visual motor response or a
larval photomotor response test. Zebrafish have rhythmic tail coiling movements starting at 1721 hpf. Exposure to a light source around 24-30 hpf will cause a reflex increase in activity level,
called the photomotor response (PMR). The reflex is mediated through non-visual, hindbrain
pathways (Kokel et al., 2013) and provides an early testable phenotype in developmental toxicity
assays. In a screen of ToxCast™ chemicals, hypoactivity or hyperactivity during the 24 hpf PMR
is associated with an increased relative risk for developmental malformations at 120 hpf (Reif et
al., 2016). Interestingly in the same study, behavioral alterations could be observed for some
chemicals, such as abamectin, milbemectin, and emamectin benzoate, at lower chemical
concentrations than what causes morphological alterations (Reif et al., 2016). Larval zebrafish at
approximately 5 days post fertilization have robust locomotor responses to changes in light based
through a visually mediated reflex (visual motor response; VMR). Larval zebrafish tend to have
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increased activity in light compared to dark, but exhibit paradoxical increased behavior in dark
after a sudden change from light to dark (MacPhail et al., 2009). VMR endpoints, such as
duration of movement, distance moved, and velocity, if altered by chemical exposure, can
provide support for toxicity and can help establish pathways effected or mechanisms of action.
For example, the VMR has been used to evaluate the irritant effect of particulate matter (PM) on
larval zebrafish behavior and investigate possible mechanisms. Stevens et al. (2018) evaluated
the effects of acrolein and compressor-generated diesel exhaust PM on the locomotor behavior of
zebrafish and found that inhibition of the transient receptor potential (TRP) cation channel
blocked the response to acrolein and exhaust PM. Although the PMR and VMR tests provide a
phenotypic outcome of toxicity, limitations of both tests are a general lack of standardization in
methods across laboratories, which is concern for reproducibility of results, and the challenge of
tying behavioral data to molecular initiating events.
1.5.6.2 Adult Behavior
Adult behavioral assays are emerging as tools to evaluate changes in activity level, anxiety,
learning, and other neurobehavioral outcomes after xenobiotic exposure. Adult zebrafish can be
used to model complex behaviors related to stress and anxiety, learning, and social interactions,
such as shoaling or aggression. Methods of monitoring adult behavior are becoming more
sophisticated. Video tracking software can routinely calculate parameters such as total distance
moved, velocity, turn angle, and angular velocity of single zebrafish. The basic technology has
expanded to include the monitoring of multiple fish in a single area (Green et al., 2012) and 3D
methods that allow for more accurate tracking and a greater range of observable endpoints from
a single test (Stewart et al., 2015b).
Although many behaviors can be altered by chemical or drug exposure, tests that measure
parameters associated with stress and anxiety are often used in studies of neurotoxicity to
determine functional outcomes of xenobiotic exposure. Three common tests are the Novel Tank
Test (NTT), the Light-Dark Box (LDB), and the Open Field Test (OFT) (Figure 1.8). Other tests
modified from rodents, such as T-mazes and opioid self-administration assay (Bosse et al., 2017)
can provide measures of learning and cognition or addictive behavior respectively. For example,
Gao et al. (2017) evaluated the effect of early-life exposure to benzo[a]pyrene on adult
behavioral performance on a NTT and a T-maze and was able to link a phenotype of
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Figure 1.8. Adult zebrafish behavioral assays. Three common adult zebrafish behavioral assays are the Novel Tank
Test (NTT), the Light-Dark Box (LDB), and the Open Field Test (OFT). The NTT(A) introduces an adult zebrafish
to a novel tank and evaluates endpoints such as time spent in upper and lower zone, latency to zone transitions, and
number of zone entries, with an anxious phenotype spending more in the bottom zone. The LDB (B) introduces a
zebrafish to a tank set up with dark walls on one half of the tank and white walls on the other half and evaluations
similar endpoints such as time spent in light and dark zones, number of zone entries, and the latency between zone
entries. The OFT (C) is similar to the rodent test and evaluates thigmotaxis (wall hugging) and exploratory behavior
in a novel environment, with anxious fish. Time spent in central versus peripheral zones, latency to zone entry, and
number of zone entries, as well as zebrafish startle movements, are recorded. Red tracks in each example highlight
the swimming pattern of the fish (red dot) in the test arena.
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neurodegeneration to changes in DNA methyltransferase expression, decreased neurotransmitter
levels, and decreased dopaminergic neurons in brain sections. Although adult zebrafish behavior
testing is well described, factors such as biological replicate, test day, and experimental protocols
can have a strong effect on behavioral results (Kalueff et al., 2016a), highlighting the need for
reporting and standardization of information, such as acclimation period, to help improve
reproducibility of results (Melvin et al., 2017).
1.5.7 Visualization of Neurotransmitters and Neurotransmitter Systems
The visualization of neurotransmitters has been important for evaluating the location, relative
quantity, and pathologic alterations of neurotransmitters and neurotransmitter pathway
components. A multitude of techniques, including immunohistochemistry, in situ hybridization,
immunofluorescence, calcium indicators, selective fluorescent reporters (Ahrens et al., 2013;
Connaughton et al., 1999; deCarvalho et al., 2014; Fetcho et al., 1997; Garaschuk et al., 2006;
Marvin et al., 2013) (and reviewed by O’Malley et al. (2003)) have been used to study
neuroanatomy and neurotransmitter systems in zebrafish. The imaging of neurotransmitters,
transporters, and receptors in zebrafish brains has classically been used in the study of
developmental biology (Mueller et al., 2003) and recently for neural systems mapping
(Arrenberg et al., 2013; Garaschuk et al., 2006). A recent review by Arrenberg and Driever
(2013) highlights the use of optogenetics and calcium indicator activity probes in the
development of functional maps of the zebrafish brain. Currently this methodology has been
underused in studies of chemical toxicity, but could provide powerful information when
combined with the other approaches mentioned.
1.5.8 Pharmacology screens
The advantages of the zebrafish model system allow for high throughput screening of
pharmacologic agents which can help identify neuropathways, mechanisms of toxicity, possible
therapeutic drugs, and help classify zebrafish behavior (reviewed by (Bruni et al., 2014; Magno
et al., 2015; Maximino et al., 2011; McCarroll et al., 2016; Rihel et al., 2012; Stewart et al.,
2015a)). The neuropharmacology of the monoamine neurotransmitters was reviewed by
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Maximino and Herculano (2010b). Kalueff et al. (2016b) have also recently written a highly
recommended review that evaluates the zebrafish system in neurobehavior and pharmacology
screenings.

1.6

Specific Examples of Chemical Toxicity Targeting Neurotransmitter Systems

Zebrafish have been used as a model organism to study the effect of multiple classes of
chemicals on neurodevelopment and neural function. Classes of chemicals examined include
drugs, especially ethanol, pesticides, and metals.
1.6.1 Drugs
The effects of alcohol have been extensively studied in zebrafish. Rico et al. (2007) found that
adult zebrafish exposed to ethanol had increased AChE activity in a 1% ethanol treatment group
although the mRNA levels of AChE were decreased, suggesting post-transcriptional or posttranslational modifications to AChE. Chatterjee and Gerlai (2009) found that adult zebrafish
exposed to ethanol for 1 hour had an increase in brain dopamine levels at all treatment levels,
while 5-HT and 5-HIAA increased at the highest (1%) ethanol group. Chatterjee and Shams
(2014) found a similar increase in dopamine and 5-HT after acute ethanol exposure in AB strain
zebrafish, but not in SF strain zebrafish. Puttonen et al. (2013), found that larval Turku strain
zebrafish with acute exposure to ethanol had increased locomotor activity at lower treatment
levels, decreased locomotor activity at the highest treatment level (3%), upregulation of hdc
(histidine decarboxylase), th1, and th2 at higher treatment levels, no alterations in the
dopaminergic

and

histaminergic

systems

according

to

in

situ

hybridization

and

immunohistochemistry, and a decrease in dopamine levels, as measured by HPLC . These results
suggest that ethanol has the ability to alter the cholinergic, dopaminergic, and histaminergic
neurotransmitter systems and that neurobehavior can be a sensitive measure of altered
neurotransmitter systems.
The effects of alcohol on zebrafish behavior appear to have an inverted U shaped doseresponse, with increased locomotor activity and shoaling behavior at lower doses and decreased
locomotor activity and shoaling behavior at higher doses, as well as either increased or decreased
measures of anxiety (Chatterjee et al., 2014; Gerlai et al., 2008; Gerlai et al., 2006; Kurta et al.,
2010; Tran et al., 2013). Although this finding appears to be dependent on the specific zebrafish

43
strain (AB, SF, WIK, or Turku strain) used and therefore, needs further analysis (Chatterjee et
al., 2014; Gerlai et al., 2008; Pannia et al., 2014; Puttonen et al., 2013). Bailey et al. (2015)
found juvenile AB strain zebrafish with developmental exposure to ethanol had increased
locomotor activity overall and after stress or anxiety inducing stimuli. A latent learning
neurobehavioral assay performed by Luchiari et al. (2015) suggested that AB strain zebrafish
have impaired memory recall after ethanol exposure. Echevarria et al. (2011) have reviewed
additional behavioral outcomes of ethanol exposure in zebrafish.
Zenki et al. (2014) found that alcohol and its metabolite acetaldehyde decreased the activity
of glutamate transporters, based on measuring the in vitro rate of glutamate uptake in tissue
sections, in adult zebrafish and that acetaldehyde was more toxic than ethanol when measuring
cell viability via 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction
and extracellular lactate dehydrogenase (LDH) activity.
Nicotine is often used to study nicotinic cholinergic receptors, but nicotine also is a drug
known for anxiolytic effects. Levin et al. (2007) and Bencan and Levin (2008), found that adult
zebrafish exposed to nicotine had reduced time spent in the bottom of a novel tank (novel tank
test) and found that the anxiolytic effect was mediated through the Chrna7 and Chrna4b receptor
subunits (Bencan et al., 2008; Levin et al., 2007). Levin and Chen (2004), also found that adult
zebrafish exposed to low dose nicotine had improved memory based on a 3-chambered tank test
for learning assessment while zebrafish exposed to higher concentrations of nicotine had
impaired memory function.
1.6.2 Pesticides
Pesticides represent a broad group of chemicals that include herbicides, insecticides, fungicides,
and rodenticides. Some pesticides are important environmental toxicants while others are more
acutely toxic to humans (for example, during application or manufacturing).
The effects of organophosphate pesticides on brain acetylcholinesterase are well known,
however, exposure to organophosphates can also affect other brain neurotransmitter systems.
Eddins et al. (2010) studied the effects of developmental exposure of zebrafish to chlorpyrifos.
Adult zebrafish previously exposed to chlorpyrifos had greater startle responses in a startle
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response and habituation behavioral assay that persisted into the habituation period.
Additionally, decreased dopamine and serotonin levels and increased transmitter turnover were
measured in larval zebrafish while only the decreased dopamine persisted to adulthood (Eddins
et al., 2010).
Atrazine is a commonly used herbicide in the Midwestern United States that often
contaminates drinking water supplies. Wirbisky et al. (2015) found decreased levels of the
serotonin metabolite 5-HIAA and decreased serotonin turnover (5-HIAA/5-HT) in the brain of
adult female zebrafish aged 9 months that were exposed to atrazine only during embryogenesis.
Transcriptomic analysis via microarray identified multiple molecular pathways related to brain
development, function, and behavior that were altered in the treatment groups including several
targets associated with the serotoninergic system (Wirbisky et al., 2015).
Semicarbazide is a contaminant formed from the breakdown of azodicarbonamide, a
chemical used to treat flour. Semicarbazide derivatives have also been used as herbicides. Adult
zebrafish exposed to semicarbazide for 96 hours had increased expression of gad1 while adult
zebrafish with 28 day exposure had down regulation of gad1, gabrr1, gabbr2 (Yu et al., 2016).
Yu et al. (2016) suggest the alterations of the GABAergic pathway genes could indirectly result
in alterations in the hypothalamus-pituitary-gonadal axis.
Strychnine is commonly used as rodent bait. Roy et al. (2012) found that zebrafish embryos
treated with strychnine had decreased expression of glra4 at 24 and 48 hpf, gad1 at 24-96 hpf,
and slc17a6a and slc17a6b (VGLUT2) at 48 hpf.
1.6.3 Metals
Some metals, such as lead and mercury are important environmental toxicants (Depledge et al.,
2009; Tchounwou et al., 2012; Wigle et al., 2007). Developmental lead exposure is linked to a
number of CNS effects, including lowered IQ and attention deficit disorders (Baghurst et al.,
1992; Joe et al., 2006; Kuhlmann et al., 1997; Schwartz, 1994). Wirbisky et al. (Wirbisky et al.,
2014) found that developmental exposure to lead resulted in altered expression of GABAergic
pathway genes including gad2, gad1b, slc6a1 (gat1), slc32a1 (vgat), gabbr1, and gabbr1a as
well as altering GABA levels during development. Furthermore, Lee and Freeman (2016) found
that adult zebrafish with a developmental lead exposure had altered gene expression in pathways
associated with neurodevelopment and neurotransmission.
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In addition, studies have also started to evaluate the impact of mercury exposure on
neurotransmitter systems. The toxicity of mercury depends on its chemical form. Methylmercury
is associated with Minamata disease and nervous system impairment. Cambier et al. (2012) fed
adult male fish food contaminated with methylmercury and found changes in gene expression in
the GABA synthesis and metabolism pathways. Inorganic mercury is associated with acute
toxicity and renal failure; however, Richetti et al. (2011) found that adult zebrafish exposed to
mercury chloride and lead acetate had decreased activity of acetylcholinesterase, but no
alterations in the gene expression of AChE.

1.7

Emerging Areas in Toxicology

1.7.1 Epigenetics
Throughout the last decade, the importance of epigenetic changes in toxicological research is
increasingly appreciated. Epigenetic alterations are implicated in chemical toxicity (Chappell et
al., 2016; Szyf, 2011), carcinogenesis (Kanwal et al., 2015), and endocrine disruption (Xin et al.,
2015). Also of note, epigenetic alterations are heritable, implicating epigenomic alterations in
multi- and transgenerational toxicity (Jimenez-Chillaron et al., 2015).
Although there are some differences in the zebrafish epigenome, such as fewer, more
highly methylated CpG islands and only maternal genome reprograming during imprinting, the
epigenetic machinery remains comparable (Kamstra et al., 2015). Zebrafish are proposed as
high-throughput models to study chemical-induced epigenetic alterations through the evaluation
of DNA methylation status and changes in microRNA levels (Williams et al., 2014). Zebrafish
are also proposed as a model for the role of epigenetics of aquatic toxicology (Brander et al.,
2017).
Recent studies found epigenetic alterations after exposure to low levels of environmental
toxicants. Developmental exposure of zebrafish embryos to environmentally relevant
concentrations of benzo[a]pyrene reduced genome methylation and was associated with
increased gene expression due to hypomethylation of promotor regions (Fang et al., 2013). The
herbicide atrazine was also shown to effect the zebrafish epigenome as zebrafish embryos
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exposed to atrazine had altered levels of microRNAs associated with angiogenesis,
neurodevelopment, and cancer (Wirbisky et al., 2016b), decreased DNA methyltransferase
expression and activity, and genomic DNA hypomethylation (Wirbisky-Hershberger et al.,
2017).
1.7.2 Developmental Origins of Health and Disease
The Developmental Origins of Health and Disease (DOHaD) hypothesis suggests that
developmental exposure to environmental stressors, including toxicants, can result in genetic,
epigenetic, or functional changes in tissues that increase disease risk later in life (Heindel et al.,
2015). Although the DOHaD hypothesis has expanded to recognize the importance of
environmental exposures (Haugen et al., 2015; Heindel et al., 2015), the paradigm is only
starting to be integrated into the field of toxicology (Schug et al., 2013).
In addition to their strength in developmental toxicity research, zebrafish are excellent
models for studying aging and the life course (reviewed by Sasaki et al. (2013)), especially in the
context of the DOHaD hypothesis. The ex vivo development allows for precise control of
developmental toxicant exposures and, although sexual maturity is not as rapid as in rodent
models, zebrafish reach sexual maturity in 3-4 months. Emerging zebrafish research identifying
the later in life effects of developmental toxicant exposure have investigated metals,
polychlorinated dibenzodioxins, and the herbicide atrazine. Baker et al. (2013) described
disruptions in adult skeletal structure and reproduction in zebrafish after sublethal exposure to
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and later identified microscopic and transcriptomic
alterations in male testes to help elucidate the mechanism of inheritable TCDD related infertility
(Baker et al., 2016). Developmental exposure to sublethal concentrations of cadmium lengthened
the time spent in the bottom during a novel tank test and altered the activity of antioxidant
systems through a suspected alteration in DNA methyltransferase activity (Ruiter et al., 2016).
Developmental exposure to atrazine was linked to alterations in male and female gonad and brain
transcriptome profiles, changes in female neurotransmitter levels, and decreased spawning in
adult zebrafish (Wirbisky et al., 2016a; Wirbisky et al., 2015). The identification of other
developmental toxicants that cause later life effects and the elucidation of their mechanisms of
action represent a major area for exploration.
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1.7.3 Multi- and Transgenerational Toxicity
An emerging area of toxicology somewhat related to the DOHaD paradigm is multi- and
transgenerational toxicity. This field studies the effects of xenobiotic exposure in the descendants
of the generation originally exposed. Many of the chemicals implicated in multi- and
transgenerational toxicity are not genotoxic and epigenetic alterations are thought to be the main
mechanism for inherited toxicity, possibly as a result of changes to DNA methylation in
developing germ cells (reviewed by Nilsson et al. (2015)). There is significant public health
implications for heritable, epigenetic toxicity (reviewed by Marczylo et al. (2016)) and zebrafish
can model multi- and transgenerational toxicity due to the ease of developmental exposure,
similarities in epigenetic regulation and metabolic pathways, and relatively short generational
period, with sexual maturity occurring around 3-4 months post fertilization.
When mapping multi- and transgenerational effects, the original exposure conditions
determine the type of exposure to the following generations (Figure 1.9). Multigenerational
toxicology studies are concerned with effects observable in generations originally exposed to the
xenobiotic, whether as an adult (F0), as a fetus (F1), or as a primordial germ cell (F2) in the
developing fetus with mammalian in utero exposure. In transgenerational studies, the effects in
subsequent generations (F3 and beyond in mammals) are of interest. These generations did not
have direct exposure to the xenobiotic and adverse effects observed are hypothesized to be due to
epigenetic alterations. Rather than dosing pregnant animals, the zebrafish model has external
fertilization and development that allow for in vitro exposure of F0 embryos, and because of this,
the F2 generation is considered transgenerational in comparison to the F3 generation in
mammals. One limitation of the model, though, is the inability to study placental effects on
toxicity.
A few studies using zebrafish for multi- and transgenerational toxicity work are published
to date. Wirbisky et al. (2016c) observed morphological alterations in F1 larvae after the F0
generation

had

developmental

exposure

to

atrazine,

suggesting

that

atrazine

has

multigenerational toxicity. In another multigenerational study, Liu et al. (2016) fed adult female
zebrafish a diet derived from wild-caught walleye fish contaminated with methylmercury and
found increased malformations, decreased visual responses, and altered gene expression in their
offspring. Olsvik et al. (2014) used the zebrafish model system to evaluate transgenerational
changes to DNA methylation after TCDD and methylmercury exposure and described only

48

Figure 1.9. Multi- and transgenerational studies in humans and the zebrafish. Xenobiotic exposure during
mammalian pregnancy (A) exposes the mother (F0), the fetus (F1), and the primordial germ cells within the fetus
(F2) to potential direct toxic effects. Although the F1 and F2 generations have xenobiotic exposure, the F3
generation is the first generation without exposure, although toxicity may continue through inherited epigenetic
toxicity. In zebrafish (B), developmental to a F0 generation also exposes the germ cells, resulting in indirect
xenobiotic exposure to the F1 generation. The F2 generation and beyond lack xenobiotic exposure, but may have an
altered epigenome. Pink blocks represent direct exposure to xenobiotics. Blue represents multigenerational toxicity,
where exposure occurred during germ cell stages. The white background represents transgenerational toxicity, where
the subjects had no direct xenobiotic exposure and any toxic effects are expected to from epigenetic alterations.
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modest effects. Knecht et al. (2017) found that developmental exposure of an F0 zebrafish
generation to benzo[a]pyrene caused altered behavior in the F0 and F2 generations and altered
physical parameters in both generations. Skeletal and reproductive alterations associated with
TCDD exposure were found to persist through the F1 and F2 generations (Baker et al., 2014).

1.8

Summary

Environmental chemical toxicants enter the environment and can have adverse health effects on
human populations (Lippmann et al., 2008). Chemical contamination of rivers, lakes, and ground
water is a significant public health concern (DeSimone, 2009) and chemical spill incidences can
have severe consequences to human health and the environment (Pena-Fernandez et al., 2014). To
complicate risk assessment, thousands of chemicals to which humans are exposed have no or
limited toxicological data (Tice et al., 2013). However, even low doses of chemicals in the
environment can have an effect on human health (Vandenberg et al., 2012) and it is suggested by
the Developmental Origins of Health and Disease (DOHaD) hypothesis that embryonic exposure
to toxicants alters health status and disease prevalence later in life (Baker et al., 2013; Barker et al.,
1993; Barker et al., 1986). Therefore, it is important to study the legacy, emergent, and current-use
chemicals that are found in low levels in drinking water sources to assess the risk of early
exposure.
The nervous system is an important target of chemical toxicants. Neurotransmitter levels,
gene expression, and neurobehavior can be evaluated after chemical treatment to discover
toxicant based changes in the nervous system. The neurotransmitter systems are highly
conserved between zebrafish and mammals, making the zebrafish model a powerful tool for the
study of mechanisms of chemical neurotoxicity. Although there are some differences in
neurochemistry, the pathways of neurotransmitter synthesis, metabolism, and action are highly
conserved across species. Although some genes have multiple paralogs in zebrafish, further
research into these paralogs may help identify new functions of genes in humans. New ‘-omics’
technologies provide more sensitive and powerful methods for evaluating neurotoxicity;
however, the integration of these methods along with other techniques, such as imaging and
activity assays, will be necessary to determine the mechanisms and pathogenesis of chemical
toxicant related alterations. In summary, the zebrafish is a small, but exceedingly robust model
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organism, providing an economical balance between in vitro assays and more complex,
mammalian organisms. The many advantages of the model allow for easy adoption of new
techniques, technologies, and fields of study within the realm of developmental neurotoxicity.

1.9

Structure of Dissertation

1.9.1 Central Hypothesis
The central hypothesis is that embryonic exposure to legacy, emerging, and current-use
chemicals will alter neurodevelopment. The zebrafish biomedical model is used to test this
hypothesis and evaluate acute developmental toxicity, developmental neurotoxicity, and the
delayed neurological alterations resulting from embryonic exposure to drinking water
contaminants. The overall impact of this research will help further determine the health risks
associated with developmental exposure to three environmental contaminants.
1.9.2 Specific Aims
Specific Aim 1 (Chapter 2): To test the hypothesis that embryonic exposure to regulatory and
environmental levels of trichloroethylene (TCE) alters neurodevelopment. TCE is a legacy
environmental toxicant that was recently linked to neurodegenerative disease; however, the
effects of developmental exposure on the nervous system at low concentrations need further
characterization to adequately assess risk. This aim uses acute toxicity assays, morphologic
measurements, a neurobehavioral assay, and quantitative PCR to evaluate the developmental
neurotoxicity of TCE using the zebrafish model.
Specific Aim 2 (Chapter 3): This study examines the hypothesis that 4-MCHM, crude
MCHM, and the Tank 396 liquid have different chemical compositions and will have different
toxicologic effects in the zebrafish biomedical model. In early 2014, a tank containing a crude
MCHM mixture contaminated the water supply of Charleston, West Virginia. The chemical
mixture had minimal toxicity data and this aim seeks to characterize the developmental toxicity
of 4-MCHM, crude MCHM, and the liquid contents of the faulty tank. This aim uses gas
chromatography-mass spectrometry (GC/MS) to identify the components of the crude MCHM
and tank mixtures, and acute toxicity assays, morphologic measurements, and a neurobehavioral
assay to evaluate the comparative toxicities of 4-MCHM, crude MCHM, and the tank mixture
using the zebrafish model.
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Specific Aim 3: To test the hypothesis that embryonic exposure to atrazine (ATZ) results
in age and sex-specific alterations in the brain. ATZ is a current-use herbicide previously linked
to endocrine disruption, cancer, and changes in neurotransmitter levels. The first secondary
hypothesis (Chapter 4) is that developmental ATZ exposure causes gene expression changes
throughout the time course of development, alterations in brain size and behavior, and elicits
protein level changes in larval zebrafish. The second secondary hypothesis (Chapter 5) is that
embryonic exposure to atrazine results in sex-specific transcriptomic, neurobehavioral, and
pathological alterations in adult zebrafish brain.
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CHAPTER 2. EMBRYONIC EXPOSURE TO
TRICHOROETHYLENE (TCE) ALTERS HATCHING,
NEURODEVELOPMENT, AND THE EXPRESSION OF
cyp24a1 IN ZEBRAFISH

2.1

Abstract

TCE, an industrial solvent and degreaser, is an environmental toxicant that contaminates over
half of Superfund sites. It is a known carcinogen and is linked to congenital defects and
neurodegenerative disease. The US EPA maximum contaminant level of TCE in drinking water
is 5 parts per billion (ppb; µg/L); however, ground water levels can be greater than 10,000 ppb at
Superfund sites. The developmental toxicity of TCE near regulatory levels needs further
characterization in order to better assess the risk to human health. In this study, the zebrafish
model was used to evaluate the acute developmental toxicity of near regulatory concentrations of
TCE by monitoring survivability, percent hatching, morphological measurements, and
neurobehavior. The expression of cytochrome p450 enzymes was also evaluated for induction
related to TCE metabolism. Zebrafish embryos were dosed immediately after fertilization with 0,
5, 10, 50, or 500 ppb TCE. Embryos were exposed through 72 hours post fertilization (hpf)
rinsed, and kept in control water until 120 hpf. The percent survival was not significantly
different between treatments, but the 500 ppb treatment had increased early hatching at 48 hpf.
Morphological measurements indicated that the 500 ppb treatment had significantly larger head
length to body length ratios and significantly shorter brains compared to the controls. No
significant differences were observed during the evaluation of neurobehavior. The relative
expression of cyp24a1 was decreased in the 10 ppb treatment compared to the controls, but
cyp2y3, cyp2p6, and cyp1d1 did not have altered expression. The altered hatching and
morphology indicate that embryonic TCE exposure to environmentally relevant concentrations
does alter normal growth and development in the zebrafish biomedical model and the decrease in
cyp24a1 expression could suggest altered vitamin D metabolism. These results provide support
for TCE associated developmental neurotoxicity and suggest a possible mechanism of toxicity.
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2.2

Introduction

Trichloroethylene (TCE) is a volatile organic compound linked to cancer (National Toxicology
Program, 2015), immune system abnormalities (Chiu et al., 2013), reproductive dysfunction
(Chia et al., 1996), congenital cardiac defects (Goldberg et al., 1990), and central nervous system
dysfunction and Parkinson’s disease (Guehl et al., 1999). TCE is a colorless liquid with a sweet,
chloroform-like odor and a solubility of 1.07 g/L at 20°C. TCE is lipophilic, nonflammable, and
not corrosive, which has contributed to its industrial applications (National Toxicology Program,
2015; U.S. Environmental Protection Agency, 2011). Throughout the last 75 years, TCE has
been used as a solvent, degreaser, general anesthetic, lipid extraction agent, refrigerant and
freezing point depressor, in food processing, as a dry cleaning agent, and as an intermediate in
producing chlorofluorocarbons and other chemicals (Bakke et al., 2007; Doherty, 2000; Nowill
et al., 1953). Due to the widespread use of TCE during the mid-part of the twentieth century,
TCE is a significant environmental toxicant and can be found in air, water, and soil (ATSDR,
2014) and is ranked sixteenth on the Agency for Toxic Substances and Disease Registry’s
(ATSDR) Substance Priority List as of 2017 (ATSDR, 2017).
Humans can be exposed to environmental TCE through ingestion of contaminated food
or drinking water, dermal exposure from contact with contaminated sources, or through
inhalation. Contaminated water sources can also cause vapor intrusion, and inhalation of vapors
after volatilization from heated water, such as when showering, is possible (ATSDR, 2016).
Water sources can become contaminated through direct industrial discharge, as well as leaching
from landfills and underground storage tanks (Rusyn et al., 2014). The US Environmental
Protection Agency (US EPA) regulates the level of TCE in drinking water with a 5 parts per
billion (ppb; µg/L) Maximum Contaminant Level (MCL); with a MCL goal of 0 ppb (ATSDR,
2016). However, 4.5-18% of drinking water sources tested by the US EPA had measurable TCE
contamination, although mostly at levels below 30 ppb (ATSDR, 2014). After exposure, the
lipophilic nature of TCE allows easy crossing of cell membranes and rapid absorption and
distribution though the body (National Toxicology Program, 2015). In mammals, TCE can be
exhaled unchanged through the lungs, or extensively metabolized within the body and excreted
in the urine. The 1999–2000 National Health and Nutrition Examination Survey (NHANES)
found that 12% of people in the US had measurable blood levels of TCE (Jia et al., 2012). TCE
and its metabolites have a short half-life, maximally reported at 41 hours (Ikeda et al., 1973).
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TCE can be metabolized either through cytochrome p450 oxidation or glutathione conjugation
pathways before elimination in the urine. Major metabolites include chloral hydrate,
trichloroacetic acid (TCA), dichloroacetic acid, dichlorovinyl glutathione, and dichlorovinyl
cysteine, and these metabolites are thought to mediate some of the toxic effects associated with
TCE (Chiu et al., 2013).
TCE is found in at least 1,050 of the current or former EPA National Priorities List sites
and the mean of maximum concentrations measured at Substance Priority List sites is 109 ppb,
although concentrations above 10,000 ppb have been reported (ATSDR, 2014, 2017). TCE is a
chemical with high concern in public health and is one of the three most commonly identified
chemicals of concern in cancer cluster outbreak investigations (Goodman et al., 2012).
According to the International Agency for Research on Cancer (IARC), TCE is a Group 1
chemical, or a known human carcinogen (International Agency for Research on Cancer, 2014)
and the Environmental Protection Agency (EPA) considers TCE ‘carcinogenic to humans’ by all
routes of exposure (U.S. Environmental Protection Agency, 2011). Epidemiological studies on
high profile Superfund sites with TCE contamination, such as Camp Lejeune, have identified
increased hazard ratios for kidney cancer, liver cancer, and lymphoma (Bove et al., 2014).
Developmental exposure to TCE is also associated with adverse health outcomes such as
abortion, cardiac defects, CNS defects, and low birth weight (ATSDR, 2016). Of these
developmental outcomes, the strongest epidemiological evidence is for the association between
TCE and congenital heart defects (Chiu et al., 2013). However, developmental neurotoxicity is
also linked to TCE exposure. Hypomyelination of the dorsal hippocampus (Isaacson et al.,
1989), altered behavior (Fredriksson et al., 1993; Taylor et al., 1985), and decreased
performance on language and other neuropsychological tests (Laslo-Baker et al., 2004; White et
al., 1997) have been associated with exposure to TCE during critical developmental periods in
rodents and humans.
In adults, occupational exposure is linked to neurotoxicity (Kilburn, 2002) and
Parkinson’s disease (Gash et al., 2008; Guehl et al., 1999). Rodent studies have linked TCE
exposure to nigrostriatal system damage (Lock et al., 2013), which provides a possible
pathogenesis for the Parkinson’s-like symptoms reported in humans. Oral administration of TCE
caused a dose dependent loss of dopaminergic neurons in the substantia nigra pars compacta in
rats (Liu et al., 2010). The likely neurotoxic compound is 1-trichloromethyl-1,2,3,4-tetrahydro-β-
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carboline (TaClo), which can be formed when chloral hydrate, a product of TCE oxidation by
cytochrome p450 2E1 (CYP2E1), combines with endogenous tryptamine (Bringmann et al.,
2006). The mechanism of nigrostriatal neuronal degeneration may be related to oxidative
damage and the inhibition of mitochondrial complex I, similar to other dopaminergic specific
toxins like 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Bringmann et al., 2006;
Caudle et al., 2012).
Based on the potential of developmental neurotoxicity and increased risk of Parkinson's
disease in adults, we hypothesized that embryonic exposure to environmentally relevant
concentrations of TCE (0, 5, 10, 50, and 500 ppb) would alter the neurodevelopment of zebrafish
and alter larval zebrafish behavior. The zebrafish biomedical model is a sensitive model
organism with a strong history of use in developmental toxicity assays and evaluation of
developmental neurotoxicity (Hill et al., 2005; Horzmann et al., 2018). The development of
zebrafish embryos is rapid and well-characterized (Kimmel et al., 1995), and the zebrafish has
many conserved biological processes, including metabolic pathways, endocrine axes, and
behavioral reflexes. The zebrafish genome is 70% similar to the human genome with 80%
similarity in genes related to disease (Howe et al., 2013).
We also tested the relative expression of four cytochrome p450 enzymes in zebrafish
larvae exposed to 10 ppb TCE, a concentration two fold higher than the US EPA MCL. The
developmental toxicity of TCE may be mediated by metabolites and the toxicokinetics of TCE in
zebrafish larvae is unknown. We hypothesized that embryonic TCE exposure would alter the
expression of cytochrome p450 enzymes, including enzymes similar to the human CYP2E1.
Zebrafish lack a described cyp2e1, though zebrafish Cyp2y3 and Cyp2p6 are 43% identical to
the human protein, and 42% identical to each other. These represent the closest structurally
similar cytochromes to CYP2E1 (Tsedensodnom et al., 2013). The remaining cytochrome p450
enzymes (cyp24a1 and cyp1d1) were evaluated because previous microarray analysis suggested
altered expression, although the fold change was not significant for cyp1d1 (Wirbisky et al.,
2016). Induction of cytochrome p450 expression could suggest a role in TCE metabolism and
altered gene expression could provide the basis of TCE induced developmental neurotoxicity.
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2.3

Materials and Methods

2.3.1 Zebrafish husbandry
Embryos were obtained from a breeding colony of wild-type AB strain laboratory zebrafish
(Danio rerio). Adult zebrafish are maintained in a Z-Mod System (Aquatic Habitats, Apopka,
FL) on a 14:10 light-dark cycle. Water is maintained at 28°C, the pH at 7.0-7.3 and 470-550 µS
conductivity. Fish and aquaria are monitored twice and adult fish are fed a mixture of brine
shrimp (Artemia franciscana; Artemia International LLC., Fairview, Texas), Golden Pearls 500800 µm (Artemia International LLC., Fairview, Texas), and Zeigler adult zebrafish food (Zeigler
Bros Inc., Gardners, PA). Adult zebrafish are bred in spawning tanks according to established
protocols (Peterson et al., 2011; Westerfield, 2007) and embryos are collected immediately after
the breeding interval. All protocols were approved by the Purdue University Animal Care and
Use Committee and all fish treated humanely with regard to prevention and alleviation of
suffering.
2.3.2 Chemical treatments for zebrafish assays
A stock solution of 10,000 parts per billion (ppb; µg/L) of 99.5% TCE (CAS registry number 7901-6, Sigma-Aldrich, St. Louis, MO) was prepared in filtered aquaria water. Aliquots of the
10,000 ppb stock solution were diluted with filtered aquaria water to obtain the concentrations of
5, 10, 50, and 500 ppb TCE and filtered aquaria water was used as a 0 ppb control. Zebrafish
embryos at approximately the 4-8 cell state of embryonic development were randomly sorted
into 20 mL, air-tight, glass vials (Fisher Scientific, Pittsburgh, PA), with each vial containing 5
embryos and 20 mL of a TCE dilution or control aquaria water to minimize head space. Embryos
were incubated at 28.5°C and chemical exposure in vials was maintained until 72 hours post
fertilization (hpf; the end of embryogenesis) when larvae were rinsed in filtered aquaria water
and transferred to petri dishes (Fisher Scientific, Pittsburgh, PA) containing 20 mL of filtered
aquaria water. Embryos were kept in the petri dishes until 120 hpf.
2.3.3 Acute toxicity assays
An acute toxicity assay was performed to evaluate possible effects of TCE exposure on
survivability and hatching. An acute toxicity assay was performed similar to previous
experiments (Horzmann et al., 2017; Peterson et al., 2011; Weber et al., 2013). In short, ten
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biological replicates (n=10; defined as being started from a different clutch), of 15 embryos per
treatment (considered as subsamples; 150 subsamples total per treatment) were sorted into glass
vials and dosed with 20 mL of 0, 5, 10, 50 or 500 ppb of TCE. Mortality and percent hatch were
observed three times a day (9:00am, 3:00pm, 9:00pm) through 120 hpf. An analysis of variance
(ANOVA) was performed with SAS 94 software (SAS Institute Inc., Cary, NC) for each
observational time point to compare the treatment groups. When the outcome was statistically
significant, a Fisher’s Least Significant Difference (LSD) test at α = 0.05 was performed to
determine differences between treatment groups.
2.3.4 Morphological assessment
Morphologic abnormalities were evaluated at 120 hpf as previously described (Horzmann et al.,
2017; Peterson et al., 2013; Weber et al., 2013). In short, after euthanasia via anesthetic overdose
with 0.4 mg/ml buffered tricaine-S (ethyl m-amino benzoate methanesulfonate; Western
Chemical Inc., Ferndale, WA), larvae treated with 0, 5, 10, 50 or 500 ppb of TCE were imaged
via light microscopy using a Nikon SMZ1500 stereomicroscope with a Nikon Digital Sight DSfi1 camera. NIS Elements imaging software (Melville, NY) was used to obtain the body length
(measured snout to tail), head length (snout to operculum), head width (width of head at the level
of the eyes), and brain length (rostral aspect of forebrain to caudal aspect of brainstem). The ratio
of head length/body length and head width/body length were also calculated to account for
changes in overall larval size. Nine biological replicates (n = 9) with 10 subsamples per replicate
(total of 90 subsamples per treatment) of body length, head length, and head width measurements
and nine biological replicates (n = 9) with 10-20 subsamples per replicate (total of 150
subsamples per treatment) of brain length were completed. Similar to the acute toxicity assay, an
ANOVA was used to analyze differences among treatments, and a Fisher’s LSD test at α = 0.05
was used when a significant ANOVA was observed.
2.3.5 Larval Visual Motor Response Test
Larval zebrafish behavior was monitored at 120 hpf to evaluate differences in locomotion
between treatment groups. Twelve biological replicates (n = 12) were completed with 12-16
subsamples per treatment per replicate (total of approximately 150 subsamples per treatment).
For each replicate, 12-16 larvae from each treatment, 0, 5, 10, 50 or 500 ppb of TCE and a 50
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µM R(-)-apomorphine hydrochloride hemihydrate (>98.5% purity; Sigma, St. Louis, MO)
positive control treatment were placed into separate wells in a 96-well plate with 0.5 ml of
filtered aquaria water. Apomorphine positive controls were originally dosed with filtered aquaria
water and were exposed to the 50 µM apomorphine solution approximately 10 minutes before
the start of the experiment for a period of 5 minutes. Dead or grossly malformed larvae were
excluded from analysis. Treatments were arranged in balanced rows and columns to prevent
location based test artifact. The Noldus DanioVision Observation Chamber (Noldus Information
Technology, Wageningen, Netherlands) was used to record the infrared activity tracks of the
larvae in the 96-well plate arena. Similar to other studies in the laboratory (Horzmann et al.,
2017), the plate was incubated at 28°C for 10 minutes before being transferred to the observation
chamber to reduce stress and help maintain a constant temperature. The larvae were given an
additional 10 minutes to acclimate to the testing arena before the start of the visual motor
response (VMR) test. The Noldus Temperature Control Unit maintained the observation chamber
water temperature at 28°C throughout the course of the experiment. The Noldus White Light
Routine was used to test the visual motor response by exposing the larvae to a series of 10
minute periods that alternate between dark and light for a total of 50 minutes. During the dark
phase, the closed observation chamber received no artificial light and during the light phase, a
5000 lux light was activated from underneath the observation stage. All behavioral experiments
were performed between 11:00am and 1:00pm to minimize circadian variability in movement.
The infrared movement traces were recorded at a rate of 25 frames per second with a Basler
GenICam acA 1300-60gm camera and analyzed with the Noldus EthoVision 11.5 software. Fish
were identified based on dynamic substitution of background images and tracks were smoothed
via a minimum distanced moved profile set to >0.2 mm. Data for movement endpoints such as
total distance moved, velocity, time spent moving, turn-angle, angular velocity, meander, and
turning direction were collected. An ANOVA was used to analyze differences among treatments,
and a Fisher’s LSD test at α = 0.05 was used when a significant ANOVA was observed.
2.3.6 Quantitative polymerase chain reaction (qPCR) for cytochrome p450 expression
The relative expression of 5 cytochrome p450 (cyp24a1, cyp1d1, cyp2y3, and cyp2p6) enzymes
were evaluated to determine if embryonic TCE exposure induces cyp expression. For expression
analysis, embryos were exposed to treatments of 0 ppb or 10 ppb for 72 hpf (Wirbisky et al.,
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2016). Four replicates (n=4) of 50 pooled embryos were collected for each treatment. Embryos
were euthanized via anesthetic overdose with 0.4 mg/ml tricaine-S, homogenized in Trizol (Life
Technologies, Carlsbad, CA), flash frozen in liquid nitrogen, and stored at -80ºC until RNA
isolation. RNA was isolated with the RNEasy Mini Kit (Qiagen, Germantown, MD) and cDNA
was synthesized using the Superscript First Strand Synthesis Kit (Life Technologies, Carlsbad,
CA) following established protocols (Peterson et al., 2009). The relative expression of the genes
was determined via quantitative PCR (qPCR) following MIQE guidelines (Bustin et al., 2009)
and previously described methods (Freeman et al., 2014; Peterson et al., 2011; Weber et al.,
2013; Wirbisky et al., 2016; Zhang et al., 2011). Forward and reverse primers for the target
genes (Integrated DNA Technologies, Coralville, IA) were designed using the Primer3 Website
(Table 2.1) and checked using NCBI Primer-BLAST (Untergasser et al., 2012). As in a previous
study (Wirbisky et al., 2016), β-actin was chosen as a reference gene due to consistent
expression that did not vary across TCE exposures. qPCR analysis was performed using the
SSoAdvanced Universal SYBR Green Supermix (Bio-Rad, Hercules, CA) on a CFX Connect
Real-Time PCR Detection System (Bio-Rad, Hercules, CA) per the manufacturer’s directions.
Melting and standard dilution curves and no template controls were evaluated to ensure
appropriate efficiency (100±10%) and specificity. Experimental samples were run in triplicate to
provide technical replicates. Gene expression was normalized to β-actin (gene of interest/βactin). An unpaired T-test (α = 0.05) with SAS 94 software (SAS Institute Inc., Cary, NC) was
used to determine if expression was different between the TCE treatment and the controls.

Table 2.1 Primers used in qPCR analysis
Seq ID
NM_001089458.1

Gene Symbol
cyp24a1

NM_001007310.1

cyp1d1

NM_001020822.1

cyp2y3

NM_200139.1

cyp2p6

NM_181601

β-actin

Primer Sequences
ggattggaaaagtcaacggcaa
tcaccatcatcgtcccaaaagt
cactgctcttactggctcttca
aacacgtctccatactgaaccc
tgcctctaagtcttccccacta
ctgaaagttgccattggagtcc
gggcaaattcaggaggagagat
tggtttaggagcacgagttgtt
ctaaaaactggaacggtgaagg
aggcaaataagtttcggaacaa
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2.4

Results

2.4.1 Acute toxicity assays
There was no significant difference (p>0.05) in survival between treatments at any time point
evaluated (Figure 2.1). The survival of all treatments was >80% at 120 hpf. At 48 hpf, the 500
ppb treatment had a significant (p=0.0373) increased in percent hatch compared to the 0 ppb
control treatment (Figure 2.2A); however, there was no significant difference in percent hatch
between treatments at any other time point (Figure 2.2B-D).
2.4.2 Morphological Assessment
The TCE exposed groups did not significantly (p>0.05) differ from one another with respect to
body length, head length, or head width (Figure 2.3B-D). The 500 ppb treatment had a
significantly (p=0.0042) increased head length to body length ratio (Figure 2.3E). The head
width to body length ratio was not significantly different (p>0.05) between treatments (Figure
2.3F). The 500 ppb treatment had a significantly (p=0.0008) shorter brain compared to the
control treatment (Figure 2.4).
2.4.3 Larval Visual Motor Response Test
The positive control group treated with apomorphine, a known dopamine receptor agonist, did
have significantly decreased distance moved (p<0.0001), velocity (p<0.0001), and time spent
moving (p<0.0001), and had increased time spent not moving (p<0.0001) (Figure 2.5A-D).
There was no significant difference (p>0.05) between TCE treatments with respect to total
distance moved, velocity, or time spent moving or not moving (Figure 2.5A-D). There was no
significant (p>0.05) changes between the TCE or apomorphine treatments with respect to
additional parameters such as heading, turn angle, angular velocity, and mean meander (Figure
2.6A-D). The apomorphine treated group did have a significant increase in both the frequency of
clockwise rotations (p=0.0075) and counterclockwise rotations (p=0.0025)(Figure 2.6E-F).
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Figure 2.1. Survivability after TCE Treatment. Percent survival at (A) 24, (B) 48, (C) 72, and (D) 78-120 hpf. No
significant differences between treatments were observed. n = 10, with 15 subsamples per treatment per replicate.
Error bars represent standard deviation. α = 0.05

Figure 2.2. Hatchability after TCE Treatment. Percent hatched at (A) 48, (B) 60, (C) 72, and (D) 84 hpf. The 500
ppb treatment had increased percent hatched at 48 hpf. No differences between treatments were observed at other
time points. n = 10, with 15 subsamples per treatment per replicate. Error bars represent standard deviation. * = p <
0.05.
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Figure 2.3. Alterations in morphology after embryonic TCE exposure. Representative images of 120 hpf larval
zebrafish (A). No differences in body length (B), head length (C), or head width (D) were observed between
treatments. The 500 ppb treatment had a significantly larger head length to body length ratio compared to controls
(E). No significant differences in head width to body length ratio were observed across treatments (F). n = 9, with 10
subsamples per treatment per replicate. Error bars represent standard deviation. * = p < 0.05. Bar in (A) represents 2
mm.
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Figure 2.4. Alterations in brain morphology after embryonic TCE exposure. Representative images of 120 hpf larval
zebrafish (A). The 500 ppb TCE treatment had a significantly shorter brain than the controls (B). n = 9, with 10-20
subsamples per treatment per replicate. Error bars represent standard deviation. * = p < 0.05. Bar in (A) represents
300 µm.

Figure 2.5. Neurobehavioral endpoints after embryonic TCE exposure. The positive control apomorphine had
significantly decreased total distance moved (A), velocity (B), time spent moving (C), and increased time not
moving (D) compared to the control treatment. There were no differences between TCE treatments. n = 6, with 1216 subsamples per treatment per replicate. Error bars represent standard deviation. * = p < 0.05. Apo-apomorphine.
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Figure 2.6. Additional neurobehavioral endpoints after embryonic TCE exposure. There was no difference in
heading (A), turn angle (B), angular velocity (C), or mean meander (D) between treatments. The positive control
apomorphine had increased clockwise rotation (E) and counterclockwise rotation (F) compared to controls. There
were no differences between TCE treatments. n = 6, with 12-16 subsamples per treatment per replicate. Error bars
represent standard deviation. * = p < 0.05. Apo-apomorphine.
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2.4.4 qPCR for cytochrome p450 expression
Embryonic exposure to 10 ppb TCE did not significantly alter the relative expression of cyp2y3
(p=0.8366) and cyp2p6 (p=0.2475) compared to the controls (Figure 2.7A-B). The relative
expression of cyp24a1 was decreased in the larvae exposed to 10 ppb TCE during development
compared to the controls (p=0.0474) (Figure 2.7C), but the relative expression of cyp1d1
(p=0.3005) was not altered after embryonic TCE exposure (Figure 2.7D).

Figure 2.7. Relative expression of cytochrome p450 enzymes after embryonic TCE exposure. There was no change
in relative expression of cyp2y3 (A) or cyp2p6 (B), the cytochromes most similar to human CYP2E1. The relative
expression of cyp24a1 was significantly decreased in the TCE exposed group compared to the controls (C), but the
relative expression of cyp1d1 was not altered (D). n = 4, qPCR run in triplicate, error bars represent standard
deviation, * = p < 0.05.
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Discussion

We investigated the developmental neurotoxicity associated with embryonic exposure to TCE,
an environmental toxicant of significant public health concern. We found that environmentally
relevant concentrations of TCE (0, 5, 10, 50, and 500 ppb) did not significantly alter the survival
of zebrafish embryos exposed to TCE for 72 hpf. The lack of significant mortality in our study is
in agreement with the reported 60,000 ppb TCE lethal concentration 50 (LC50; the concentration
that causes 50% lethality) in adult zebrafish exposed for 48 hours (Slooff, 1979). With our
highest treatment group having a 500 ppb TCE exposure, we did not expect to see overt
mortality in our treatments. The 500 ppb exposure group did have a significant increase in
percent hatched at 48 hpf compared to the controls. Increased hatching is a common endpoint in
zebrafish acute toxicity assays (Hill et al., 2005) and is associated with embryonic hypoxic stress
and delayed development (Warkentin, 2007). Although the acute toxicity assay is a general test
of toxicity, it suggests that embryonic exposure to TCE at levels present at Superfund sites can
produce a pathological response.
To evaluate alterations in growth and neurodevelopment after embryonic exposure to
TCE, we measured basic morphology parameters as well as brain length in our 120 hpf zebrafish
larvae. The 120 hpf endpoint has been suggested as having the greatest sensitivity in zebrafish
teratogenicity assays, although some level of background alterations in body parameters such as
body length can be present (Brannen et al., 2010). Although we did not find any significant
differences in body length or head width to body length ratio, the head length to body length
ratio was increased in the group with embryonic exposure to 500 ppb TCE compared to the
controls. Embryonic exposure to 500 ppb TCE was also associated with a decreased brain length,
so although the 500 ppb TCE treatment had a longer head, the brains were smaller. Increased
head length to body length ratio suggests dysregulation of normal craniofacial development and
decreased brain size suggests altered neurodevelopment. These two events may be related, as the
facial bones have an origin in the cells of the neural tube (Marcucio et al., 2015; Mork et al.,
2015) and an early toxicant exposure could result in altered head and brain development.
However, it is also possible that embryonic exposure to TCE causes disruptions of multiple
pathways during development. Previous microarray analysis of 72 hpf zebrafish larvae exposed
to 10 ppb TCE during embryogenesis found that the expression of genes associated with

90
organismal development, organ morphology, cellular growth and proliferation, and cellular
development pathways were altered (Wirbisky et al., 2016). The morphological alterations
observed in our study could be a result of dysregulation of these pathways.
Neural function was monitored through a visual motor response (VMR) test. Zebrafish
have well-characterized changes in behavior when exposed to a dark to light or light to dark
stimulus (MacPhail et al., 2009) and the VMR is a broad test that evaluates the visual, nervous,
and musculoskeletal systems as larvae see and respond to a light stimulus. Alterations in the
VMR could suggest structural defects or altered neurochemistry and function (Kalueff et al.,
2013; Zhang et al., 2017). We hypothesized that the suspected neurotoxic product of TCE
metabolism, TaClo, would act specifically on dopaminergic neurons and cause hypoactivity. To
evaluate the sensitivity of the VMR in detecting changes to the dopaminergic system, a 50µM
apomorphine treatment was added to serve as a positive control during the behavioral assay.
Apomorphine is a non-selective dopamine receptor agonist that has been used to alter larval
zebrafish behavior (Irons et al., 2013). Although we did not see any significant differences in
movement or other behavioral parameters related to embryonic TCE exposure, the apomorphine
positive control group was hypoactive and had significantly decreased movement parameters
such as distance moved, velocity, and time spent moving. Additionally, the frequency of both
clockwise and counterclockwise rotations were increased, which could suggest neurological
impairment (Kalueff et al., 2013). In our study we saw a significant decrease in activity while
Irons et al. (2013) reported a biphasic response to different concentrations of apomorphine, with
hyperactivity occurring in both low (0.2µM) and high (50µM) treatments. Ek et al. (2016) and
Palmér et al. (2017) both reported initial decreased activity after 50 µM apomorphine
administration but increased activity over time, and our results likely are attributed to the
reported early hypoactivity. Although the 500 ppb embryonic TCE exposure group had increased
early hatching and altered head and brain measurements, there was no change in behavior.
Embryonic exposure to TCE is associated with developmental neurotoxicity in other
species. In one study by Taylor et al. (1985), the pups of female Sprague-Dawley rats with
gestational exposure to 312,000-1,250,000 ppb TCE in drinking water had increased exploratory
and locomotor activity. In another study using Sprague-Dawley rats by Isaacson et al. (1989),
maternal exposure to 312,000 or 625,000 ppb TCE in drinking water resulted in an estimated
fetal exposure of 0.003 ppb and 0.012 ppb and hypomyelination in the stratum
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lacunosummoleculare of the mid-CA1 dorsal hippocampus. Epidemiological evidence in humans
suggests that children consuming well water contaminated with 400-1024 ppb TCE had
cognitive deficits including decreased performance on naming and academic tests (White et al.,
1997). The lack of significant behavioral alterations in our study could suggest that embryonic
TCE exposure does not cause neurobehavioral alterations in zebrafish at the concentrations used
in this study, or that the zebrafish larvae may not adequately model mammalian TCE
developmental neurotoxicity. However, it is also possible that zebrafish exposed to 500 ppb TCE
during embryogenesis are able to compensate for the morphologic alterations during the VMR
test (Vandenberg et al., 2012) or that the VMR test was not sensitive enough to detect more
subtle changes in behavior and nervous function.
The relative gene expression of four cytochrome p450 enzymes was measured to
determine if embryonic TCE exposure would induce cytochrome expression. In mammals,
CYP2E1 is the major liver cytochrome p450 responsible for the oxidative metabolism of TCE
(Lash et al., 2000; Nakajima et al., 1992); however, the toxicokinetics of TCE is currently
unknown in the zebrafish. The relative expressions of cyp2y3 and cyp2p6, the two zebrafish
cytochromes with greatest similarity to human CYP2E1 (Tsedensodnom et al., 2013), were not
altered in 72 hpf zebrafish with embryonic exposure to 10 ppb TCE. The lack of induction is
consistent with mammalian literature. Cyp2e1 does not appear to be induced by TCE in male
B6C3F1/J mouse livers and kidneys (Zhou et al., 2017). Rather, Zhou et al. (2017) found that
Cyp2c29, Cyp2c67, and Cyp2j6 genes exhibited differential isoform usage after TCE exposure,
suggesting that metabolism of TCE may be altered as a result of exposure.
We also evaluated the relative expression of two additional cytochrome p450 enzymes,
cyp24a1 and cyp1d. These genes were selected based on previous microarray analysis (Wirbisky
et al., 2016), which suggested these genes may have altered expression, although the fold change
was less than 1.5 for cyp1d1. The zebrafish cyp24a1 gene has 63% amino acid identity to human
CYP24A1 and is thought to be functionally similar to the mammalian enzyme (Goldstone et al.,
2010). CYP24A1 is the enzyme responsible for the degradation of 25-hydroxyvitamin D3 and
1,25-dihydroxyvitamin D3 (active vitamin D) into 24-hydroxylated products (Jones et al., 2012).
In our study, the relative expression of cyp24a1 was significantly decreased in the 72 hpf larvae
with embryonic exposure to 10 ppb TCE. This would suggest altered vitamin D metabolism and
a possible increase in available vitamin D3 in zebrafish tissues. In zebrafish, the vitamin D3
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receptor is expressed in the developing eye, brain, and otic vesicle at 48 and 96 hpf (Craig et al.,
2008). Vitamin D is implicated in the normal development of multiple organs, including bones
and the brain (Hart et al., 2014) and vitamin D3 receptor expression is associated with apoptosis
and decreased mitosis in the brains of developing Sprague-Dawley rats (Burkert et al., 2003).
Vitamin D receptor signaling is also critical for the development of the heart and inner ear in
zebrafish (Kwon, 2016a, b). It is possible that decreased metabolism of vitamin D3 could
increase the available concentration of vitamin D3 in the larval zebrafish and alter normal
developmental processes.
Zebrafish cyp1d1 is a paralog for CYP1A, with 45% amino acid identity and a similar
gene structure (Goldstone et al., 2009). In zebrafish, cyp1d1 is expressed in the liver and brain,
and is highly expressed during development, with highest expression at 9 hpf with a subsequent
decrease over time (Goldstone et al., 2009). CYP1D1 is only present as a pseudogene in humans,
but has been characterized as a functional xenobiotic metabolizing enzyme in non-human
primates (Uno et al., 2011). In zebrafish, Cyp1d1 appears to have less substrate activity
compared to other Cyp1 enzymes, which could suggest either unknown, specialized biological
function or that Cyp1d1 is an evolutionally remnant (Stegeman et al., 2015). The relative
expression of cyp1d1 was not altered in 72 hpf zebrafish with embryonic exposure to 10 ppb
TCE signifying cyp1d1 is not a target of TCE developmental toxicity.
Although animal models are invaluable to research and help support the plausibility of
suggested human health effects, differences in animal species physiology and metabolism may
limit the translatability of research findings and either over or under estimate the risk of adverse
health outcomes (Lash et al., 2014). For instance, different strains of mice have differences in
TCE metabolism that cause variation in liver and kidney tissue toxicity (Yoo et al., 2015a; Yoo
et al., 2015b) and species differences between TCE metabolism in mice and rats have been
reported (Larson et al., 1992). Correctly modeling the metabolism of TCE is important, as the
metabolites of TCE are thought to influence toxicity. The products of glutathione conjugation are
considered more toxic than the products of oxidation due to their instability and reactivity and are
often linked to cancer (Lash et al., 2014); however, the neurotoxic compound TaClo is formed from a
product of oxidative metabolism. It will be critical to characterize the toxicokinetics of TCE in
zebrafish in the future.
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2.6

Conclusions

TCE is an important environmental toxicant and the effects of long term, low-dose exposure is
still under investigation. This study evaluated the developmental toxicity of environmentally
relevant concentrations of TCE using the zebrafish model. The altered hatching and head and
brain morphology indicate that embryonic TCE exposure to environmentally relevant
concentrations does alter normal growth and development. Additionally, decreased expression of
cyp24a1 could suggest altered vitamin D metabolism after embryonic TCE exposure. Although
the toxicokinetics of TCE in zebrafish require additional study, our results suggest that
developmental TCE toxicity is still a concern at environmentally relevant concentrations and that
TCE should remain a priority environmental toxicant.
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CHAPTER 3. COMPARATIVE ANALYTICAL AND
TOXICOLOGICAL ASSESSMENT OF
METHYLCYCLOHEXANEMETHANOL (MCHM)
MIXTURES ASSOCIATED WITH THE ELK RIVER
CHEMICAL SPILL2

3.1

Abstract

On January 9, 2014, a chemical mixture containing crude methylcyclohexanemethanol (MCHM)
contaminated the water supply of Charleston, West Virginia. Although the mixture was later
identified as a mix of crude MCHM and stripped propylene glycol phenyl ethers, initial risk
assessment focused on 4-MCHM, the predominant component of crude MCHM. The mixture’s
exact composition and the toxicity differences between 4-MCHM, crude MCHM, and the tank
mixture were unknown. We analyzed the chemical composition of crude MCHM and the tank
mixture via GC/MS and, based on identified spectra, found that crude MCHM and the tank
mixture differed in chemical composition. To evaluate acute developmental toxicity, zebrafish
embryos were exposed to 0, 1, 6.25, 12.5, 25, 50, or 100 parts per million (ppm; mg/L) of 4MCHM, crude MCHM, or the tank mixture. The percent mortality and percent hatch, larval
morphology alterations, and larval visual motor response test were used to establish toxicity
profiles for each of the chemicals or mixtures. The acute toxicity differed between 4-MCHM,
crude MCHM and the tank mixture with significant differences in survival, hatching,
morphology, and locomotion at levels as low as the short-term screening level of 1 ppm,
suggesting a need for further research into human health risks. This study is the first to evaluate
the developmental toxicity of the tank mixture and highlights that studies evaluating risk should
not assume the effects of 4-MCHM or crude MCHM are representative of the Tank 396 mixture.

2

The contents of this chapter were originally published as: Horzmann, K. A., de Perre, C., Lee,
L. S., Whelton, A. J., and Freeman, J. L. (2017). Comparative analytical and toxicological
assessment of methylcyclohexanemethanol (MCHM) mixtures associated with the Elk River
chemical spill. Chemosphere 188, 599-607.
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3.2

Introduction

On January 9, 2014 over 37,854 L (10,000 gallons) of a chemical mixture leaked into the Elk
River near Charleston, West Virginia. The spill occurred 2.4 km (1.5 mi) upriver of the water
intake for West Virginia American Water Company’s Kanawha Valley Water Treatment Plant.
This water treatment facility provided water to the nine counties surrounding Charleston, West
Virginia—roughly 15% of the state’s population. Corrosion caused a leak in an above ground,
150,000 L (40,000 gallon) capacity holding tank, tank number 396, on the site of Freedom
Industries, Inc. From approximately 2009 to the time of the incident, Tank 396 had been used to
store a proprietary chemical mixture called “Shurflot 944” prior to its sale for use in chemical
coal flotation (CSB, 2016). The liquid that entered the Elk River contained crude
methylcyclohexanemethanol (MCHM) and stripped PPH, a mixture of propylene glycol phenyl
ether (PPH) and dipropylene glycol phenyl ether (DiPPH). The contaminated river water
overwhelmed the Kanawha Valley Water Treatment Plant’s filtration system and was distributed
to approximately 300,000 people. Whelton et al. (2017) provides a timeline of events, but in
summary, a do-not-use drinking water order was issued the evening of January 9 by the State of
West Virginia’s Governor’s Office and a state of emergency was declared later the same night
(Mistich et al., 2014). The process of lifting the do-not-use order began on January 13 and
continued through January 18, although low levels of contaminants were present in the drinking
water as late as March 2014 (Whelton et al., 2015).
On the night of January 9, 2014, the Centers of Disease Control and Prevention (CDC)
used available information, which was limited to the crude MCHM SDS issued by Eastman
Chemical Company (Eastman, 2016a), to create a short-term 4-MCHM drinking water screening
level of 1 part per million (ppm; mg/L) (CDC, 2014b). The initial response was focused on 4MCHM, the predominant component in crude MCHM, as the presence of stripped PPH in the
tank was unknown to public officials at that time. Screening levels for other components of crude
MCHM, such as methyl 4-methylcyclohexanecarboxylate (MMCHC), were not established,
although PPH, DiPPH, and MMCHC were detected in the drinking water by other organizations
(Foreman et al., 2015).
The actual human exposure during the incident is uncertain. Approximately 37% of
households used drinking water during the do-not-use order (Burrer et al., 2017; CDC, 2014a).
Water company testing results revealed 4-MCHM present at “>100 ppm” at the Kanawha Valley
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Water Treatment Plant intake, up to 13.7 ppm inside the water treatment plant and 4.6 ppm
exiting the treatment plant (CSB, 2016). On January 10, 4-MCHM was detected as high as 3.773
ppm in the water distribution system (McIntyre, 2014). During the following week, between <10
ppb and 420 ppb 4-MCHM was detected in area households (Weidhass et al., 2015; Whelton et
al., 2015). 4-MCHM was measured in both the Kanawha and Ohio rivers in the days after the
incident with 4-MCHM detected in the Ohio river at low levels (4.2-5.5 ppb) 350 miles
downstream near Louisville, KY on January 17, 2014 (Foreman et al., 2015). 4-MCHM was still
detected in water exiting the treatment plant at levels between 42 and 60 ppb in March 2014;
however once the carbon filters were replaced at the treatment plant (June 2014), 4-MCHM
could no longer be detected (Whelton et al., 2015).
Eastman Chemical Company originally performed basic toxicology assays on crude
MCHM in 1977 and 1998 (Eastman, 2016b; Light, 1998a, b; Terhaar, 1977); however, at the
time of the chemical spill, little else was known about the toxicity, health effects, and
environmental fate of crude MCHM or 4-MCHM. Although recent research has focused on
modeling the environmental fate and transport of chemicals in the spill (Bahadur et al., 2015; He
et al., 2015; Noble et al., 2016; Stolze et al., 2015; Weidhaas et al., 2016; Weidhaas et al., 2017;
Yuan et al., 2016a; Yuan et al., 2016b), the physiologic and toxicological effects of these
chemicals require further investigation.
Evaluating single compounds may not adequately identify the risks and hazards associated
with exposure to mixture of two or more chemicals, which can have additive, synergistic,
potentiated, or inhibitory toxicological effects (McCarty et al., 2006; Monosson, 2005; Tsatsakis
et al., 2016). Crude MCHM and the Tank 396 mixture may have very different biological effects
when compared to 4-MCHM due to the presence of components other than 4-MCHM in crude
MCHM and the stripped PPH added to the Tank 396 liquid (Phetxumphou et al., 2016). It
should also be mentioned that the measured composition of different crude MCHM samples have
varied from the reported concentrations given on the safety data sheet (SDS) (Eastman, 2016a;
NTP, 2016c). Additionally, 4-MCHM is composed of a mixture of cis and trans isomers. These
isomers appear to have different physical properties, which may cause differences in toxicity and
environmental fate (DeYonker et al., 2016; Dietrich et al., 2015). The difficulty in assessing the
human health risk of contaminated water exposure from the spill stems largely from a lack of
toxicity and environmental fate data for the components of the Tank 396 mixture, and early
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toxicological assessment using only 4-MCHM or crude MCHM may not accurately predict the
potential health effects of the mixture that leaked into the Elk River due to differences in
composition. No study to date has used the Tank 396 mixture to study the physiological and
toxicological effects that may be associated with contaminated water exposure during the Elk
River incident. This study examines the hypothesis that 4-MCHM, crude MCHM, and the Tank
396 liquid have different chemical compositions and that 4-MCHM, crude MCHM, and the Tank
396 liquid will have different toxicological effects in the zebrafish (Danio rerio) model
organism. To investigate this hypothesis, components of both crude MCHM and the Tank 396
liquid were identified and quantified to determine the composition of the chemical mixtures.
Zebrafish embryos were used to evaluate the acute developmental toxicity potential of the Tank
396 liquid as well as 4-MCHM and crude MCHM. The zebrafish is a well-recognized
biomedical research model used extensively in the study of developmental biology, drug
discovery, pharmacology, genetics, and toxicology (as reviewed by Lele and Krone (1996); Hill
et al. (2005); Yang et al. (2009), and Bowman and Zon (2010)). Zebrafish survival and
hatchability were evaluated after developmental exposure to 4-MCHM, crude MCHM, and the
Tank 396 liquid. Additionally, larval morphology was assayed to evaluate for the presence of
minor morphological alterations, and a visual motor response test was used to monitor the
locomotor activity and behavior of the exposed zebrafish.

3.3

Materials and Methods

3.3.1 Analytical Analysis of Crude MCHM and Tank 396 Mixtures
A 2014 batch of crude methylcyclohexanemethanol (MCHM) (provided by Eastman Chemical
Company, Kingsport TN), and a mixture of crude MCHM and stripped propylene glycol phenyl
ethers (PPH) obtained from Freedom Industries Tank 396 (provided to AW from US Geological
Survey, Leetown Science Center, Kearneysville, WV) were analyzed following the protocol
described in the “chemical identity and purity screen final report” from MRI Global submitted to
the National Institute of Environmental Health Sciences (MRIGlobal, 2015). Stock solutions of
the MCHM and Tank 396 mixtures were prepared in duplicate for each by diluting about 100 mg
of the crude MCHM or the Tank 396 mixture into 100 ml and 25 ml dichloromethane,
respectively. For the two crude MCHM stock solutions, test solutions were obtained after
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dilution 2.5 times in dichloromethane. Blank stock and test solutions were prepared using only
dichloromethane in similar glassware. Analyses were performed using a Shimadzu Gas
Chromatograph - Mass Spectrometer GCMS-QP2010 equipped with an AOC-20i autosampler. A
30 m × 0.25 mm, 1.4 μm Rtx-VMS (Restek) column was used with the following temperature
gradient: 50°C for 2 min, 10°C/min to 240°C, which was held for 4 min. The injector was
operated in splitless mode at 240 °C with a helium carrier gas set at linear velocity of 1.1 ml/min.
The MS source and interface temperatures were 230 °C and 250 °C, respectively. Quantification
of identified molecules was performed in Single Ion Monitoring (SIM) mode for m/z 97, 81, 95,
83 from 5 to 16 min, and m/z 5, 45, 55, 41 from 16 to 25 min. Three compounds were quantified
using external calibration standards adapted to the concentrations of the samples and prepared in
dichloromethane with standards obtained as follows: 4-methyl-1-cyclohexanemethanol (MCHM,
cis and trans mixture, 99.7% purity, Tokyo Chemical Industry Co., Tokyo, Japan),
cyclohexanemethanol (CHM, 99.2% purity, Sigma-Aldrich, St Louis, MO, USA), 1,4cyclohexanedimethanol (CHDM, cis and trans mixture, 99.8% purity, Sigma-Aldrich). For
quantification of 4-methyl-1-cyclohexanemethanol, the two MCHM crude test solutions and the
two tank mixture stock solutions were diluted another 50 times to be within the linear range of
the standard curve. The isomeric composition of the standard was not available, so the same
response coefficient was assumed for both isomers.

3.3.2 Zebrafish Husbandry
Embryos were obtained from a breeding colony of wild-type AB strain laboratory zebrafish
(Danio rerio). Adult zebrafish are maintained in a Z-Mod System (Aquatic Habitats, Apopka,
FL) on a 14:10 light-dark cycle. Water is maintained at 28°C, the pH at 7.0-7.3, and salinity at
470-550 µS conductivity. Fish and aquaria are monitored and fed twice daily. Adult fish are fed
a mixture of brine shrimp (Artemia franciscana, Artemia International LLC., Fairview, Texas),
Golden Pearls 500-800 µm (Artemia International LLC., Fairview, Texas), and Zeigler adult
zebrafish food (Zeigler Bros Inc., Gardners, PA). Adult zebrafish are bred in spawning tanks
according to established protocols (Peterson et al., 2011; Westerfield, 2007) and embryos are
collected immediately after the breeding interval, approximately at the 4-8 cell stage of
embryonic development. The embryos are rinsed and randomly sorted into groups for
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experimentation. All embryos used in experiments are incubated at 28°C for 120 hours post
fertilization (hpf). All protocols were approved by the Purdue University Animal Care and Use
Committee and all fish treated humanely with regard to prevention and alleviation of suffering.
3.3.3 Chemical Treatments for Zebrafish Assays
100 parts per million (ppm; mg/L) stock solutions of 4-MCHM (>98% purity, CAS 34885-03-5,
TCI America, Portland OR), crude methylcyclohexanemethanol MCHM, and Tank 396 liquid
were prepared in filtered aquaria water based on density. Density was determined by weighing in
triplicate 1 mL samples of each liquid. The mean density and standard deviation of crude
MCHM and the tank mixture were 913.6 ± 9.0 mg/mL and 866.2 ± 14 mg/mL respectively; the
density of 4-MCHM was reported to be 915.0 mg/mL by TCI America (Novy, 2015). For each
chemical, aliquots of 100 ppm stock solution were diluted with filtered aquaria water to obtain
the concentrations of 50, 25, 12.5, 6.25, and 1 ppm. Filtered aquaria water was used as a 0 ppm
control. The pH of all stock solutions was the same as the filtered aquaria water control.
3.3.4 Acute Toxicity Assays
An acute toxicity assay was performed independently for crude MCHM, 4-MCHM, and the tank
mixture to determine a relative toxicity of these chemicals to zebrafish. The acute toxicity assay
was performed similar to previous experiments (Peterson et al., 2011; Weber et al., 2013). In
short, three biological replicates (n=3; defined as being started from a different clutch), of 50
embryos (considered as subsamples) per treatment were sorted into 100 mm x 20 mm
polystyrene petri dishes and dosed immediately after fertilization (approximately at the 4-8 cell
stage of embryonic development) with 20 mL of 0, 1, 6.25, 12.5, 25, 50 or 100 ppm of chemical.
Mortality and hatching were observed three times a day (9:00am, 3:00pm, 9:00pm) through 120
hpf. An analysis of variance (ANOVA) was performed with SAS 94 software (SAS Institute
Inc., Cary, NC) for each observational time point to compare the treatment groups. When the
outcome was statistically significant, a Least Significant Difference (LSD) test at α = 0.05 was
performed to determine differences between treatment groups.
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3.3.5 Morphological Assessment
Morphologic abnormalities were evaluated at 120 hpf as previously described (Weber et al.,
2013) in which larvae were euthanized via anesthetic overdose with 0.4 mg/ml tricaine-S (ethyl
m-amino benzoate methanesulfonate; Western Chemical Inc., Ferndale, WA) and body length,
head length, and head width measured. For each replicate, twenty larvae from each treatment
(considered as subsamples) were imaged via light microscopy using a Nikon SMZ1500
dissecting microscope with a Nikon Digital Sight DS-fi1 camera. NIS Elements imaging
software (Melville, NY) was used to obtain the body length (measured snout to tail), head length
(snout to operculum), and head width (width of head at the level of the eyes). The ratio of head
length/body length and head width/body length were calculated to account for changes in overall
larval size. Additionally, the ratios of head length to body length and head width to body length
were compared between treatment groups. Three biological replicates (n = 3), with 20 larvae per
treatment (considered subsamples) were completed independently for crude MCHM, 4-MCHM,
and the tank mixture. Treatments groups of 0, 1, 6.25, 12.5, and 25 ppm were evaluated; the 50
and 100 ppm treatments were not included in this assessment due to increased gross
malformations (bent axes) in the 50 ppm Tank 396 treatment (data not shown) and the increased
to complete mortality in the 100 ppm treatments. An ANOVA was used to analyze differences
among treatments, and a LSD test at α = 0.05 was used when a significant ANOVA was
observed.
3.3.6 Visual Motor Response Test
Larval zebrafish behavior was monitored at 120 hpf to evaluate differences in locomotion
between treatment groups. Four biological replicates (n = 4) were completed independently for
crude MCHM, 4-MCHM, and the tank mixture. Six treatments were included in this assay: 0, 1,
6.25, 12.5, 25 and 50 ppm. The 100 ppm treatment was excluded due to acute toxicity. For each
replicate, 16 larvae from each treatment (considered as subsamples) were placed into separate
wells in a 96-well plate with 0.5 ml of filtered aquaria water. Dead or grossly malformed larvae
were excluded from analysis. Treatments were arranged in balanced columns to prevent location
based test artifact. The Noldus DanioVision Observation Chamber (Noldus Information
Technology, Wageningen, Netherlands) was used to record the infrared activity tracks of the
larvae in the 96-well plate arena. The loaded 96-well plate was incubated at 28°C for 10 minutes
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before being transferred to the observation chamber to reduce stress and help maintain a constant
temperature. The Noldus Temperature Control Unit maintained the observation chamber water
temperature at 28°C throughout the course of the experiment. The larvae were given 10 minutes
in the dark, with the observation chamber water held at 28°C to acclimate to the testing arena
before the start of the visual motor response test. The Noldus White Light Routine was used to
test the visual motor response by exposing the larvae to series of 10 minute periods that alternate
between dark and light for a total of 50 minutes. During the dark phase of the White Light
Routine, the closed observation chamber received no artificial light and during the light phase, a
5000 lux light was activated from underneath the observation stage. All behavioral experiments
were performed 11am-1pm to minimize circadian variability in movement. The infrared
movement traces were recorded at a rate of 25 frames per second with a Basler GenICam acA
1300-60gm camera and analyzed with the Noldus EthoVision 11.5 software. Fish were identified
based on dynamic substitution of background images and tracks were smoothed via a minimum
distanced moved profile set to >0.2 mm. Data for movement endpoints such as total distance
moved, velocity, time spent moving, turn-angle, angular velocity, meander, and turning direction
were collected. An ANOVA was used to analyze differences among treatments, and a LSD test
at α = 0.05 was used when a significant ANOVA was observed.

3.4

Results

3.4.1 Chemical Components of Crude MCHM and Tank 396 Mixtures
The GC/MS analysis of the crude MCHM in scan mode revealed five major peaks that
responded at about 12.3, 13.3, 13.7, 17.1, and 17.3 min on the chromatogram. The comparison
with NIST 95 MS spectra allowed the identification of cyclohexanemethanol (CHM, 96%
similarity), 4-methylcyclohexanemethanol (MCHM, 2 isomers, 95% similarity), 1,4cyclohexanedimethanol (CHDM, 89% similarity), and 1,2-cyclohexanedimethanol (CHDM,
84% similarity). However, after injection of standards with the same method, 1,4cyclohexanedimethanol exhibited a retention of 18.9 min, thus 1,4-CHDM was not one of the
major components of the mixture. According to NIST 14, the compounds at 17.1 and 17.3 min
may be 4-(methoxymethyl)cyclohexanemethanol (4-MMCHM, 80-88% similarity). Other minor
compounds were identified as 2-ethyl-1-hexanol (12.4 min, 97% similarity), methyl 4-methyl-
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carboxylic

acid

(MMCHCA,

13.9

min,

92%

similarity),

and

1,4-

cyclohexanedicarboxylic acid dimethyl ester (CHDCADE, 19.3 min, 91% similarity) (Table
3.1). Other minor compounds detected were < 90% in similarity to anything in the NIST libraries
and their relative amount based on area response was < 0.1%. The composition of the Tank 396
mixture was very similar to the crude MCHM, except for the presence of compounds with
retention times between 20.5 and 21 min that are likely dipropylene glycol phenyl ethers (6.5%
of total area response, Figure 3.1), but could not be identified formally, as we could not obtain
standards and they are not part of the NIST database. Propylene glycol phenyl ethers were also
present in the mixture and identified by both databases from 16.6 to 16.7 min (90-96%
similarity). Other minor compounds (9 peaks making up to 0.55% of the total relative amount
based on area response) were also detected between 22.6 and 24.7 min; they could be
tripropylene glycol phenyl ethers or similar but with longer chain alkenes, but could not be
identified using the database. Another minor difference with the crude MCHM was that the
compound with a retention time of 12.4 min did not match the NIST MS spectrum for 2-ethyl-1hexanol, but no molecule in the database was a good match. The concentrations of compounds in
the crude mixture for which standards were available are given in Table 3.2. Both the crude
MCHM and Tank 396 mixtures had similar concentrations for the five compounds (trans and cis
isomers 4-methylcyclohexanemethanol, cyclohexanemethanol, and trans and cis isomers 1,4cyclohexanedimethanol), except that the cis isomer of 1,4-cyclohexanedimethanol was not
detected in the crude MCHM (it was very low in the tank mixture). The identification of the cis
and trans isomers of 4-methylcyclohexane-methanol and 1,4-cyclohexanedimethanol was
determined by injecting the standards in scan mode and comparison with the NIST database. The
similarity for the trans isomer to be the first peak for both compounds was higher. Overall, our
percent compositional analysis of crude MCHM (Table 3.1) correlated well with results reported
by the National Toxicology Program (NTP, 2016c) except we believe based on the mass spectra
of the new NIST databases what NTP reported as being 1,4 cyclohexanedimethanol (CHDM)
(reported as 7.15% in Table 3.1) was actually 4-(methoxymethyl)-cyclohexanemethanol (4MMCHM).

Table 3.1. Components of crude MCHM and the Tank 396 Mixture

Crude MCHM
Eastman SDS
Chemical Name

CAS:

Composition

4-Methylcyclohexanemethanol (4-MCHM)

34885-03-5

68-89 %

4-(Methoxymethyl)-cyclohexanemethanol (4-MMCHM)

98955-27-2

4 – 22 %

Water

7732-18-5

4-10 %

Methyl 4-methylcyclohexanecarboxylate (MMCHC)

51181-40-9

5%

Dimethyl 1,4-cyclohexanedicarboxylate

94-60-0

1%

Methanol

67-56-1

1%

1,4-Cyclohexanedimethanol (CHDM)

105-08-8

1–2%

Cyclohexanemethanol (CHM)

a

Crude MCHM

Analysis of Crude

Analysis of Tank

obtained late in

MCHM obtained

Mixture Obtained

2014 by NTP
Composition
90.35 %

b

from Eastman
Composition
85.7-87.2 %

d

c

in early 2014c
Composition
85.1 % d

9.8-10.0 %e

5.2 %

0.5 %

0.4 %

0.3 %

<1 %

0.2 %

0.1 %

7.15 %f

0.0 % d

0.04 % d

100-49-2

1.82 %

1.6-1.8 %d

1.5 %d

2-ethyl-1-hexanol

104-76-7

0.06 %

0.5 %

cis-Octahydroisobenzofuran

13149-01-4

0.13 %

propylene glycol phenyl ethers (PPH)

0.0 %

0.2 %

Dipropylene glycol phenyl ethers (DiPPH)

0 .0 %

6.5 %

a

Safety Data Sheet (SDS) from Eastman (2016a)
National Toxicology Program (NTP, 2016c)
c
Current work based on % area response
d
Chemicals whose identity was checked by comparison with standards. Other chemical identities were obtained by comparison to the NIST database.
e
Assuming the NIST 14 database is correct for chromatographic retention times are 17.1 and 17.3 min for the 2 isomers of this component
f
Based on the mass spectra in the NIST 14 database, we believe this is for 4-(methoxymethyl)-cyclohexanemethanol (4-MMCHM)
b
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Figure 3.1. Chromatograms of the crude MCHM and Tank 396 mixtures in scan mode. Bottom chromatogram is a
zoom of the top one corrected for the dilution factor differences of the crude MCHM compared to Tank 396 for
direct comparison
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Table 3.2. Concentrations of analytes for which standards were available in crude MCHM and Tank 396 mixtures.
trans 4-Methylcyclohexanemethanol (MCHM)
cis 4-Methylcyclohexanemethanol (MCHM)
Cyclohexanemethanol (CHM)
trans 1,4-Cyclohexanedimethanol (CHDM)
cis 1,4-Cyclohexanedimethanol (CHDM)

Crude MCHM (mg/g)
508-576
231-260
10.03-11.56
0.10-0.11
Non detected

Tank 396 (mg/g)
523-537
259-263
12.68-12.74
0.15-0.16
0.018-0.021

We also assessed the cis and trans isomer ratios, which were different between 4-MCHM and
crude MCHM. We obtained cis:trans ratios of 1.91:1, 1:1.38, and 1:1.66 for 4-MCHM, crude
MCHM, and Tank 396 respectively, which were similar in trend to those reported by Dietrich et
al. (Dietrich et al., 2015) for 4-MCHM (2.08:1) and crude MCHM (1:1.75), and by Foreman et
al. (Foreman et al., 2015) (ratios of 1:1.85) for the tank mixture. Therefore, pure 4-MCHM will
have different properties (and thus different toxicity profiles) compared to crude MCHM and the
Tank 396 mixture.
3.4.2 Developmental Toxicity Assays
3.4.2.1 Acute Toxicity Assay – Survival
The 120 hpf survival for 4-MCHM, crude MCHM, and the Tank 396 mixture are shown in
Figure 3.2. A significant difference between treatment group survival was observed throughout
the time course for 4-MCHM (Figure 3). The 100 ppm treatment group had only 55.0% of
embryos surviving at 24 hpf (p=0.0472), with no significant difference between the 0, 1, 6.25,
12.5, 25 or 50 ppm treatment groups (Figure 3.3B). This trend stayed consistent throughout
development and at 120 hpf survival in the 100 ppm treatment group remained significantly
different (p=0.0173) with 37.0% survival compared to the other treatment groups (which
averaged 78.2% survival) (Figure 3.2A).
A significant difference between treatment group survival was also observed for crude
MCHM throughout the time course (p<0.0001). Although there was no difference in survival in
the 50 ppm and lesser treatment groups, the 100 ppm treatment group had a significant decrease
in survival, with complete mortality by 30 hpf (Figure 3.4). Throughout the remainder of the
assay and up to 120 hpf, the 0, 1, 6.25, 12.5, 25, and 50 ppm treatment groups had similar
survival, with an average of 78.3% survival among treatment groups, and were not significantly
different from each other (Figure 3.2B; Figure 4).
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The Tank 396 liquid also had a significant difference between treatment groups
throughout the time course (p<0.0001). By 48 hpf, there was complete mortality of the 100 ppm
treatment group compared to an average of 84.67% survival among the other treatment groups
(Figure 3.5D). In addition, starting at 54 hpf (Figure 3.5E), the 50 ppm treatment group also had
significantly decreased survival (76.0%) compared to the 0, 1, 6.25, 12.5, and 25 ppm treatment
groups (average survival 85.9%; p<0.0001) and this persisted through 120 hpf (50 ppm group
survival 76.0%, average survival of other groups 85.7%; Figure 3.2C).

Figure 3.2. Percent survival and hatching of zebrafish embryos with developmental exposure to 4-MCHM, crude
MCHM, or the tank mixture. Zebrafish embryos exposed to seven concentrations of 4-MCHM (A) or crude MCHM
(B) immediately after fertilization had significantly decreased survival in the highest (100 ppm) treatment group by
120 hpf. Zebrafish embryos exposed immediately after fertilization to seven concentrations of the Freedom
Industries Tank 396 mixture had significantly decreased survival of both the 50 ppm and 100 ppm treatment groups
at 120 hpf (C). Zebrafish embryos exposed to 4-MCHM (D) or crude MCHM (E) had no differences in the percent
hatched among treatment groups at 72 hpf. A significant decrease in percent hatched was observed at 72 hpf for
zebrafish embryos in the 50 ppm treatment group of the Freedom Industries Tank 396 mixture (F). *Significantly
different from the 0 ppm control group (p < 0.05). # signifies treatment had complete mortality. Values are the mean
± standard deviation.
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Figure 3.3. Time course of acute toxicity in zebrafish embryos during 4-MCHM exposure. The 100 ppm treatment
group had significantly decreased survival compared to controls starting at 12 hpf (A). The decreased survival of the
100 ppm treatment group continued at 24 hpf (B), 36 hpf (C), 48 hpf (D), 54 hpf (E), 60 hpf (F), 72 hpf (G), 84 hpf
(H), and 96 hpf (I), with no other treatment groups having altered survivability. *Significantly different from the 0
ppm control group (p < 0.05). Values are the mean ± standard deviation.
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Figure 3.4. Time course of acute toxicity in zebrafish embryos during crude MCHM exposure. The 100 ppm
treatment group had significantly decreased survival compared to controls at 12 hpf (A), 24 hpf (B), and reached
100% mortality by 30 hpf (not shown). There was no survival between other treatments at 36 hpf (C), 48 hpf (D), 54
hpf (E), 60 hpf (F), 72 hpf (G), 84 hpf (H), and 96 hpf (I). *Significantly different from the 0 ppm control group (p <
0.05). Values are the mean ± standard deviation.
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Figure 3.5. Time course of acute toxicity of zebrafish embryos during exposure to Freedom Industries Tank 396
mixture. The 100 ppm treatment group had significantly decreased survival compared to controls at 12 hpf (A),
which decreased further at 24 hpf (B) and 36 hpf (C). By 48 hpf the 100 ppm treatment group had 100% mortality.
Starting at 54 hpf (E), the 50 ppm treatment group also had significantly decreased survival compared to controls
which continued at 60 hpf (F), 72 hpf (G), 84 hpf (H), and 96 hpf (I). *Significantly different from the 0 ppm control
group (p < 0.05). Values are the mean ± standard deviation.

3.4.2.2 Acute Toxicity Assay – Hatching
The 72 hpf percent hatched for 4-MCHM, crude MCHM, and the Tank 396 mixture are shown in
Figure 3.2. Throughout the time course for 4-MCHM, no significant differences in hatching were
observed between any treatment groups (p>0.05; Figure 3.2D; Figure 3.6). Alternatively, for
crude MCHM a significant difference (p=0.0282) in percent hatched was observed at 54 hpf with
the 50 ppm treatment group having significantly fewer embryos hatched compared to the
controls (Figure 3.6D). The 50 ppm treatment group had an average of 42.4% hatched compared
to an average of 70.0% hatched for the remaining treatments. However, by 60 hpf, there was no
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Figure 3.6. Hatching of developing zebrafish embryos exposed to 4-MCHM, crude MCHM, or Tank 396 mixture.
There was no difference in the percent hatched of zebrafish embryos treated with the different 4-MCHM
concentrations at 54 hpf (A), 60 hpf (B), or 120 hpf (C). Surviving zebrafish embryos exposed to concentrations of
crude MCHM had significantly decreased hatching in the 50 ppm treatment group at 54 hpf (D); however, there was
no difference in percent hatched at 60 hpf (E) or 120 hpf (F). Surviving zebrafish embryos exposed to concentrations
of the Tank 396 mixture had significantly decreased percent hatched in the 6.25, 12.5, 25, and 50 ppm treatment
groups at 54 hpf (G), but by 60 hpf, only the 50 ppm treatment group had decreased percent hatched (H), and by 120
hpf there were no differences between treatment groups (I). *Significantly different from the 0 ppm control group (p
< 0.05). # Signifies treatment had complete mortality. Values are the mean ± standard deviation.

significant difference in hatching between treatment groups and this trend continued throughout
the remaining time points (p>0.05; Figure 3.2E; Figure 3.6E,F). A greater impact on percent
hatched was observed for the tank mixture. A significant difference (p <0.0010) in hatching was
observed at 54 hpf with the 6.25, 12.5, 25, and 50 ppm treatment groups having significantly

119
fewer embryos hatched (Figure 3.6G). From 60-72 hpf, a significant decrease in percent hatched
remained for the 50 ppm treatment group (p< 0.0001; Figure 2F; Figure 3.6H). However, by 78
hpf, there was no significant difference in hatching between treatment groups and this continued
through 120 hpf (p>0.05; Figure 3.6I).
3.4.3 Morphology
No increase in gross malformations was noted for 4-MCHM, crude MCHM, or the Tank 396
liquid at treatment levels 25 ppm or lower, although increased bent axes (58-74% of hatched
larvae, data not shown) were noted during the acute toxicity assay for the 50 ppm Tank 396

Figure 3.7. Morphologic alterations in zebrafish larvae at 120 hpf after developmental exposure to different
concentrations of 4-MCHM, crude MCHM, or the tank mixture. All 4-MCHM treatment groups were significantly
smaller than the control 0 ppm group with respect to total body length (A), head length (B), and head width (C). For
larvae with developmental exposure to crude MCHM, there were no significant differences in total body length (D)
or head length (E) between treatment groups. The 6.25 ppm crude MCHM treatment group did have a statistically
significant decrease in head width (F). For larvae in the Tank 396 treatment groups, the 25 ppm group was
significantly smaller than the control group with respect to body length (G) and head length (H). The 12.5 and 25
ppm treatments both had a significantly narrower head compared to controls (I). *Significantly different from the 0
ppm control group (p < 0.05). Values are the mean ± standard deviation.

120
liquid treatment. For the 4-MCHM treatments, the body length (p<0.0010), head length
(p<0.0001), and head width (p<0.0001) were significantly different between treatment groups,
with all 4-MCHM treated groups (1, 6.25, 12.5 and 25 ppm) being significantly smaller than the
control treatment group (Figure 3.7A-C).
The ratio of head length to body length was significantly different (p=0.0029) between
treatment groups with the 12.5 and 25 ppm treatments having a significantly smaller ratio than
the other treatment groups (Figure 3.8B). The head width to body length ratio was not
significantly different across the treatment groups (p=0.1821; Figure 8C).

Figure 3.8. Additional morphologic alterations in zebrafish larvae at 120 hpf after developmental exposure to
different concentrations of 4-MCHM. Representative images of larval zebrafish measured at 120 hpf after
developmental exposure to 4-MCHM concentrations (A). When evaluated as a ratio to today body length, the 12.5
and 25 ppm treatment groups had a proportionally shorter head than controls (B) but no proportional difference in
head width (C). *Significantly different from the 0 ppm control group (p < 0.05). Values are the mean ± standard
deviation. Bar in (A) represents 2 mm.
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There were no significant differences in body length (p=0.0656) or head length
(p=0.4013) between treatment groups for crude MCHM (Figure 3.7E,F). The head width was
statistically different between treatment groups, with the 6.25 ppm treatment group having
narrower heads (p=0.0233; Figure 3.7F). The ratios of head length to body length (p=0.9126)
and head width to body length (p=0.4816) were not significantly different between treatment
groups (Figure 3.9B,C).
For the Tank 396 treatments, the body length (p=0.0215), head length (p=0.0055), and
head width (p<0.0001) were significantly different between treatment groups (Figure 3.7G-I).
The 25 ppm treatment group had a significantly smaller body length (Figure 3.7G) and head
length (Figure 3.7H) than the other treatment groups and the 12.5 and 25 ppm treatments had
narrower heads than the other treatments (Figure 3.7I). There was no significant differences
between treatments for either the head length to body length ratio (p=0.3321) or the head width
to body length ratio (p=0.1834) (Figure 3.10B,C).

Figure 3.9. Additional morphologic alterations in zebrafish larvae at 120 hpf after developmental exposure to
different concentrations of crude MCHM. Representative images of larval zebrafish measured at 120 hpf after
developmental exposure to crude concentrations (A). When head length to body length ratio (B) or head width to
body length (C) were evaluated, there was no significant differences between treatments. *Significantly different
from the 0 ppm control group (p < 0.05). Values are the mean ± standard deviation. Bar in (A) represents 2 mm.
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Figure 3.10. Additional morphologic alterations in zebrafish larvae at 120 hpf after developmental exposure to
different concentrations of the Tank 396 mixture. Representative images of larval zebrafish measured at 120 hpf
after developmental exposure to tank mixture concentrations (A). When head length to body length ratio (B) or head
width to body length ratio (C) were evaluated, there was no significant differences between treatments.
*Significantly different from the 0 ppm control group (p < 0.05). Values are the mean ± standard deviation. Bar in
(A) represents 2 mm.

3.4.4 Visual Motor Response Test
In the locomotor assay, the 4-MCHM treatment groups were significantly different from one
another with respect to distance moved (p=0.0347), velocity (p=0.0347), and time spent moving
(p=0.0196) (Figure 3.11A-C). The 1, 12.5, and 25 ppm treatment groups had increased distance
moved, velocity, and time spent moving compared to the controls. There was no difference in
other locomotor parameters including turn angle, angular velocity, or meander (p>0.05; data not
shown). In addition, a significant difference between treatment groups was observed in both the
frequency of clockwise rotation (p=0.0005) and the frequency of counterclockwise rotation
(p=0.0003) with the 1 and 25 ppm treatment groups having increased frequency of clockwise
rotations and the 1, 25, and 50 ppm treatment groups having increased frequency of
counterclockwise rotation (Figure 3.12A,B).
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Figure 3.11. Alterations in behavior in 120 hpf zebrafish larvae after developmental exposure to different
concentrations 4-MCHM, crude MCHM, or Tank 396 mixture. Larvae with developmental exposure to 1 ppm, 12.5
ppm, or 25 ppm 4-MCHM had significantly altered locomotor activity compared to controls, with increased distance
moved (A), velocity (B), and time spent moving (C). Larvae with developmental exposure to 1 ppm, 12.5 ppm, or
50 ppm crude MCHM had significantly decreased locomotor activity compared to controls, with decreased distance
moved (D) and velocity (E). The 1 ppm and 50 ppm crude MCHM treatment groups also had significantly decreased
time spent moving (F) compared to the control treatment. Larvae with developmental exposure to 1 ppm or 50 ppm
tank mixture concentrations had significantly altered locomotor activity compared to controls, with the 1 ppm
treatment group having increased and the 50 ppm treatment group having decreased distance moved (G) and
velocity (H) compared to controls. The 50 ppm tank mixture also had a significant decrease in time spent moving
compared to controls (I). *Significantly different from the 0 ppm control group (p < 0.05). Values are the mean ±
standard deviation.

The crude MCHM treatment groups were significantly different from one another with
respect to distance moved (p=0.0022), velocity (p=0.0020), and time spent moving (p=0.0127)
(Figure 3.11D-F). The 1, 12.5, and 50 ppm treatment groups had decreased distance moved and
velocity compared to the controls and the 1 and 50 ppm groups had decreased time spent moving
compared to the controls. There was no difference (p>0.05) in other locomotor parameters
including turn angle, angular velocity, meander (data not shown), or direction of rotation (Figure
3.12C,D).

124
The Tank 396 treatment groups were also significantly different from one another with
respect to total distance moved (p=<0.0001), velocity (p=<0.0001), and time spent moving
(p=<0.0001) (Figure 3.11G-I). The 1 ppm and 50 ppm treatment groups had significantly altered
total distance and velocity compared to the controls, with the 1 ppm treatment group having
increased total distance moved and velocity and the 50 ppm treatment group having decreased
distance moved and velocity. In addition, the 50 ppm treatment group had significantly
decreased time spent moving compared to the controls. There was no difference (p>0.05) in
other locomotor parameters including turn angle, angular velocity, meander (data not shown), or
direction of rotation (Figure 3.12E,F).

Figure 3.12. Alterations in directional rotation in 120 hpf zebrafish larvae after developmental exposure to different
concentrations 4-MCHM, crude MCHM, or Tank 396 mixture. Larvae with developmental exposure to 4-MCHM
had significantly altered frequency of clockwise rotation. Larvae exposed to 1 and 25 ppm 4-MCHM had a
significantly increased frequency of clockwise rotation compared to controls (A) and larvae exposed to 1, 25, and 50
ppm 4-MCHM had a significantly increased frequency of counterclockwise rotation compared to controls (B).
Larvae with developmental exposure to crude MCHM did not significantly differ in the frequency of clockwise
rotation (C) or counterclockwise rotation (D). Similarly, larvae with developmental exposure to the tank mixture did
not significantly differ in the frequency of clockwise rotation (E) or counterclockwise rotation (F). *Significantly
different from the 0 ppm control group (p < 0.05). Values are the mean ± standard deviation.
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Results of the acute toxicity assays, morphology measurements, and visual motor
response test in larval zebrafish are summarized in Table 3.3 for 4-MCHM, crude MCHM, and
the Tank 396 mixture treatments.

Table 3.3. Summary of the acute toxicity assays, morphologic alterations, and visual motor response in locomotor
activity in larval zebrafish for 4-MCHM, crude MCHM, and Tank 396 liquid.
Chemical
or mixture

Survival

Hatching

Morphology

Visual Motor Response
Test

4-MCHM

Decreased survival
at 100 ppm

No differences in
hatching between
treatment groups

Body length: All
treatments smaller

Velocity: Increased at
1, 12.5, and 25 ppm

Head length: All
treatments smaller

Distance moved:
Increased at 1, 12.5, and
25 ppm

Head width: All
treatments smaller

Crude
MCHM

100% mortality at
100 ppm

Delayed hatching in 50
ppm treatment at 54 hpf

Body length: No
differences
Head length: No
differences
Head width: Decreased
head width at 6.25 ppm

Tank 396

100% mortality at
100 ppm
Decreased survival
at 50 ppm

Delayed hatching in
6.25, 12.5, 25, and 50
ppm treatments at 54
hpf
Delayed hatching in 50
ppm treatment at 60 and
72 hpf

Body length:
Decreased length at 25
ppm
Head length: Decreased
length at 25 ppm
Head width: Decreased
width at 12.5 and 25
ppm

Time spent moving:
Increased at 1, 12.5, and
25 ppm
Velocity: Decreased at
1, 12.5, and 50 ppm
Distance moved:
Decreased at 1, 12.5,
and 50 ppm
Time spent moving:
Decreased at 1 and 50
ppm
Velocity: Increased at
1ppm; Decreased at 50
ppm
Distance moved:
Increased at 1ppm;
Decreased at 50 ppm
Time spent moving:
Decreased at 50 ppm
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3.5

Discussion

This study determined the chemical composition of crude MCHM and the Tank 396 liquid and
compared the acute developmental toxicity of 4-MCHM, crude MCHM, and the Tank 396 liquid
in the zebrafish model. The percent compositional analysis of crude MCHM correlated well with
NTP data (NTP, 2016c). However, 4-MMCHM was identified as a component of both crude
MCHM and the Tank 396 mixture and CHDM, which had previously been identified by NTP as
a component of crude MCHM, was not observed. The identification of 4-MMCHM is based on
newer NIST databases, and the CHDM identified by NTP may actually be 4-MMCHM. The cisand trans- isomer ratios of crude MCHM (1:2.2) and the Tank 396 (1:2.0) mixture were agreement
with the previous literature (1:1.75 and 1:1.85 respectively) (Dietrich et al., 2015; Foreman et al.,
2015). However, the measured cis:trans ratio sof crude MCHM and the Tank 396 liquid are reversed
from the previously reported cis:trans ratio of 4-MCHM (2.08:1) (Dietrich et al., 2015). Although
both crude MCHM and the Tank 396 are only 85% 4-MCHM, the differences in cis:trans isomer
ratios may explain differences in toxicity observed between 4-MCHM and crude MCHM or the Tank
396 liquid in the zebrafish experiments. The cis- and trans- isomers of 4-MCHM have different
physical properties, such as odor, odor threshold, partitioning coefficients, and solubility
(DeYonker et al., 2016; Dietrich et al., 2015). It is currently unknown if the 4-MCHM isomers also
have different effects in biological systems, but other toxicants such as pyrethroid insecticides have
enantiomeric differences in toxicity (Liu et al., 2005).
A strength of this study is that 4-MCHM, crude MCHM, and the actual contents of Tank
396 were evaluated for relative toxicity. 4-MCHM had the least acute toxicity according to the
percent mortality and percent hatch; however, 4-MCHM exposure resulted in morphological
alterations at exposure levels as low as 1 ppm. Crude MCHM had intermediate acute toxicity
with no significant differences in morphology at any exposure concentration, and the Tank 396
mixture had the greatest acute toxicity with morphological alterations only at 12.5 and 25 ppm
exposures. The acute toxicity increased with increased complexity of the chemical mixtures,
suggesting that the additional components in the mixtures may cause synergistic or potentiated
effects. It is possible that the decrease in concentration of 4-MCHM or the reversal in cis:trans
isomer ratios between 4-MCHM and the chemical mixtures is responsible for the lack of
morphological alterations observed in the larvae exposed to crude MCHM. Additional chemicals
in the Tank 396 liquid, such as PPH and DiPPH, may increase developmental toxicity.
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Results of the visual motor response test showed that developmental exposure to 4MCHM, crude MCHM, or the tank mix caused nonmonotonic disruption of behavior, including
hyper- and hypoactivity. Interestingly, the 1 ppm treatment groups for 4-MCHM, crude MCHM,
and the tank mixture all had alterations in the distance moved and velocity. The presence of
significant alterations in locomotor activity at the 1 ppm short-term screening level is of concern.
It should be noted that the larvae exposed to 50 ppm of the Tank 396 liquid did have an increase
incidence of bent axes (data not shown). It is possible that hypoactivity observed at 50 ppm is
related to this malformation. The nonmonotonic response suggests a disruption of hormesis and
may represent disruptions of multiple or overlapping pathways (Conolly et al., 2004). The visual
motor response test is a broad evaluation of multiple body systems, including the ocular, neural,
and musculoskeletal systems. Endpoints such as distance moved, velocity, and time spent
moving could be associated with disruptions of any of these pathways. Other endpoints, such as
rotational frequency have been lined to neurological impairment (Kalueff et al., 2013). The
mechanism of action and possible target tissues is unknown, as few reports have studied the
physiological and toxicological effects of exposure to the chemicals involved in the Elk River
incident. Quantitative structure-activity relationship ((Q)SAR) modeling predicted that crude
MCHM constituents would be developmental toxicants (Paustenbach et al., 2015). A quantitative
toxicogenomics approach using Saccharomyces cerevisiae yeast cells and a human lung
epithelial A549 cells found that 4-MCHM and its metabolites cause chemical and protein stress
and can damage DNA (Lan et al., 2015). Further investigation of the toxicokinetics and
toxicodynamics of 4-MCHM, crude MCHM, and the Tank 396 mixture is needed.
Although higher than the level of 4-MCHM measured in household tap water, the treatment
concentrations for 4-MCHM, crude MCHM, and the Tank 396 mixture used in this study mimic
the original concentrations (0, 6.25, 12.5, 25, 50, and 100 ppm) used by Eastman Chemical
Company in their 1998 acute fathead minnow (Pimephales promelas) and Daphnia magna crude
MCHM toxicity studies (Eastman, 2016b). The current study added a 1 ppm treatment group to
evaluate the toxicity at the CDC’s short-term screening level. In the 1998 acute fathead minnow
test, juvenile (109-day-old) fish were exposed to the treatment solutions for 96 hours. The 96hour LC50 (lethal concentration where 50% mortality occurs) and No-Observed-Effect
Concentration (NOEC) were 57.4 ppm and 25 ppm respectively, resulting in a moderate concern
level for aquatic organisms based on US EPA criteria. The current study used zebrafish larvae
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exposed immediately after fertilization and, although the zebrafish and fathead minnow are
comparable models, the relative sensitivity of each species to an individual chemical is difficult
to determine (Jeffries et al., 2014), and the assay results may not be directly comparable due to
differences in age and chemical exposures. For the 1998 Daphnia study, which used neonates
<24 hours old, the 48-hour LC50 value was 98.1 ppm and the NOEC was determined to be 50
ppm. An LC50 value was not calculated for the chemicals and mixtures in the current study due
to limitations associated with the set treatment concentrations. It is important to note that the
original Eastman studies did not analytically verify the chemical composition of crude MCHM,
thus the treatment concentrations used in their study, and this study, represent the ppm of the
crude mixture and not of 4-MCHM or any individual component. Therefore, the concentration of
4-MCHM in the crude MCHM and Tank 396 mixtures is proportionally lower.
Additional zebrafish toxicity studies have been performed by the National Toxicology
Program. The NTP research focused on 4-MCHM, crude MCHM, and other crude MCHM
components; however, NTP did not have access to the liquid contents of Tank 396. NTP
evaluated the toxicity for a batch of crude MCHM obtained from Eastman Chemical Company in
late 2014, and a few of its reported constituents separately (NTP, 2016a). NTP used a narrower
range of treatment concentrations (0.3, 2.3, 4.5, 6.5, 8.5, 10.6, and 12.8 ppm) and evaluated the
embryos for survival and major malformations at 24 hpf and 120 hpf only. Also noteworthy,
NTP began the chemical exposures at 6 hpf and removed the chorion, while in the studies
presented here, exposure was started immediately after the breeding interval and the embryos
were not dechorionated. NTP found that crude MCHM did not result in acute toxicity at the
treatment levels tested, but dimethyl 1,4-cyclohexanedicarboxylate did cause physical
malformations including a curved or bent axis, pericardial edema, pectoral fin malformations,
and yolk sac edema at levels as low as 13 ppm (NTP, 2015b, c). Additionally, NTP performed a
photomotor assay at 24 hpf. This test evaluates the ability of zebrafish embryos to non-visually
respond to light stimuli (Kokel et al., 2013), and thus complements our locomotor behavioral test
performed at 120 hpf which monitors activity changes after visual recognition of a light stimulus.
NTP reported that 4-MCHM exposure caused alterations in the photomotor response at
concentrations as low as 4.5 ppm in one round of testing (NTP, 2015a, 2016b). Hyperactivity
was reported at 4.5 ppm, while hypoactivity was observed at 8.5, 10.8, and 12.8 ppm. The
hypoactivity observed at 10.8 ppm was confirmed in a second round of testing. No changes in
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activity were reported at the intermediate treatment concentration of 6.5 ppm in either round of
study. Hyperactivity at 4.5 ppm is similar to what we observed at 1, 12.5, and 25 ppm, along
with the nonmonotonic dose response. Hypoactivity at 10.8 ppm crude MCHM treatment was
also observed in one round of the NTP studies, but not in a second round. We also observed
hypoactivity with a decrease in distance moved, velocity, and time spent moving upon
developmental exposure to crude MCHM. Overall, the findings from this study and the NTP
support the potential for toxicity.
Paustenbach et al. (2015) extensively reviewed the available data on the toxicity of
individual crude MCHM constituents and presumptive metabolites. They concluded that there is
no toxicological risk to humans at the CDC’s 4-MCHM short-term screening level of 1 ppm.
However, in vitro cytotoxicity assays using multiple cell lines suggest that 4-MCHM and PPH
separately do not cause cytotoxicity except at concentrations higher than 100 ppm 4-MCHM or
PPH. However, a co-exposure at levels as low as 1.28 ppm 4-MCHM and 15.2 ppm PPH result
in cytotoxicity (Han et al., 2017). This suggests synergism or potentiation between chemicals in
the mixture and raises concern since residents of Charleston, WV were exposed to multiple
chemicals simultaneously in the drinking water, including MMCHC, 4-MMCHM, PPH, and
DiPPH in addition to 4-MCHM. Additionally, due to desorption of chemicals from carbon filters,
the population’s long-term (up to 3 months) total exposure to lower 4-MCHM concentrations
and other tank liquid ingredients is uncertain.

3.6

Conclusion

In summary, the results of this study demonstrate different toxicological profiles for 4-MCHM,
crude MCHM, and the actual Tank 396 liquid, likely associated with differences in chemical
compositions of the crude MCHM and Tank 396 mixtures. The results support the need for
further research the physiological effects of Tank 396 liquid exposure, including mechanisms of
action, and the effects of on long-term, low-dose exposure. The differential toxicity observed
between the chemicals and mixtures in this study also highlights the need to chemically
characterize mixtures for accurate risk assessment. The identification of the chemical or mixture
in a chemical spill is as equally important as the toxicological testing that follows a chemical
spill incident.
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CHAPTER 4. EMBRYONIC ATRAZINE EXPOSURE
ELICITS PROTEOMIC, BEHAVIORAL, AND BRAIN
ABNORMALITIES WITH DEVELOPMENTAL TIME
SPECIFIC GENE EXPRESSION SIGNATURES 3

4.1

Abstract

The developmental period is characterized by dynamic changes in gene expression and exposure
to environmental toxicants during this critical period can have far reaching effects on organismal
development. Atrazine (ATZ), although banned in the European Union, is the second most
commonly used herbicide in the United States and frequently contaminates groundwater sources
at levels above the 3 parts per billion (ppb; µg/L) US Environmental Protection Agency
maximum contaminant level. ATZ is an endocrine disrupting chemical and is linked to cancer.
Using the larval zebrafish (Danio rerio) model, this study tested the hypothesis that the effects of
embryonic ATZ exposure are dependent on the timing of exposure, and that embryonic ATZ
exposure alters normal brain development and function and changes global protein levels. The
relative expression of six genes was monitored throughout the embryonic time course to
determine normal expression and to determine if embryonic exposure to 0, 0.3, 3, or 30 ppb ATZ
altered expression. One gene, cyp17a1, had dynamic expression during development that was not
related to ATZ exposure, but ttc3 and tpd52l1 both had ATZ related changes in relative gene
expression before 72 hours post fertilization (hpf). The brain lengths were measured and larval
behavior was monitored through a visual motor response (VMR) test to determine physical and
functional outcomes of embryonic ATZ exposure. Increased brain length was observed in larvae
exposed to 0.3 ppb ATZ, while hypoactivity was observed in larvae with embryonic exposure to
30 ppb ATZ on the VMR test. Proteomic analysis identified 28 genes with a significant labelfree quantification (LFQ) intensity value and the proteins were associated with pathways related
to organism and organ system development, intracellular signaling, protein handling and

3
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degradation, epigenetic regulation of gene expression, and genital tract cancer. The results
indicate that the effects of embryonic ATZ exposure involve the interaction of broad pathways
associated with adverse health outcomes of ATZ toxicity.

4.2

Introduction

Exposure to environmental stressors, including environmental toxicants, during the
developmental period can cause immediate and long lasting health effects (Heindel et al., 2015).
Toxic effects appear at much lower exposure concentrations in developing organisms compared
to the concentration of toxicant required to cause adverse effects in adults, and multiple
characteristics of developing organisms, including limited biotransformation of xenobiotics, lack
of a blood-brain-barrier, immature immune system, and increased metabolic rate may contribute
to greater toxicity during development (Newbold et al., 2007). In addition, developmental
plasticity is thought to be significant and critical, as perturbations in physiologic pathways during
development can result in non- or maladaptive phenotypes of disease (Hanson et al., 2014).
Certain time points in the embryonic period represent critical windows for gene-environment
interactions and heightened susceptibility to extrinsic and intrinsic stressors that result in
phenotypic alterations (Burggren et al., 2015).
Endocrine disrupting chemicals (EDCs) represent a broad class of chemicals that
interfere with the action of hormones. Exposure to EDCs can disrupt normal physiology and
homeostasis throughout development and the life course of an organism (Diamanti-Kandarakis et
al., 2009; Gore et al., 2015), though organisms appear to have the greatest sensitivity to EDCs
during the developmental period (Bern, 1992). Hormones are critical for the normal growth and
development of many organs and tissues, from reproductive organs to the brain. Any disruptions
of the hormonal milieu has the potential to cause irrevocable changes in tissue and organ
structure or function (Welshons et al., 2003). In addition to reproductive dysfunction (Dickerson
et al., 2007), developmental EDC exposure is associated with cancer (Birnbaum et al., 2003),
alterations in innate immune function (Jin et al., 2010), obesity (Janesick et al., 2011), and
altered cognition, including learning and memory (Schantz et al., 2001). Furthermore, low-dose
exposure to EDCs can have significant health implications, as EDCs often have nonmonotonic,
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U-shaped, inverted U-shaped, or other non-traditional dose response curves (Vandenberg et al.,
2012; Welshons et al., 2003). EDCs include chemicals found in plastics and resins, plasticizers,
pharmaceuticals, and pesticides (Gore et al., 2015; Wirbisky et al., 2015a).
Atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine; ATZ), is a triazine
herbicide used to control broadleaf and select grassy weeds. As of 2012, it was estimated that
between 64 and 74 million pounds was used annually in the United States, making ATZ the
second most commonly used agricultural pesticide (Attwood et al., 2017). Post-application
rainfall causes ATZ to leach from fields into ground and surface water where it can persist in the
environment (Dao et al., 1979; Schwab et al., 2006; Thurman et al., 1991; Vonberg et al., 2014).
The heavy use combined with the estimated 146 day half-life of ATZ in groundwater results in
ATZ being the most common pesticide detected in agricultural stream water and both
agricultural and urban groundwater sources (Gilliom et al., 2006). Due to the presence of ATZ in
public water sources, the US Environmental Protection Agency (EPA) regulates the
concentration of ATZ in drinking water with a Maximum Contaminant Level of 3 parts per
billion (ppb; µg/L) (U.S. Environmental Protection Agency, 2006); however, in 2003, the
European Union effectively banned ATZ due to concerns over groundwater contamination and
environmental persistence (European Commission, 2003).
ATZ is a significant environmental toxicant because it is linked to endocrine disruption,
cancer, reproductive disorders, birth defects, and altered nervous system function (Mostafalou et
al., 2017). Epidemiological studies link ATZ exposure to decreased semen quality in Midwestern
men (Swan et al., 2003), increased risk of breast cancer for women living in areas with medium
or high exposure (Kettles et al., 1997); menstrual cycle irregularities (Cragin et al., 2011), and
increased prevalence of small-for-gestational-age infants (Ochoa-Acuna et al., 2009). ATZ
exposure in amphibians is associated with abnormal metamorphosis and feminization (Brodeur
et al., 2013; Freeman et al., 2005; Hayes et al., 2002a; Hayes et al., 2010), and in rodents, ATZ
disrupts the hypothalamic-pituitary-gonadal axis (Cooper et al., 1996; Foradori et al., 2013;
Friedmann, 2002; Song et al., 2014; Victor-Costa et al., 2010). The central nervous system is
also a target of ATZ, with ATZ exposure altering dopaminergic and serotonergic
neurotransmission as well as neurobehavior (Bardullas et al., 2011; Coban et al., 2007; Li et al.,
2014; Lin et al., 2014; Rodriguez et al., 2013; Wirbisky et al., 2015b). Although evidence
suggests ATZ is an EDC, the mechanism of action is still under investigation. ATZ does not
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appear to have intrinsic estrogenic activity and does not bind to the estrogen receptor (Tennant et
al., 1994). Instead, ATZ seems to alter intracellular signaling through the inhibition of type 4
cyclic nucleotide phosphodiesterases (PDE4), resulting in an increase in cyclic adenosine
monophosphate (cAMP) and decreased expression of steroidogenic proteins (Abarikwu et al.,
2011; Kucka et al., 2012; Roberge et al., 2004; Sanderson et al., 2002). Additionally, ATZ
appears to modify the epigenome. ATZ alters microRNA levels (Wirbisky et al., 2016b) and
inhibits the activity and expression of DNA methyltransferases, resulting in decreased global
DNA methylation (Wirbisky-Hershberger et al., 2017). These epigenetic modifications further
provide a mechanism of altered gene expression.
The zebrafish (Danio rerio) biomedical model has many advantages in toxicological
research, including small size, large clutches, easy husbandry, well-characterized and rapid ex
vivo development, short generational interval, a sequenced genome, and conserved metabolic
pathways (Bailey et al., 2013; de Esch et al., 2012; Hill et al., 2005; Howe et al., 2013; Kimmel
et al., 1995). A previous study from our laboratory characterized the effects of embryonic,
environmentally relevant, low-dose ATZ exposure on the growth and development and the
transcriptome of larval zebrafish and found alterations in head length and disruptions of gene
pathways associated with neuroendocrine system development and function, reproductive system
development and function, and carcinogenesis (Weber et al., 2013). This study delves deeper
into the effects of embryonic ATZ exposure in zebrafish by evaluating how gene expression
changes over normal development and after ATZ exposure, how ATZ effects brain development
and behavior, and how ATZ changes the larval zebrafish proteome. We expect that embryonic
ATZ exposure dynamically alters the expression of select genes during critical windows for
toxicity. To test this hypothesis, six genes were chosen from the previous study that had altered
gene expression at 72 hours post fertilization (hpf; the end of embryogenesis) as a result of
embryonic ATZ exposure (Weber et al., 2013). The genes are cytochrome P450 family 17,
subfamily A, member 1 (cyp17a1), glyoxalase I (glo1), ring finger protein 14 (rnf14), salt
inducible kinase 2 (sik2), tetratricopeptide domain 3 (ttc3), and tumor protein D52 like 1
(tpd52l1). Each of the genes had altered expression in at least two of the ATZ treatments (3 ppb
and 30 ppb) and are associated with cancer (cyp17a1, glo1, rnf14, sik2, ttc3 and tpd52l1), the
central nervous system (cyp17a1, glo1, sik2, and ttc3), and/or the endocrine system (cyp17a1,
glo1, rnf14, sik2, ttc3, and tpd52l1) (Weber et al., 2013). The normal expression of these genes
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was monitored throughout embryogenesis and the effects of embryonic ATZ exposure evaluated
at each developmental time point (24, 36, 48, 60, and 72 hpf). We also hypothesize that
embryonic ATZ exposure alters the neurodevelopment of larval zebrafish. We measured brain
length and behavioral responses to a visual motor response test to evaluate brain morphology and
function. Finally, we performed a proteomic analysis to identify differences in protein levels
resulting from embryonic ATZ exposure. We hypothesized that pathways associated with cancer,
neurological disease, reproductive system disease, and cell cycle and proliferation, which were
previously altered on transcriptomic analysis, would also have altered protein levels and that
these pathways would be associated with adverse health outcomes of atrazine toxicity. By
performing a proteomic analysis we aim to link changes in protein levels to behavioral
alterations, changes in brain morphology, and changes in gene expression throughout
development.

4.3

Materials and Methods

4.3.1 Zebrafish Husbandry and Treatment
Embryos were obtained from a breeding colony of wild-type AB strain laboratory zebrafish
(Danio rerio). Adult zebrafish are maintained in a Z-Mod System (Aquatic Habitats, Apopka,
FL) on a 14:10 light-dark cycle. Water is maintained at 28°C, the pH at 7.0-7.3, and salinity at
470-550 µS conductivity. Fish and aquaria are monitored twice daily and fed a mixture of brine
shrimp (Artemia franciscana; Artemia International LLC., Fairview, Texas), Golden Pearls 500800 µm (Artemia International LLC., Fairview, Texas), and Zeigler adult zebrafish food (Zeigler
Bros Inc., Gardners, PA). Adult zebrafish were bred in spawning tanks according to established
protocols (Peterson et al., 2011; Westerfield, 2007) and embryos collected immediately after the
breeding interval, approximately at the 4-8 cell stage of embryonic development. The embryos
were rinsed, randomly sorted into treatment groups, exposed to 0 (filtered aquaria water), 0.3, 3,
or 30 ppb (µg/L) ATZ and incubated at 28.5°C. The ATZ solutions were prepared from aliquots
of a stock solution of technical grade atrazine (98.1% purity) (CAS 1912-24-9; Chem Service,
West Chester, PA) as previously described (Weber et al., 2013; Wirbisky et al., 2015b). ATZ
treatment concentrations were confirmed with an US EPA approved immunoassay kit (Abraxis
Atrazine ELISA Kit, Warminster, PA) as previously described (Freeman et al., 2005; Wirbisky
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et al., 2016). Unless collected beforehand, larvae were rinsed at 72 hours post fertilization (hpf)
with aquaria water to end ATZ exposure and then maintained in clean aquaria water until
collected. All protocols were approved by the Purdue University Animal Care and Use
Committee and all fish treated humanely with regard to prevention and alleviation of suffering.
4.3.2 Transcript Analysis
Genes previously identified as being altered by ATZ exposure at 72 hpf were evaluated for
normal changes in expression through development and time specific alterations in gene
expression resulting from ATZ exposure. For the developmental time course, each replicate
consisted of 4 petri dishes containing 50 embryos treated with filtered aquaria water. A petri dish
was then collected at 24, 36, 48, 60, and 72 hpf. For the atrazine exposure, 50 embryos per petri
dish per treatment were exposed to 0, 0.3, 3, or 30 ppb ATZ. For each replicate, a petri dish of
embryos from each treatment was collected at each of the 24, 36, 48, and 60 hpf time points. For
both the time course and atrazine exposures a total of 6 biological replicates (n = 6) were
collected, with each biological replicate representing embryos from a different breeding clutch.
During collection, embryos were euthanized via anesthetic overdose with 0.4 mg/ml tricaine-S
(ethyl m-amino benzoate methanesulfonate; Western Chemical Inc., Ferndale, WA),
homogenized in Trizol (Life Technologies, Carlsbad, CA), flash frozen in liquid nitrogen, and
stored at -80ºC until RNA isolation. RNA was isolated with the RNEasy Mini Kit (Qiagen,
Germantown, MD) and cDNA was synthesized using the Superscript First Strand Synthesis Kit
(Life Technologies, Carlsbad, CA) following established protocols (Peterson et al., 2009). The
relative expression of cyp17a1, glo1, rnf14, sik2, ttc3, and tpd52l1 was determined via
quantitative PCR (qPCR) following similar methods as described previously (Freeman et al.,
2014; Peterson et al., 2011; Weber et al., 2013; Zhang et al., 2011) and MIQE guidelines (Bustin
et al., 2009). Forward and reverse primers for the target genes (Integrated DNA Technologies,
Coralville, IA) were designed using the Primer3 Website (Table 4.1) and checked using NCBI
Primer-BLAST (Untergasser et al., 2012). As in previous studies (Peterson et al., 2013; Peterson
et al., 2011; Weber et al., 2013; Wirbisky et al., 2015b) β-actin was chosen as a reference gene
due to consistent expression that did not vary across atrazine exposures. qPCR analysis was
performed using the SSoAdvanced Universal SYBR Green Supermix (Bio-Rad, Hercules, CA)
on a CFX Connect Real-Time PCR Detection System (Bio-Rad, Hercules, CA) with a standard
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protocol (Zhang et al., 2011). Melting and dilution curves and no template controls were
evaluated to ensure appropriate efficiency (100±10%) and specificity. Experimental samples
were run in triplicate to provide technical replicates. Gene expression was normalized to β-actin
(gene of interest/β-actin). A one-way ANOVA on SAS 94 software (SAS Institute Inc., Cary,
NC) was used to evaluate for differences between groups. When the outcome was statistically
significant, a Fisher’s Least Significant Difference (LSD) post hoc test at α = 0.05 was
performed to determine groups significantly different from either the control (72 hpf time point
for the time course and 0 ppb treatment for ATZ exposures).

Table 4.1: Primers used in qPCR analysis
Seq ID

Gene Symbol

Primer Sequences a

Biological Function

NM_212806.3

cyp17a1

gtgtgtttccatacgagaccaa

Steroid biosynthesis

atcagcacgtgatcctctgtaa
NM_213151.1

glo1

gcgccatttcatcatatactcc

Formation of s-lactoyl-glutathione

ggtcggtcatttttaggtgtgt
NM_001002087.1

ENSDART00000089953

XM_009305043.1

rnf14

sik2

ttc3

gtttgcgggatgagtatctttc

Binds

to

androgen

receptor

and

ttctgtatattggtgccacagc

coactivator of target gene expression

gaggatgatcatacccacgttt

Regulation of insulin receptor signaling

tgacccatgctgaacagtttac

pathway

acccctacactgatgaggaaga

Negative regulator of cell differentiation

ctcaccactgttgttctcgaag
NM_001020734.1

tpd52l1

gctaatatggagcccagacaac

Cell proliferation and calcium signaling

actcattctccatttcctctcg
NM_181601
a

β-actin

ctaaaaactggaacggtgaagg

Cell motility, structure, and integrity

aggcaaataagtttcggaacaa

(Reference gene)

Primer sequences for cyp17a1, glo1, sik2, and tpd52l1 originally appeared in Weber et al.(2013)

4.3.3 Brain Measurement Analysis
To determine if brain development was altered by ATZ exposure, 50 embryos per treatment were
exposed to 0, 0.3, 3, or 30 ppb ATZ. At 72 hpf, larvae were euthanized via anesthetic overdose
and the brain lengths, defined as the distance from the most rostral aspect of the brain to the
brainstem spinal cord junction (Peterson et al., 2013), of 20 randomly selected larvae (considered
subsamples) were measured per treatment per replicate. A total of six biological replicates (n =
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6) were imaged via light microscopy using a Nikon SMZ1500 dissecting microscope with a
Nikon Digital Sight DS-fil camera. NIS Elements imaging software (Nikon Instruments Inc.,
Melville, NY). A one-way ANOVA was used to analyze differences among treatments, and a
Fisher’s LSD test at α = 0.05 was used when a significant ANOVA was observed.
4.3.4 Larval Visual Motor Response Test
To evaluate if developmental ATZ exposure was associated with behavioral alterations, larval
zebrafish behavior during a visual motor response (VMR) test was monitored at 120 hpf. This is
the earliest time in which zebrafish have robust, testable, locomotion when reared at 28.5°C
(Padilla et al., 2011). A total of 5 biological replicates (n = 5) were completed. For each
replicate, 50 embryos per treatment were exposed to 0, 0.3, 3, or 30 ppb ATZ and 24 larvae from
each treatment (considered subsamples) were placed into separate wells in a 96-well plate with
0.5 mL of filtered aquaria water. Grossly malformed or dead larvae were excluded. Treatments
were balanced between columns to reduce location based test artifact. The loaded 96-well plate
was incubated at 28°C for 10 minutes before being transferred to the Noldus DanioVision
Observation Chamber (Noldus Information Technology, Wageningen, Netherlands). The Noldus
Temperature Control Unit maintained the observation chamber water temperature at 28°C
throughout the course of the experiment. Following a 10 minute dark acclimation period, the
Noldus White Light Routine was used to test the VMR by exposing the larvae to series of 10
minute alternating dark and light periods for a total of 50 minutes (Horzmann et al., 2017). All
behavioral experiments were performed between 11am and 1pm to minimize circadian
variability in movement. The infrared movement traces were recorded at a rate of 25 frames per
second with a Basler GenICam acA 1300-60gm camera and analyzed with the Noldus
EthoVision 11.5 software. Tracks were smoothed via a minimum distanced moved profile set to
>0.2 mm and data for movement endpoints such as total distance moved, velocity, time spent
moving, turn-angle, angular velocity, meander, and turning direction were collected. An
ANOVA was used to analyze differences among treatments, and a Fisher’s LSD test at α = 0.05
was used when a significant ANOVA was observed.
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4.3.5 Proteomics
To determine if embryonic ATZ exposure results in altered protein levels, 50 embryos per
treatment were exposed to 0, 0.3, 3, or 30 ppb ATZ. At 120 hpf, larvae were euthanized via
hypothermic shock and 30 randomly selected larvae from each treatment per replicate were
pooled in a 1.5 mL microcentrifuge tube, rinsed in phosphate buffered saline (PBS), flash frozen
in liquid nitrogen, and stored at -80ºC until further processing. A total of 6 biological replicates
were collected. Samples were collected at 120 hpf to minimize the presence of yolk proteins. For
proteomic analysis, 100 µl of 100 mM ammonium bicarbonate (ABC) was added to the zebrafish
before transferring the samples into reinforced 2 ml tubes containing 2.8 mm ceramic (zirconium
oxide) beads (Cayman Chemical, Ann Arbor, MI). The tubes were loaded into a Precellys 24
homogenizer (Bertin Instruments, Montigny-le-Bretonneux, France), and samples were
homogenized at 6500 rpm in 3 cycles of 20 seconds each. Protein concentration was determined
using a bicinchoninic acid (BCA) assay, and 50 µg of protein was isolated for digestion using an
acetone precipitation. After removing acetone, samples were reduced and alkylated, and
sequence grade Lys-C/Trypsin (Promega) was used to enzymatically digest the extracted protein.
All digestions were carried out in the Barocycler NEP2320 at 50°C under 20,000 psi for 1 hour.
Digested samples were cleaned over C18 spin columns (The Nest Group Inc., Southborough,
MA) and dried in a vacuum centrifuge. Resulting pellets were resuspended in 97% purified
H2O/3% acetonitrile (ACN)/0.1% formic acid (FA).
For liquid chromatography/mass spectrometry (LC/MS), samples were analyzed using
the Dionex UltiMate 3000 RSLC Nano System coupled to the Q Exactive™ HF Hybrid
Quadrupole-Orbitrap Mass Spectrometer (Thermo Scientific, Waltham, MA). Peptides were
loaded onto a trap column (20 µm x 350 mm) and washed using a flow rate of 5 µl/minute with
98% purified water/2% ACN/0.01% FA. The trap column was switched in-line with the
analytical column after 5 minutes, and peptides were separated using a reverse phase Acclaim
PepMap RSLC C18 (75 µm x 15 cm) analytical column using a 120 minute method at a flow
rate of 300 nl/minute. Mobile phase A consisted of 0.01% FA in water while mobile phase B
consisted of 0.01 % FA in 80% ACN. The linear gradient started at 5% B and reached 30% B in
80 minutes, 45% B in 91 minutes, and 100% B in 93 minutes. The column was held at 100% B
for the next 5 minutes before being brought back to 5% B and held for 20 minutes. Sample was
injected into the QE HF through the Nanospray Flex™ Ion Source fitted with an emission tip
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from Thermo Scientific. Data acquisition was performed monitoring the top 20 precursors at
120,000 resolution with an injection time of 100 milliseconds. For quality assurance and quality
control, instrument evaluations and calibrations are run weekly and a standard E. coli digest
(Waters, Milford, MA) is used routinely to check instrument performance.
The files from the MS were processed using the MaxQuant computational proteomics
platform version 1.5.5.1 (Cox et al., 2008). The peak list generated was searched against the
Danio rerio sequences from UNIPROT retrieved on 10/25/2016 and a common contaminants
database. The following settings were used for MaxQuant: default Orbitrap parameters,
minimum peptides length of seven amino-acid, data was analyzed with ‘Label-free
quantification’ (LFQ) checked and the ‘Match between runs’ interval set to 1 min, protein FDR
was set to 1%, enzyme trypsin and LysC allowing for two missed cleavage and three
modifications per peptide, fixed modifications were Iodoethanol(C), variable modifications were
set to Acetyl (Protein N-term) and Oxidation (M).
An in-house script was used to perform the following steps on the MaxQuant results:
removed all the common contaminant proteins, log transformed [log2(x)] the LFQ intensity
values, input the missing values using the average values of the other two samples when just one
sample was missing and use half of the lowest intensity when all three samples were missing in
one group and presented in all three samples in the other group. The statistical analyses were
performed in R® (www.cran.r-project.org). An ANOVA was performed on the LFQ intensities
and only proteins with p-value < 0.05 were used in all analyses. Tukey’s post hoc test identified
differences between treatment groups. The list of proteins was imported into Ingenuity Pathway
Analysis (IPA; Qiagen, Germantown, MD) for gene ontology and molecular pathway analysis.

4.4

Results

4.4.1 Gene Expression Through Development and After ATZ Exposure
The normal expression of target genes cyp17a1, glo1, rnf14, sik2, ttc3, and tpd52l1 was
determined throughout a developmental time course (24, 36, 48, 60, and 72 hpf). These genes
were chosen based on identification of altered expression at 72 hpf in a previous study (Weber,
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et al., 2013) and their association with cancer, the central nervous system, and/or the endocrine
system. The effect of ATZ exposure during embryogenesis was evaluated by comparing gene
expression across treatments at 24, 36, 48, and 60 hpf.

Figure 4.1: The relative expression of select genes throughout the time course of development. The relative
expression of cyp17a1 was significantly decreased at 24 and 60 hpf compared to the expression at 72 hpf (A). The
relative expression of glo1 (B), rnf14 (C), sik2 (D), ttc3 (E), and tpd52l1 (F) was not significantly different from the
expression at 72 hpf at any time point. n = 6, qPCR run in triplicate, error bars represent standard deviation, * = p <
0.05.
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4.4.1.1 cyp17a1
The developmental time course for cyp17a1 showed significant alterations in expression, with
significantly decreased relative expression of cyp17a1 at 24 hpf and 60 hpf (p=0.0001; Figure
4.1A) compared to 72 hpf. However, following atrazine exposure, there were no significant
changes at 24, 36, 48, or 60 hpf (p=0.3892, p=0.9207, p=0.6050, and p=0.2709, respectively;
Figure 4.2 A-D).

Figure 4.2. The time course of cyp17a1 relative expression after developmental ATZ exposure. No significant
differences in relative expression were observed between treatment groups at 24 hpf (A), 36 hpf (B), 48 hpf (C), or
60 hpf (D). n = 6, qPCR run in triplicate, error bars represent standard deviation, α = p < 0.05.
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4.4.1.2 glo1
There were no significant differences in the relative expression of glo1 during the developmental
time course (p=0.2491; Figure 4.1B). Exposure to ATZ did not significantly alter relative gene
expression at 24, 36, 48, or 60 hpf (p=0.4299, p=0.3210, p=0.3952, and p=0.6788, respectively;
Figure 4.3A-D).

A

B

Figure 4.3. The time course of glo1 relative expression after developmental ATZ exposure. No significant
differences in relative expression were observed between treatment groups at 24 hpf (A), 36 hpf (B), 48 hpf (C), or
60 hpf (D). n = 6, qPCR run in triplicate, error bars represent standard deviation, α = p < 0.05.
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4.4.1.3 rnf14
During the developmental time course, no significant differences in the relative expression of
rnf14 were observed (p=0.2431; Figure 4.1C). Similarly, ATZ exposure did not elicit significant
changes in relative gene expression at 24, 36, 48, or 60 hpf (p=0.4726, p=0.3905, p=0.8840, and
p=0.1657, respectively; Figure 4.4A-D).

A

B

Figure 4.4. The time course of rnf14 relative expression after developmental ATZ exposure. No significant
differences in relative expression were observed between treatment groups at 24 hpf (A), 36 hpf (B), 48 hpf (C), or
60 hpf (D). n = 6, qPCR run in triplicate, error bars represent standard deviation, α = p < 0.05.
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4.4.1.4 sik2
The relative expression of sik2 was not significantly altered during the developmental time
course (p=0.0711; Figure 4.1D). There were no statistically significant changes in the relative
expression of sik2 following ATZ exposure at 24, 36, 48, and 60 hpf (p=0.0596, p=0.4104,
p=0.2148, and p=0.2822, respectively; Figure 4.5A-D).

A

B

Figure 4.5. The time course of sik2 relative expression after developmental ATZ exposure. No significant
differences in relative expression were observed between treatment groups at 24 hpf (A), 36 hpf (B), 48 hpf (C), or
60 hpf (D). n = 6, qPCR run in triplicate, error bars represent standard deviation, α = p < 0.05.
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4.4.1.5 ttc3
The relative expression of ttc3 did not significantly change throughout the developmental time
course (p=0.3893; Figure 4.1E). Although no significant differences in relative gene expression
were observed at 24, 36, or 48 hpf (p=0.2589, p=0.2369, and p=0.2949; Figure 4.6A-C), at 60
hpf, the relative expression of ttc3 was increased in the 3 ppb treatment group as compared to the
0 ppb controls (p=0.0099; Figure 4.6D).

Figure 4.6: The time course of ttc3 relative expression after developmental ATZ exposure. No significant
differences in relative expression were observed between treatment groups at 24 hpf (A), 36 hpf (B), or at 48 hpf
(C). At 60 hpf, the 3 ppb treatment had increased relative expression as compared to the controls (D). n = 6, qPCR
run in triplicate, error bars represent standard deviation, * = p < 0.05.
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4.4.1.6 tpd52l1
Throughout the developmental time course, relative tpd52l1expression did not significantly
change (p=0.0714; Figure 4.1F). In the ATZ treated groups, there were no significant differences
in relative gene expression at 24 and 48 hpf (p=0.2360, p=0.3040; Figure 4.7A,C). However,
ATZ exposure did alter the relative expression of tpd52l1 at 36 and 60 hpf. At 36 hpf the 0.3 and
3 ppb treatment groups had a significant increase in relative gene expression compared to the
control (p=0.0253; Figure 4.7B). At 60 hpf, there was a decrease in relative expression for all
ATZ treatments (0.3, 3, and 30 ppb) compared to the controls (p=0.0246; Figure 4.7E).

Figure 4.7: The time course of tpd52l1 relative expression after developmental ATZ exposure. No significant
differences in relative expression were observed between treatment groups at 24 hpf (A). At 36 hpf, the 0.3 and 3
ppb treatment groups had a significant increase in relative gene expression compared to the controls (B), but there
was no significant differences between treatments again at 48 hpf (C). At 60 hpf, the 0.3, 3, and 30 ppb treatments
all had a significant decrease in relative expression compared to the controls (D). n = 6, qPCR run in triplicate, error
bars represent standard deviation, * = p < 0.05.
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4.4.2 Brain Morphology
Brain length measurements were taken at 72 hpf. The 0.3 ppb treatment group had a significantly
longer brain as compared to the 0 ppb controls (p=0.0027, Figure 4.8A-B). The 3 ppb and 30 ppb
brain lengths were not significantly different from the controls.

Figure 4.8: Brain length in 72 hpf larvae with developmental ATZ exposure. Representative images of larval
zebrafish measured at 72 hpf after developmental exposure to ATZ (A). The 0.3 ppb treatment group had a
significantly longer brain compared to the controls (B). n = 6, 20 subsamples per replicate, error bars represent
standard deviation, * = p < 0.05. Bar in (A) represents 500 µm.

4.4.3 Larval Behavior
In the VMR test, the 30 ppb treatment group was significantly different from the 0 ppb controls
with respect to distance moved (p=0.0199), velocity (p=0.0197), and time spent moving
(p=0.0123) (Figure 4.9A-C). The 30 ppb treatment had decreased distance moved, decreased
velocity, and spent less time moving compared to the controls. There was no difference in other
locomotor parameters including heading, turn angle, angular velocity, meander, or rotational
direction (p=0.567, p=0.8384, p=0.8384, p=0.8568, p=0.4418, and p=0.1798; Figure 4.10).
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Figure 4.9: Behavioral alterations after developmental ATZ exposure. A VMR test performed at 120 hpf found that
the 30 ppb treatment group had decreased total distance moved (A), decreased velocity (B), and spent less time
moving (C) than the controls. n = 5, 24 subsamples per replicate, error bars represent standard deviation, * = p <
0.05.
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A

B

Figure 4.10. Additional behavioral endpoints were not altered after developmental ATZ exposure. There was no
difference in other locomotor parameters including heading (A), turn angle (B), angular velocity (C), meander (D),
frequency of clockwise rotation (E), or frequency of counterclockwise rotation (F). n = 5, 24 subsamples per
replicate, error bars represent standard deviation, α = p < 0.05.

Table 4.2. List of proteins altered after embryonic ATZ exposure
Protein ID

Protein Name

Gene Symbol

Biological Function

M5BFV8

Collagen type XXII
alpha 1 chain

prp col22a1

Extracellular matrix/blood
vessel morphogenesis

Q6IQL7

Peptidylprolyl
isomerase D

ppid

Protein folding

<0.0001

Q6P2V1

Cathepsin C

ctsc

0.0083

F1R6L1

Adducin 3 (gamma) a

add3a

Cysteine-type peptidase
activity
Cytoskeleton

Q567V5

Small nuclear
ribonucleoprotein D2
polypeptide

Spliceosomal snRNP assembly

0.0115

E7F5L1

Myosin, heavy chain
7B, cardiac muscle, βb

snrpd2 si:dkey113g17.2
DKEY113G17.2-001
myh7bb

Myosin complex/ATP binding

0.0118

A0A140LGU1

hp1bp3

Heterochromatin organization

0.0123

E7F0A1

Heterochromatin
protein 1 binding
protein 3
Profilin

pfn1

0.0138

Q7ZVJ0

Profilin

pfn2l

E7FBD5

IQ motif containing
GTPase activating
protein 1
Creatine kinase; muscle
a
NADH dehydrogenase
1 beta subcomplex, 6
Capping protein (actin
filament), gelsolin-like
b

iqgap1

Actin cytoskeleton
organization
Actin cytoskeleton
organization
Wnt signaling

ckma ckm
ndufb6
zgc:73375
capgb

Q90X19
Q6PBJ6
A0A0R4IML0

ANOVA
p-value
<0.0001

Log2 Fold Change

0 ppb vs 30 ppb
0.3 ppb vs 30 ppb
3 ppb vs 30 ppb
0 ppb vs 30 ppb
0.3 ppb vs 3 ppb
0.3 ppb vs 30 ppb
3 ppb vs 30 ppb
0 ppb vs 30 ppb
0.3 ppb vs 30 ppb
0 ppb vs 30 ppb
3 ppb vs 30 ppb
0.3 ppb vs 3 ppb
0.3 ppb vs 30 ppb

Tukey
p-value
<0.0001
<0.0001
<0.0001
<0.0001
0.0493
<0.0001
0.0110
0.0549
0.0138
0.0078
0.0290
0.0100
0.0398

0 ppb vs 30 ppb
0.3 ppb vs 30 ppb
3 ppb vs 30 ppb
0 ppb vs 3 ppb
0.3 ppb vs 3 ppb

0.0195
0.0356
0.0330
0.0101
0.0491

0.9816
0.8968
0.9078
-1.4097
-1.1167

0.3 ppb vs 30 ppb

0.0177

-0.9328

0.0144

0.3 ppb vs 30 ppb

0.0136

-0.4454

ATP binding/kinase activity

0.0172

0 ppb vs 30 ppb

0.0122

0.3759

Integral component of
membrane
Barbed-end actin filament
capping

0.0178

0.3 ppb vs 30 ppb

0.0101

-0.923

0.0188

0 ppb vs 0.3 ppb

0.0274

-0.3859

0.0085

Tukey Grouping

9.3083
8.8497
9.2391
-0.7583
-0.3597
-0.8092
-0.4495
-0.6671
-0.8241
0.7959
0.665
-0.7198
-0.5903

0.0139
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Table 4.2: Continued.
Protein ID

Protein Name

Gene Symbol

Biological Function

Q6DHT8

Ferritin

zgc:92066

A1A5Y7

High mobility group
nucleosomal binding
domain 7
Phosphotriesteraserelated protein
Kelch-like family
member 24a
Proteasome subunit beta
type (EC 3.4.25.1)
Keratin 17/91

hmgn7
zgc:158409

Cellular iron ion
homeostasis/transport
Chromatin

F1RBR6
Q08BL9
Q568F3
Q6DHB6
A0A0R4IWP3
B8JK21
H0WES8
B6IDE1
A0A0A0MPG3
Q6NUY8
Q9PUS1
U3JB26
Q6IQD7

Proteasome Subunit
Beta 2
Caspase 3
Uncharacterized protein
Slow myosin heavy
chain 2
Gamma-crystallin N-B
Ndufa9 protein
Proteasome subunit beta
type
Serine/arginine-rich
splicing factor 2a
Tropomyosin 2

pter

ANOVA
p-value
0.0206
0.0219

Tukey Grouping

Log2 Fold Change

0 ppb vs 3 ppb
0 ppb vs 30 ppb
3 ppb vs 30 ppb

Tukey
p-value
0.0444
0.0462
0.0120

0 ppb vs 0.3 ppb
0.3 ppb vs 30 ppb
0 ppb vs 30 ppb

0.0375
0.0315
0.0271

0.5627
-0.5789
-0.3795

0.0462
0.0373
0.0318

0.5755
-0.5964
0.9372

0.6707
0.6662
-0.6686

Zinc ion binding/catabolic
process
Protein ubiquitination

0.0231

Proteasome core complex

0.0280

krt17 krt91
zgc:92533
psmb2

Intermediate filament

0.0283

0 ppb vs 0.3 ppb
0.3 ppb vs 30 ppb
0 ppb vs 30 ppb

Proteasome core complex

0.0291

0.3 ppb vs 30 ppb

0.0164

-0.9035

casp3a
si:dkeyp80c12.10
smyhc2 smyhc3

Execution of apoptosis
Mitochondrial protontransporting ATP synthase
Slow-twitch skeletal muscle
fiber contraction
-Response to hypoxia
Proteasome core complex

0.0320
0.0323

0 ppb vs 30 ppb
0 ppb vs 30 ppb

0.0393
0.0183

-0.5241
-1.2348

0.0349

0.3 ppb vs 30 ppb

0.0215

0.8071

0.0361
0.0418
0.0420

0 ppb vs 3 ppb
0 ppb vs 30 ppb
0 ppb vs 30 ppb

0.0230
0.0257
0.0492

0.6599
0.8526
-0.7667

Nucleic acid/nucleotide
binding
striated muscle thin filament

0.0456

0 ppb vs 30 ppb

0.0485

0.9047

klhl24a klhl24
zgc:153342
psmb4

crygn2
ndufa9a ndufa9
psmb7 PSMB7
srsf2a
tpm2 zgc:86810

0.0240

0.0480
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4.4.4 Proteomics
Out of a total of 1690 proteins identified, 28 proteins had significant (p < 0.05) LFQ intensity
values (Table 4.2). Of the 28 proteins, 26 proteins had significantly altered levels in at least one
Tukey post hoc comparison between ATZ treatments. 3 proteins had significant differences in
levels between the 0 ppb and 0.3 ppb treatment groups, 14 proteins had significant differences in
levels between the 0 ppb and 3 ppb groups, and 3 proteins had significant differences in levels
between the 0 ppb and 30 ppb treatments. 36% of altered proteins were upregulated in the 0.3
ppb treatment compared to the controls, with 64% of proteins being downregulated. In the 3 ppb
treatment group, 46% of proteins were upregulated and 54% were downregulated compared to
the controls and in the 30 ppb treatment, 68% were upregulated and 32% downregulated
compared to controls.
Pathway analysis was performed on all 28 identified proteins to elucidate pathways
altered by ATZ exposure. The list of proteins was enriched in canonical pathways associated
with actin cytoskeleton signaling, epithelial adherens junction signaling, and calcium signaling
(Table 4.3). The top diseases and biological functions associated with the protein list included
cardiovascular disease, organismal injury and abnormalities, and cancer (Table 4.4). The most
enriched physiological system development and function pathways included cardiovascular
system development and function, organ morphology, and organismal development (Table 4.5).
15 proteins from the list were associated with male and female genital tract cancers, including
prostate cancer (Figure 4.11). Networks associated with cellular assembly and organization,
protein trafficking, and developmental disorders were also enriched (Figure 4.12).

Table 4.3: Top enriched canonical pathways
Name
p-valuea
Overlap
Actin Cytoskeleton Signaling
9.38E-05
1.8% (4/227)
Epithelial Adherens Junction Signaling
5.01E-04
2.1% (3/146)
Calcium Signaling
9.05E-04
1.7% (3/179)
Hepatic Fibrosis / Hepatic Stellate Cell Activation
9.65E-04
1.6% (3/183)
Protein Ubiquitination Pathway
2.78E-03
1.1% (3/265)
a
Derived from the likelihood of observing the degree of enrichment in a protein set of a given size by chance alone.

159
Table 4.4: Top enriched diseases and disorders
Name
Cardiovascular Disease
Hereditary Disorder
Organismal Injury and Abnormalities
Skeletal and Muscular Disorders

p-valuea
4.63E-02 - 3.97E-05
4.06E-02 - 3.97E-05
4.84E-02 - 3.97E-05
4.70E-02 - 3.97E-05

# Moleculesb
7
10
19
10

Cancer
4.84E-02 - 1.08E-03
17
a
Derived from the likelihood of observing the degree of enrichment in a protein set of a given size by chance alone.
b
Classified as being differentially expressed that relate to the specified function category; protein may be present in
more than one category.

Table 4.5: Top enriched physiological system development and function pathways
Name
p-valuea
# Moleculesb
Cardiovascular System Development and Function
4.74E-02 - 1.70E-04
6
Organ Morphology
4.53E-02 - 1.70E-04
7
Organismal Development
4.74E-02 - 1.70E-04
8
Organ Development
4.74E-02 - 1.87E-04
4
Embryonic Development
4.74E-02 - 4.42E-04
5
a
Derived from the likelihood of observing the degree of enrichment in a protein set of a given size by chance alone.
b
Classified as being differentially expressed that relate to the specified function category; protein may be present in
more than one category.
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Figure 4.11: Genital Cancer Network. Based on network analysis, 15 out of 28 proteins with a significant LFQ
intensity were associated with female genital tract cancers, prostate cancer, or genital tract cancer in general. Red
indicates proteins with altered levels.
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Figure 4.12. Cellular Assembly and Organization, Protein Trafficking, Developmental Disorder Network. Based on
pathway analysis 12 out of 28 proteins with a significant LFQ intensity were associated with a network involving
cellular assembly and organization, protein trafficking, and developmental disorders. Red indicates proteins with
altered levels.
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4.5

Discussion

During the embryonic period, the expression of certain genes is dynamically regulated to control
normal development and differentiation (Zeitlinger et al., 2010). Of the 6 selected genes with
expression changes at 72 hpf, only cyp17a1 was dynamically expressed earlier during the
developmental time course under normal conditions, with lowered expression at 24 and 60 hpf.
cyp17a1 is a critical enzyme in steroid hormone biosynthesis, having both 17α-hydroxylase and
17,20-lyase activities. When cyp17a1 favors 17α-hydroxylase activity, the steroidogenic
pathway favors the production of glucocorticoids; however, when the 17,20-lyase activity
predominates the pathway favors the creation of androgens and estrogens (Busby et al., 2010;
Gilep et al., 2011). Glucocorticoids and sex hormones are both important for regulating
development, with altered sex hormone levels causing reproductive abnormalities and altered
cortisol levels causing impaired growth, altered somitogenesis, and embryonic malformations
(Alsop et al., 2008; Nesan et al., 2012; Tokarz et al., 2013). Although we identified cyp17a1 as a
dynamically regulated

gene

during zebrafish

development,

embryonic

exposure

to

environmentally relevant levels of the herbicide ATZ did not alter the relative gene expression of
cyp17a1 at 24, 36, 48, or 60 hpf. In a previous study, cyp17a1 expression was altered in all three
ATZ exposure at 72 hpf, suggesting 72 hpf is a critical time point in ATZ toxicity (Weber et al.,
2013).
Developmental exposure to ATZ did, however, selectively disrupt the relative gene
expression of ttc3 and tpd52l1 before 72 hpf. ttc3 codes for an E3 ubiquitin-protein ligase
involved in the negative regulation of cell proliferation through a mechanism of ubiquitination
and increased proteasomal degradation of AKT1 (Dey-Guha et al., 2015; Suizu et al., 2009). ttc3
is also linked to Down Syndrome (Kong et al., 2014), and increased expression is associated
with inhibition of neuronal differentiation and decreased neurite formation associated with
abnormal actin polymerization and altered Golgi organization (Berto et al., 2007; Berto et al.,
2014). In our study, the relative expression of ttc3 was increased compared to controls in the 3
ppb ATZ exposure group at 60 hpf. At 72 hpf, the expression of ttc3 was upregulated at both 3
and 30 ppb (Weber et al., 2013), indicating that developmental ATZ exposure has
nonmonotonic, but stimulatory effects on the relative expression of ttc3 at 60-72 hpf. tpd52l1
codes for a protein with a coiled-coil domain that was first identified associated with human
breast carcinoma (Byrne et al., 1996) and is implicated in cell proliferation (Boutros et al., 2005)
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and calcium signaling (Byrne et al., 1998), as well as in the regulation of apoptosis signalregulating kinase 1 (ASK1) induced apoptosis (Cho et al., 2004). In our study, the relative
expression of tpd52l1 was altered by developmental exposure to ATZ. The upregulation at 36
hpf followed by down relation at 60 hpf suggests that the effect of ATZ on tpd52l1 expression is
time sensitive. Interestingly, at 72 hpf, tpd52l1 was again upregulated in the 3 and 30 ppb ATZ
treatment groups (Weber et al., 2013). The nonmonotonic changes in relative expression of ttc3
and tpd52l1 combined with the dynamic up- and downregulation suggests compensation in
expression to maintain normal homeostatic conditions.
The relative expression of the remaining genes (glo1, rnf14, and sik2) was not altered
either in the developmental time course, or after developmental ATZ exposure at the time points
evaluated. However, in our previous study glo1, rnf14, and sik2 were upregulated in the 3 and 30
ppb ATZ groups at 72 hpf (Weber et al., 2013). The lack of earlier alterations in gene expression
suggests that 72 hpf represents a critical window for these genes in developmental ATZ toxicity.
It is also possible that other overlapping pathways are disrupted at specific time points, leading to
an adaptive response though up- and downregulation of associated pathways that is observable at
72 hpf (Conolly et al., 2004).
It is important to note that although we chose to investigate the effect of ATZ on the
relative expression of 6 genes (cyp17a1, glo1, rnf14, sik2, ttc3, and tpd52l1) throughout a
developmental time course, in reality, developmental ATZ exposure also effects the expression
of hundreds of other genes (Weber et al., 2013). Developmental ATZ toxicity is a result of the
dynamic changes in the global transcriptome. Thus, by evaluating the relative expression of
select genes linked to cancer, the central nervous system, and the endocrine system, we did not
seek to establish a mechanism of toxicity, but rather to characterize normal expression through a
developmental time course and identify the critical time points for developmental ATZ toxicity.
Moreover, the ATZ related disruption of epigenetic mechanisms (Wirbisky-Hershberger et al.,
2017; Wirbisky et al., 2016b) provides a basis to explain why ATZ seems not to consistently
target a single process within a cell (Lasserre et al., 2012), as transcriptomic and epigenetic
alterations can compound after developmental exposure to toxicants (Balmer et al., 2014; Xin et
al., 2015).
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We also sought to characterize the effects of altered gene expression on the nervous
system and hypothesized that embryonic ATZ exposure would alter normal neurodevelopment.
This hypothesis is based on evidence suggesting developmental ATZ exposure alters
transcriptomic pathways associated with neuroendocrine system function and neurological
disease in zebrafish larvae, and on the previous finding of altered head lengths in 72 hpf larvae
with embryonic exposure to ATZ. In Weber et al. (2013), larvae exposed to 0.3, 3, and 30 ppb
ATZ had significantly increased head lengths compared to control larvae. However, in our study,
only larvae with exposure to 0.3 ppb ATZ had significantly larger brains when compared to
controls at 72 hpf. The lack of significant brain length changes in the 3 and 30 ppb ATZ
treatment groups could suggest that either the brain is proportionally smaller than head, which
would indicate impaired brain development or suggest activation of compensatory pathways at
higher exposures (Vandenberg et al., 2012). We did not measure head lengths in our larvae and
are thus unable to determine if the brains of the 3 and 30 ppb groups are proportionally smaller.
However, the increased brain size of the 0.3 ppb group does suggest that low dose ATZ exposure
during embryogenesis perturbs normal neurodevelopment.
We further hypothesized that developmental ATZ exposure would alter neurologic
function. We used the VMR behavioral assay to determine if changes in gene expression and
altered brain morphology could be linked to behavioral alterations. The VMR is a broad test of
neurologic and locomotor function and behavioral differences in larvae can be a result of altered
neurological signaling or structural defects (Kalueff et al., 2013; Zhang et al., 2017). It is
therefore possible that both alterations in gene expression and brain development contributed to
the altered VMR test results in our study. Hypoactivity, characterized by decreased distance
moved, decreased velocity, and decreased time spent moving, was observed in the 30 ppb
treatment group, our highest developmental exposure. Interestingly, Liu et al (2016) performed a
similar experiment with developmental ATZ exposures of 30, 100, and 300 ppb ATZ, and in a
similar locomotor assay found decreased free swimming distance in the 100 and 300 ppb
treatments but not the 30ppb treatment (Liu et al., 2016). Experimental conditions were different
between our study and Liu et al (2016). In their study, ATZ concentrations were made in 0.01%
dimethyl sulfoxide (DMSO) while our ATZ was prepared in filtered aquaria water. Similarly, the
length of the experiment and light settings were different between experiments, and our sample
size was larger, with 120 total individual subsamples (n=5, 24 subsamples per treatment per
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replicate) compared to 24 (n=4 with 6 subsamples per treatment per replicate). It is possible that
the increased power associated with a larger sample size and the differences in experimental
protocols account for the differences in results. Behavioral alterations have also been observed in
C57BL/6 mice with gestational and lactational exposure to ATZ. Juvenile offspring of dams
exposed to 1.4 mg/kg/day ATZ had altered performance on forced swim and marble burying
tests and were hyperactive in an open field test (Lin et al., 2014). Although the exposures are
difficult to compare, these results provide additional support for ATZ related behavioral changes.
The proteome after developmental ATZ exposure was also evaluated to determine if
changes in gene expression were translated into altered protein levels. The pathways identified
by IPA are centered around organism and organ development, cardiovascular disease,
musculoskeletal disorders, and cancer. Although there are no overlap between genes found
altered at 72 hpf in our previous study (Weber et al., 2013) and in the current list of altered
proteins, the pathways identified are complementary. The lack of overlap may be due in part to
the difference in sample collection time, with transcriptomic evaluation occurring at 72 hpf, but
proteomic evaluation occurring at 120 hpf to avoid the overwhelming presence of yolk proteins.
It is likely that proteomic evaluation at 120 hpf is catching downstream changes in protein levels
that result from transcriptomic alterations at 72 hpf and are related to adverse health outcomes
previously associated with atrazine toxicity in studies by our laboratory and others (Hayes et al.,
2002; Li et al., 2014; Lin et al., 2014; Stanko et al., 2010; Stoker et al., 1999; Victor-Costa et al.,
2010; Weber et al., 2013; Wirbisky-Hershberger et al., 2017; Wirbisky et al., 2017; Wirbisky et
al., 2016a; Wirbisky et al., 2016c; Wirbisky et al., 2015).
The pathways altered on proteomic analysis are related to development, intracellular
signaling, and protein processing. Proteins with significant LFQ values include those associated
with ATP binding, the proteasome complex, mRNA processing, and regulation of apoptosis.
These processes are associated with either epigenetic regulation of gene expression or cell cycle
progression and thus potentially carcinogenesis. The human orthologs of zebrafish proteins
Myh7bb and Ckma both bind to ATP in skeletal muscle and therefore have roles in both energy
management and musculoskeletal development (England et al., 2013; Wallimann et al., 2011).
Creatine kinase (CK) normally converts ATP to phosphocreatine in a reversible reaction. Altered
CK levels have been linked to cancer as dysregulated cellular ATP handling can lead to
abnormal regulation of mitosis and cell division (Yan, 2016). Psmb2, Psmb4, and Psmb7 are all
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proteosomal subunits and are involved in the removal of unwanted proteins. Proteasomes are
highly conserved, multi-subunit complexes that traditionally have a role in the degradation of
ubiquitin-tagged proteins (Gu et al., 2014). Proteasomes have also been non-canonically
implicated in the regulation of chromatin structure and function, in that proteasomes can act as
canonical proteases but also as protein chaperones to alter the initiation of transcription and the
modification of chromatin (McCann et al., 2014). Small nuclear ribonucleoproteins form the
protein component of the spliceosome, which functions to process pre-mRNA and remove
introns from mRNA transcripts (Wahl et al., 2009). Altered levels of Snrpd2 could suggest
altered pre-mRNA handling. Finally, Casp3a is an executioner caspase involved in apoptosis;
however, caspase 3 is also implicated in tissue differentiation and neurodevelopment in
mammals (Shalini et al., 2015).
A few of the proteins with significant LFQ values also have a role in epigenetic
regulation of gene expression. Hp1bp3, Hmgn7, and Srsf2a have roles in heterochromatin,
nucleosome, or nucleic acid biding respectively. Hp1bp3 is a binding protein of heterochromatin
protein 1 (Hp1) and is related to the linker histone H1 family, a group of proteins that bind to
nucleosomes and interact with nucleosomal DNA (Garfinkel et al., 2015). Hmgn7 has been
identified in zebrafish but no direct ortholog has been identified in other species to date. In
general, high mobility group nucleosomal binding proteins are members of a family of proteins
that bind to nucleosomes and promote conformational changes in chromatin that facilitate
transcription, DNA replication, and repair (Bustin, 2001). Similarly, Srsf2a has been
provisionally identified in zebrafish, but orthologs for the srsf2a gene have yet to be identified.
Serine/arginine-rich splicing factors are involved in both alternative and constitutive splicing of
pre-mRNAs (Haynes et al., 2006). Altered levels of these proteins suggests a possible epigenetic
component to developmental ATZ exposure, as altered expression of genes that regulate DNA
accessibility or post-transcriptionally modify RNA could have far reaching effects on gene
expression.
Although there are no previous reports of global proteomic alterations in zebrafish after
developmental ATZ exposure, livers from adult female zebrafish with 14 day exposure to either
10 or 1000 ppb ATZ had 7 proteins with altered levels after ATZ exposure and the proteins were
associated with cellular stress, oncogenesis, lipid metabolism, and protein transport (Jin et al.,
2012). This suggests that acute and developmental ATZ exposure are associated with
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carcinogenesis and disruptions of cellular signaling pathways. Our results are also in accordance
with proteomic changes in other species observed after ATZ exposure. For example, gonads
from Xenopus laevis tadpoles exposed to 100 ppb ATZ had altered protein pathways associated
with p53 signaling, apoptosis, tight junctions, and amino acid metabolism, and lipid metabolism
(Chen et al., 2015). Similarly, the liver proteome in 1-year-old largemouth bass (Micropterus
salmoides) had altered levels of proteins associated with energy production, lipid oxidation, and
protein folding and catabolism after an acute, 96 hour exposure to a 3 µg/g total body burden
exposure (Sanchez et al., 2009). Finally, human MCF-7 breast cancer cells exposed to 100 ppb
of ATZ for 24 hours had altered levels of proteins involved in oxidative stress, cell morphology,
and ubiquitination (Lasserre et al., 2009), while exposure to 200 ppb of ATZ for 24 hpf altered
the levels of membrane proteins (Lasserre et al., 2012). Thus ATZ seems to consistency affect
molecular and cellular networks associated with carcinogenesis, protein processing, and cellular
signaling. Although only 28 proteins were identified as having significant LFQ values in our
study, this is in line with other zebrafish embryo toxicity studies (Hanisch et al., 2010) and the
total number of detected proteins (1690) in our study is higher than 2DE (Hanisch et al., 2010;
Link et al., 2006; Shi et al., 2009; Tay et al., 2006) but equivalent to SDS-PAGE (Palmblad et
al., 2013) gel methods used in other zebrafish embryo studies.

4.6

Conclusions

The developmental period is characterized by marked plasticity, with dynamic changes in the
expression of genes important for growth and development. Perturbations during this period can
disrupt normal gene expression in multiple, compensatory pathways, as an organism seeks to
maintain homeostatic conditions. We have identified genes, such as cyp17a1 that are
dynamically expressed during development as well as genes such as ttc3 and tpd52l1 that have
critical windows before 72 hpf where exposure to ATZ will disrupt normal gene expression.
Developmental exposure to ATZ has physical outcomes of increased brain size and functional
changes observed through decreased activity and locomotion. Proteomic evaluation at 120 hpf
indicates that ATZ alters the levels of proteins associated with organism and organ system
development, cellular processes, epigenetic regulation of gene expression, and cancer. Our
results highlight the utility of pathways analysis in evaluating the effects of ATZ exposure and
link transcriptional and proteomic alterations to physiological outcomes. Changes in epigenetic
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regulation of gene expression and changes in intracellular processes have broad effects that may
activate compensatory signaling pathways or other processes. Thus the effects of developmental
ATZ exposure are broad, time sensitive, and involve the interaction of many pathways.
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CHAPTER 5. DEVELOPMENTAL ORIGINS OF
ATRAZINE NEUROTOXICITY: EMBRYONIC
EXPOSURE TO ATRAZINE CAUSES SEX-SPECIFIC
BEHAVIORAL, TRANSCRIPTOMIC, AND
PATHOLOGICAL ALTERATIONS IN ADULT
ZEBRAFISH BRAIN

5.1 Abstract
According to the developmental origins of health and disease (DOHaD) hypothesis, exposure to
environmental stressors during early development can cause genetic, epigenetic, or functional
changes in tissues that increase disease risk later in life. Atrazine (ATZ) is a commonly used
pesticide that frequently contaminates rural and urban water sources at levels above the 3 parts
per billion (ppb; µg/L) maximum contaminant level set by the US Environmental Protection
Agency. Exposure to ATZ is linked to endocrine disruption, cancer, changes in genome
methylation, and alterations in neurochemistry and behavior. This study tests the hypothesis that
embryonic exposure to ATZ results in sex-specific changes in behavior, the adult brain
transcriptome, and adult body and brain pathology, according to the DOHaD hypothesis.
Zebrafish (Danio rerio) embryos were exposed to 0, 0.3, 3, or 30 ppb ATZ during the period
from fertilization through 72 hours post fertilization (hpf), and then were rinsed and raised to
maturity with no further exposure. At 9 months post fertilization (mpf), a novel tank test, a lightdark box, and an open field test evaluated adult behavior. Transcriptomic analysis investigated
ATZ related differences in gene expression and the brain was evaluated histopathologically for
morphometric alterations in the area of the dorsal telencephalon, posterior tuberculum, and raphe
populations. At 14 mpf, the body length, weight, and brain weight was measured to evaluate
effects of ATZ on mature body and brain size. The 9 mpf adult behavioral tests found
nonmonotonic, sex-specific behavior changes, with male zebrafish having decreased activity and
female zebrafish having increased signs of anxiety. Transcriptomic analysis identified sexspecific alterations, with females having altered expression of genes in pathways related to
cancer and organismal injury and males having altered gene expression in organismal
development and reproductive system development and function pathways. Morphometric
analysis identified a decreased number of cells in male raphe populations and adult zebrafish also
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had nonmonotonic, sex-specific alterations in body length, body weight, and brain weight. These
results suggest that developmental exposure to ATZ does cause sex-specific alterations in adult
neural function.

5.2

Introduction

The Developmental Origins of Health and Disease (DOHaD) paradigm advances that
developmental exposure to environmental stressors can cause genetic, epigenetic, or functional
changes in tissues that are associated with later life disease (Heindel et al., 2015). Although, this
hypothesis was first proposed by Barker and Osmond in 1986 after observing increased risk of
heart disease in adults who had poor nutrition during development (Barker et al., 1993; Barker et
al., 1986), the concept has been expanded to include the later life effects of developmental
exposure to environmental toxicants (Haugen et al., 2015; Heindel et al., 2015). Immune system
dysfunction, obesity and metabolic syndrome, altered neurodevelopment and neurological
deficits, and cancer have been linked to developmental exposure to environmental toxicants
(Schug et al., 2013). One class of chemicals frequently implicated in causing later life health
effects within the DOHaD framework are endocrine disrupting chemicals (EDCs).
An EDC is an exogenous chemical that can disrupt the normal action of hormones.
Alterations in normal hormone action can cause irrevocable changes in tissue and organ structure
or function (Welshons et al., 2003) and exposure to EDCs can alter physiology and cause
adverse health outcomes throughout the entire life course of an organism (Diamanti-Kandarakis
et al., 2009; Gore et al., 2015). The developmental period is thought to be the most sensitive to
the effects of EDCs (Bern, 1992), as hormones are critical for the normal growth and
development of many organs and tissues, including the brain. Developmental exposure to EDCs
can alter gene expression or the epigenome, and while no altered phenotype may be detectible
early on, the functional implications may be observed later in life (Barouki et al., 2012).
Exposure to low-doses of EDCs can have significant health implications; however, and because
EDCs often cause nonmonotonic, U-shaped, inverted U-shaped, or other non-traditional dose
response curves (Vandenberg et al., 2012), the effects of EDCs cannot be predicted by high dose
tests (Barouki et al., 2012). Developmental exposure to EDCs has been linked to reproductive
dysfunction in both sexes (Dickerson et al., 2007), cancer (Birnbaum et al., 2003), alterations in
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innate immune function (Jin et al., 2010), obesity (Janesick et al., 2011), and altered cognition,
including learning and memory (Schantz et al., 2001). EDCs are found in resins and plastics and
can be industrial compounds, pharmaceuticals, and pesticides (Gore et al., 2015; Wirbisky et al.,
2015a).
Atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine; ATZ), is a common herbicide
and suspected EDC. ATZ was first registered in 1958 for control of broadleaf and select grassy
weeds and is now one of the two most commonly used agricultural herbicides in the United States
based on weight of active chemical applied (U.S. Environmental Protection Agency, 2006). ATZ
use is particularly high in the Midwest and upper Great Plains states due to extensive corn crop
farming. ATZ is water soluble and can leach from fields into surface and ground water sources
(Thurman et al., 1991) where it can persist in the environment (Dao et al., 1979; Schwab et al.,
2006; Thurman et al., 1991; Vonberg et al., 2014). The heavy use combined with the estimated
146 day half-life of ATZ in groundwater results in ATZ being the most common pesticide
detected in agricultural stream water and both agricultural and urban groundwater sources
(Gilliom et al., 2006) with concentrations up to 224 parts per billion (ppb; µg/L) recorded in
Midwestern streams (Battaglin et al., 2000). The US Environmental Protection Agency (EPA)
regulates the concentration of ATZ in drinking water with a maximum contaminant level (MCL) of
3 ppb (U.S. Environmental Protection Agency, 2006); however, in 2003, the European Union
effectively banned ATZ due to concerns over groundwater contamination and environmental
persistence (European Commission, 2003).
ATZ is a significant environmental toxicant because it is linked to endocrine disruption,
cancer, reproductive disorders, birth defects, and altered nervous system function (Mostafalou et
al., 2017). As an EDC, ATZ is associated with abnormal metamorphosis and feminization in
amphibians (Brodeur et al., 2013; Freeman et al., 2005; Hayes et al., 2002), disruption of the
hypothalamic–pituitary–gonadal axis in rodents (Cooper et al., 1996; Foradori et al., 2011;
Foradori et al., 2013; Friedmann, 2002; Song et al., 2014; Victor-Costa et al., 2010), and
epidemiological studies link ATZ to reproductive abnormalities in women, including increased
prevalence of small-for-gestational-age infants in Indiana (Ochoa-Acuna et al., 2009), menstrual
cycle irregularities (Cragin et al., 2011), and increased risk of breast cancer in women living in
counties in the state of Kentucky with medium or high triazine exposure (Kettles et al., 1997).
The mechanism of ATZ related endocrine disruption is still under investigation. ATZ does not
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appear to have intrinsic estrogenic activity and does not bind to the estrogen receptor (Tennant et
al., 1994). Instead, ATZ seems to alter intracellular signaling through the inhibition of type 4
cyclic nucleotide phosphodiesterases (PDE4), resulting in an increase in cyclic adenosine
monophosphate (cAMP) and decreased expression of steroidogenic proteins (Abarikwu et al.,
2011; Kucka et al., 2012; Roberge et al., 2004; Sanderson et al., 2002). The delayed health
effects of many EDCs are caused by chemical induced epigenetic alterations (Barouki et al.,
2012; Dolinoy et al., 2008) and ATZ exposure is also suspected to cause epigenetic changes in
methylation and microRNA activity (Wirbisky-Hershberger et al., 2017; Wirbisky et al., 2016c)
which may provide a mechanism for a developmental origin of adult disease.
The central nervous system is also a target of ATZ toxicity, with ATZ exposure altering
dopaminergic and serotonergic neurotransmission as well as neurobehavior in rodent and
zebrafish studies (Bardullas et al., 2011; Coban et al., 2007; Li et al., 2014a; Lin et al., 2014a;
Rodriguez et al., 2013; Wirbisky et al., 2015b). The zebrafish (Danio rerio) biomedical model
has many advantages in toxicological research, including small size, large clutches, easy
husbandry, well-characterized and rapid ex vivo development, short generational interval, a
sequenced genome, and conserved metabolic pathways (Bailey et al., 2013; de Esch et al., 2012;
Hill et al., 2005; Howe et al., 2013; Kimmel et al., 1995). Previous studies from our laboratory
using the zebrafish model suggest embryonic exposure to ATZ may alter brain development and
serotonin related pathways (Weber et al., 2013; Wirbisky et al., 2015b). Genes related to
neuroendocrine system development were altered in 72 hours post fertilization (hpf) larval
zebrafish with exposure to low levels (0.3, 3, and 30 ppb) of ATZ (Weber et al., 2013). Adult
zebrafish with embryonic ATZ exposure had sex-specific alterations at 6 months post
fertilization (mpf) in gene expression in pathways related to nervous system development and
function and 9 mpf female zebrafish had a decrease in the level of the serotonin metabolite, 5Hydroxyindoleacetic acid (5-HIAA), and decreased serotonin turnover (Wirbisky et al., 2016b;
Wirbisky et al., 2015b).
In this study, we sought to further investigate the developmental origins of ATZ related
neurotoxicity by testing the hypothesis that embryonic ATZ exposure results in age and sexspecific changes in adult behavior, the brain transcriptome, brain histopathology, and body and
brain size. We evaluated the performance of 9 mpf zebrafish on a battery of three
neurobehavioral tests of anxiety, the novel tank test (NTT), the light dark box (LDB), and an
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open field test (OFT) to determine if embryonic ATZ exposure causes functional changes in
neurobehavior. We expected to see alterations in anxiety related endpoints in 9 mpf female
zebrafish after embryonic ATZ exposure based on previous evidence of altered serotonin
neurotransmission (Wirbisky et al., 2015b). We also performed transcriptomic analysis of female
and male zebrafish brain at 9 mpf to evaluate the persistence of gene expression changes through
the zebrafish life course and to provide a transcriptomic basis of any behavioral phenotype
observed. To determine if embryonic exposure to ATZ causes physical disruptions of the
nervous system, we evaluated female and male zebrafish brain sections for histopathological
alterations and performed morphometric analysis of cellular density in three regions of the
zebrafish brain that have been associated with neurological conditions (Kozol et al., 2016): the
dorsal telencephalon (similar to the mammalian hippocampus and amygdala), the posterior
tuberculum (similar to basal nuclei), and the raphe populations. Finally, we evaluated body size
and brain size to determine if embryonic ATZ exposure altered overall growth and development
over the zebrafish life course. The assessment of later life nervous system outcomes after
developmental ATZ exposure is important because decreased or altered serotonergic neuronal
activity has been associated with depression and anxiety (Graeff et al., 1996; Plaznik et al.,
1989; Ressler et al., 2000), which could have implications for human mental health in heavy
ATZ use areas.

5.3

Materials and Methods

5.3.1 Zebrafish husbandry and treatment
A 10 parts per million (ppm; mg/L) stock solution of technical grade (98.1% purity) ATZ (CAS
1912-24-9; Chem Service, West Chester, PA) was made as previously described (Weber et al.,
2013; Wirbisky et al., 2015b). Aliquots of the stock solution were diluted with filtered aquaria
water to create 0.3, 3, and 30 ppb (µg/L) exposure solutions and filtered aquaria water was used
as a 0 ppb control. ATZ exposure solutions concentrations were confirmed with an US EPA
approved immunoassay kit (Abraxis Atrazine ELISA Kit, Warminster, PA) as previously
described (Freeman et al., 2005; Wirbisky et al., 2016b). Embryos were obtained from a
breeding colony of AB wild-type zebrafish (Danio rerio) maintained in a Z-Mod System
(Aquatic Habitats, Apopka, FL). The adult fish are kept on a 14:10 light-dark cycle and system
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water is kept at 26-28°C, with pH 7.0-7.3, and 470-550 µS conductivity. Fish and aquaria are
monitored twice daily and fed a mixture of brine shrimp (Artemia franciscana; Artemia
International LLC., Fairview, Texas), Golden Pearls 500-800 µm (Artemia International LLC.,
Fairview, Texas), and Zeigler adult zebrafish food (Zeigler Bros Inc., Gardners, PA). Adult
zebrafish were bred in spawning tanks according to established protocols (Peterson et al., 2011;
Westerfield, 2007). The embryos (4-8 cell stage) were collected immediately following the
breeding interval, rinsed, randomly sorted into treatment groups, exposed to 0, 0.3, 3, or 30 ppb
ATZ and incubated at 28.5°C. The ATZ exposure lasted from immediately after collection to 72
hours post fertilization (hpf; the end of embryogenesis). At 72 hpf, the larvae were rinsed in
filtered aquaria water to remove ATZ exposure and then reared under normal conditions until 9,
12, or 14 months post fertilization (mpf). All protocols were approved by the Purdue University
Animal Care and Use Committee and all fish treated humanely with regard to prevention and
alleviation of suffering.
5.3.2 Zebrafish Behavior
At 9 mpf, 10 male and 10 female zebrafish (considered subsamples) were randomly chosen from
each of 4 biological replicates (grown from separate clutches) to undergo a battery of three
behavioral tests: the Novel Tank Test (NTT), the Light-Dark Box (LDB), and the Open Field
Test (OFT). Before testing, the zebrafish were placed in approximately 8 x 9 x 6 cm holding
tanks which were kept in a water bath heated to 28°C and allowed to acclimate 10 minutes
before starting the first test. All fish saw the tests in the same order, but the sexes and treatments
were varied in their testing order to reduce bias. After each test, fish were placed back in the
holding tank and allowed to recover for 80-160 minutes before starting the next test. Testing
occurred throughout the day; time of day does not have a significant effect on adult zebrafish
behavior (Kalueff et al., 2016). One to two subsamples per sex and treatment were tested per
day. All behavior was tracked at a rate of 5 frames per second with an Ikegami ICD-49 SuperCube DSP Monochrome Camera (Ikegami, Tokyo, Japan) connected to a PC equipped with
Noldus EthoVision XT 12 (Noldus Information Technology, Wageningen, Netherlands). Fish
were identified based on dynamic subtraction of background images with 1 pixel contour erosion
followed by 1 pixel contour dilation and no track smoothing. Two observers (KH and BT)
manually confirmed correct video tracking and recognition of zebrafish subjects.
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For the NTT, a clear 1.5 L polycarbonate, 25 x 6 x 16 cm, tank (Marine Biotech /Aquatic
Habitats, Apopka, FL) was filled to a depth of 12 cm. The tank was divided into a bottom zone
and an upper zone at the midpoint of the water level. The camera was set up horizontally to the
testing arena. Zebrafish were transferred by net to the center of the testing area and gently
dropped into the arena. Video recording started 1 second after the fish were detected, but
movement traces and evaluations of behavior did not begin until zebrafish dropped into the
bottom zone. The movement of the zebrafish was recorded for a period of 10 minutes.
Parameters evaluated included distance moved, velocity, time moving, percent time moving,
mean and total meander, time spent in bottom and upper zones, frequency of bottom and upper
zone entries, latency to upper zone entry, percent time spent in bottom and upper zones,
minimum, mean, and max acceleration, heading, turn angle, and angular velocity.
A similar 25 x 6 x 16 cm tank filled do a depth of 6 cm was used for the LDB. Half of the
tank was externally covered with black construction paper on three walls and the other half of the
tank was externally covered with white construction paper, creating two approximately 12.5 x 6
x 6 cm zones (dark zone and light zone). The bottom of the tank was covered with white
construction paper to aid in detection of the zebrafish subject. The camera was located above the
testing arena and orientated downwards. Zebrafish were transferred by net to the center of the
testing area and gently dropped into the arena. Video recording started 1 second after the fish
were detected and the movement of the zebrafish was recorded for a period of 10 minutes.
Parameters evaluated included distance moved, velocity, time moving, percent time moving,
mean and total meander, time spent in light and dark zones, frequency of light and dark zone
entries, latency to light zone entry, percent time spent in light and dark zones, minimum, mean,
and max acceleration, heading, turn angle, and angular velocity.
The OFT used a 30 cm diameter, white ceramic, circular arena with a wall height of 6 cm
filled to a depth of 2 cm. An inner zone with a diameter of 18 cm created a 6 cm wide peripheral
outer zone. The camera was located above the testing arena and orientated downwards. Zebrafish
were transferred by net to the center of the testing area and gently dropped into the arena. Video
recording started 1 second after the fish were detected and the movement of the zebrafish was
recorded for a period of 10 minutes. Parameters evaluated included distance moved, velocity,
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time moving, percent time moving, mean and total meander, time spent in inner and outer zones,
frequency of inner and outer zone entries, latency to inner zone entry, percent time spent in inner
and outer zones, minimum, mean, and max acceleration, heading, turn angle, and angular
velocity.
5.3.3 Microarray Evaluation of Adult Zebrafish Brain Transcriptome
At 9 mpf, 1 fish of each sex was randomly identified from each treatment group (0, 0.3, 3, or 30
ppb ATZ) in each biological replicate (n = 4) and euthanized via anesthetic overdose with 0.4
mg/ml buffered tricaine-S (ethyl m-amino benzoate methanesulfonate; Western Chemical Inc.,
Ferndale, WA). The brains were dissected, homogenized in Trizol (Life Technologies, Carlsbad,
CA), and then flash frozen in liquid nitrogen and stored at -80°C until further analysis. Total
RNA was extracted using the RNeasy MinElute Cleanup Kit (Qiagen, Venlo, Netherlands). For
transcriptomic microarray analysis, a custom one-color multiplex zebrafish 4x180k expression
platform (Agilent Technologies, Santa Clara, CA) was used to compare differences in gene
expression between treatments as previously described (Wirbisky et al., 2016a; Wirbisky et al.,
2016d). The platform has 4 arrays each with 180K probes interrogating 36K known and
predicted targets (3-5 probes per target) based on the Ensembl and UCSC Genome Databases.
Following hybridization, the arrays were washed in buffer solutions and scanned on an Agilent
Technologies SureScan Microarray Scanner (Agilent Technologies, Santa Clara, CA) and data
extracted using Agilent Feature Extraction Software 12.0. GeneSpring 14.9 (Agilent
Technologies, Santa Clara, CA) was used for statistical analysis. Microarray analysis was
performed according to MIAME guidelines (Brazma et al., 2001). Gene lists were uploaded into
Ingenuity Pathway Analysis (IPA) for gene ontology and molecular pathway analysis. IPA
identifies human orthologs of zebrafish genes for pathway analysis. Separate microarrays and
analyzes were performed for the male and female brain samples. The human orthologs of the
zebrafish genes altered on microarray are used for pathway analysis.
5.3.4 Quantitative Polymerase Chain Reaction (qPCR) Confirmation of Microarray Results
qPCR was performed on a subset of genes that were altered in the male microarray (aqp1a, cdk5,
cyp26b1, ifgbp7, itm2cb, and sult2b1) and on a subset of genes altered in the female microarray
(ace, decr1, krt8, nmrk2, and strip1) to confirm the microarray results. cDNA was synthesized
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from the same RNA samples used for the microarray (n = 4 per sex) using the SuperScript Firststrand synthesis system (Invitrogen, Carlsbad, CA) as previously described (Peterson et al.,
2009). Primers specific to the target genes (Integrated DNA Technologies, Coralville, IA; Table
5.1) were designed using the Primer3 website (http://primer3.ut.ee/) and checked using NCBI
Primer-BLAST (Untergasser et al., 2012). qPCR was performed on a Bio-Rad CFX Connect
Real-Time PCR Detection System (Bio-Rad, Hercules, CA) using the Bio-Rad SSO Advance
SYBR Green Supermix according to the manufacturer’s recommendations. qPCR was performed
following MIQE guidelines (Bustin et al., 2009) and as previously

Table 5.1. Primers used in qPCR analysis
Seq ID
NM_181601

Gene Symbol
β-actin

Primer Sequences
ctaaaaactggaacggtgaagg
aggcaaataagtttcggaacaa

Female
XM_689244.9

ace

NM_001002444.2

decr1

NM_131509.2

krt4

NM_001004618.2

nmrk2

NM_213521.2

strip1

agcaatggtcacactgataacg
taagcatgaacgctgaggtaga
cggctaaatctggagtggagaa
ttggttttgataggtccgggtt
aattggctctggacattgagat
ggtctgctgaacatgaatggta
attaccgccttagacatggacg
ctatcagggtcagatgtggtgg
cgaggcgaatttaccagaaacc
acttctgatcgggcaaatgagt

Male
NM_207059.1

aqp1a

NM_131719.1

cdk5

NM_212666.1

cyp26b1

NM_212924.2

igfbp7

NM_199980.1

itm2cb

NM_198914.2

sult2

ggctgcgctaatctatgacttt
gggtcactttgaggacatctct
cggatgtactgtttggtgctaa
gtctgccactgttcttctgttg
tatccttcaacatggctgtacg
ggagtgagtctcttgctcgaat
tctgatctcaccgctcactaaa
caccatctggacaggaatatca
gaaatccaaatgccgtactctc
atccgacagtggaagaaactgt
cacagctcgagtttctgctcta
gcctgatttagggaaagtgatg
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described by our laboratory (Freeman et al., 2014; Peterson et al., 2011; Weber et al., 2013;
Zhang et al., 2011). As in previous studies (Peterson et al., 2013; Peterson et al., 2011; Weber et
al., 2013; Wirbisky et al., 2015b) β-actin was chosen as a reference gene due to consistent
expression that did not vary across atrazine exposures (data not shown). Experimental samples
were run in triplicate to provide technical replicates and gene expression was normalized to βactin (gene of interest/β-actin). Melting and standard dilution curves and no template controls
were evaluated to ensure appropriate efficiency (100±10%) and specificity.
5.3.5 Zebrafish Brain Collection and Histopathology
At 9 mpf, 6 fish of each sex were randomly identified from each treatment group (0, 0.3, 3, or 30
ppb ATZ) in each of three biological replicates (n = 3) and euthanized via anesthetic overdose
with buffered tricaine. An incision was made in the ventral abdomen and the zebrafish were
fixed in toto with 4% paraformaldehyde at 4°C for 7 days at a 1:10 volume ratio, rinsed with
phosphate

buffered

saline,

and

decalcified

at

room

temperature

in

20%

EDTA

(ethylenedinitrilotetraacetic acid, disodium salt dihydrate; pH8.0) for 10 days with rocking
agitation. Once fixed and decalcified, the heads were removed, routinely processed, embedded in
paraffin (3 heads per treatment per block), sectioned twice (bilateral midsagittal sections,
approximately 750 µm apart), and stained with hematoxylin and eosin (H&E). The H&E slides
were scanned into Aperio Digital Pathology (Leica Biosystems Inc., Buffalo Grove, IL). The
slides were evaluated by a board certified veterinary pathologist (KH) for pathologic alterations.
Regions of interest (dorsal telencephalon, posterior tuberculum, and raphe) were identified and
cells counted to determine the number of cells per µm2 area with ImageScope (Leica Biosystems
Inc., Buffalo Grove, IL) software.
5.3.6 Body and brain size analysis
At 14 mpf, 14-69 zebrafish (considered subsamples) per treatment of each sex were taken from
each of 3 replicates (n = 3). After euthanasia via anesthetic overdose with buffered tricaine, the
body length (snout to tip of caudal fin) and body mass was measured. The brain was then
dissected and weighed to determine brain mass.
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5.3.7 Statistical Analysis
For the behavior, body metrics, histopathology, and methylation experiments, statistical
significance was determined by a one-way analysis of variance (ANOVA) on SAS 94 software
(SAS Institute Inc., Cary, NC). A Fisher’s Least Significant Difference (LSD) post hoc test was
used when the ANOVA was significant (α = 0.05) to determine differences between treatment
groups. Significance of microarray results was determined using GeneSpring 14.9 (Agilent
Technologies, Santa Clara, CA) using an ANOVA (α = 0.05) with Tukey HSD post-hoc test (α =
0.05) and a 1.5 fold change criteria for significance. Microarray confirmation by qPCR was
assessed by a Pearson’s correlation using log2 fold change and log2 relative expression (α =
0.05).

5.4

Results

5.4.1 Behavior
The 9 mpf fish behavior was assessed to evaluate for altered neurological function. With the
NTT, female zebrafish had no significant difference in movement related parameters such as
distance moved (p=0.9277), velocity (p=0.9275), or time spent moving (p=0.6731) (Figure 5.1AC). The treatment with embryonic exposure to 3 ppb ATZ did have a significant decrease (p=
0.0254) in the time spent in the upper zone compared to the controls (Figure 5.1E), although
there was no difference in the frequency of upper zone entry (p=0.4177) or in the latency to the
first upper zone entry (p=0.5577) (Figure 5.1D, F). For male zebrafish with embryonic ATZ
exposure, there was a general trend for decreased movement related parameters with increasing
embryonic ATZ exposure, although the difference between treatments was not significant for
distance moved (p= 0.1121) or velocity (p=0.1109) (Figure 5.2A-B). There was trending
decrease in the time male zebrafish spent moving that reached significance in the 3 and 30 ppb
exposures (p=0.0279; Figure 5.2C). Although there were no differences between exposures in
the frequency of upper zone entry (p=0.2622) or time spent in the upper zone (p=0.1700) (Figure
5.2D-E), all male zebrafish with embryonic ATZ exposure (0.3, 3, and 30 ppb) had a
significantly increased latency to the first upper zone entry compared to controls (p= 0.0383;
Figure 5.2 F).
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Figure 5.1. NTT performance of female zebrafish with embryonic ATZ exposure. Female zebrafish did not have
significant differences in the distance moved (A), velocity (B), time spent moving (C), frequency of upper zone
entry (D) or latency to first upper zone entry (F), but females with embryonic exposure to 3 ppb ATZ did have a
significantly decreased time spent in the upper zone compared to controls (E). n = 4, 10 subsamples per gender per
treatment per replicate, error bars represent standard deviation, * = p < 0.05.

On the LDB test, there was no significant differences between female treatments with
respect to distance moved (p=0.8986), velocity (p=0.8983), time spent moving (p=0.5563),
frequency of light zone entry (p=0.7536), time spent in the light zone (p=0.2858), or the latency
to first light zone entry (p=0.4033) (Figure 5.3A-F). The males with embryonic exposure to 30
ppb ATZ had significantly decreased distance moved (p=0.0086), and decreased velocity (p=
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0.0085) compared to controls (Figure 5.4A-B), but both the 0.3 ppb and the 30 ppb exposures
had a significant decrease in time spent moving compared to controls (p=0.0257; Figure 5.4C)
and a significant increased latency to the first light zone entry (p=0.0179; Figure 5.4F) compared
to controls. There was no difference between treatments in the frequency of male light zone entry
(p=0.0701) or time males spent in the light zone (p=0.4507) (Figure 5.4D-E).

Figure 5.2. NTT performance of male zebrafish with embryonic ATZ exposure. There was a general trend for
decreased movement related parameters for male zebrafish with increasing embryonic ATZ exposure in the distance
moved (A) and velocity (B), but the trend reached significance in the 3 and 30 ppb groups for the time spent moving
(C). There was no significant difference in the frequency of upper zone entries (D) or the time spent in the upper
zone (E), but the latency to first upper zone entry was increased for all ATZ treatments compared to the controls (F).
n = 4, 10 subsamples per gender per treatment per replicate, error bars represent standard deviation, * = p < 0.05.
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Figure 5.3. LDB performance of female zebrafish with embryonic ATZ exposure. Female zebrafish did not have
significant differences in the distance moved (A), velocity (B), time spent moving (C), frequency of light zone entry
(D), time spent in the light zone (E) or latency to first upper zone entry (F). n = 4, 10 subsamples per gender per
treatment per replicate, error bars represent standard deviation, α = 0.05.
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Figure 5.4. LDB performance of male zebrafish with embryonic ATZ exposure. Male zebrafish with embryonic
exposure to 30 ppb ATZ had significantly decreased distance moved (A) and velocity (B) compared to controls.
Both the 0.3 and the 30 ppb exposures spent significantly less time moving (C) than controls and had an increased
latency to the first light zone entry (F). There was no significant difference in the frequency of light zone entry (D)
or the time spent in the light zone (E) between treatments. n = 4, 10 subsamples per gender per treatment per
replicate, error bars represent standard deviation, * = p < 0.05.

On the OFT, the females with embryonic ATZ exposure did not have significant
differences in the distance moved (p=0.1559), velocity (p=0.1555), time spent moving
(p=0.1388), time spent in the inner zone (p=0.7686) or latency to first inner zone entry
(p=0.9716) (Figure5.5A-C, E-F), but the groups with 0.3 and 30 ppb embryonic ATZ exposure
had a significantly increased frequency of inner zone entry compared to controls(p=0.0396;
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Figure 5.5E). Male zebrafish with embryonic ATZ exposure had a trend towards decreasing
activity with increasing embryonic ATZ exposure, however, it did not reach significance for
distance moved (p=0.1929), velocity (p=0.1948), or time spent moving (p=0.0798) (Figure 5.6AC). Additionally, there was no significant differences in the frequency of inner zone entry
(p=0.0567), time spent in the inner zone (p=0.1547), or the latency to the first inner zone entry
(p=0.4264) between treatments (Figure 5.6D-F).

Figure 5.5. OFT performance of female zebrafish with embryonic ATZ exposure. Female zebrafish did not have
significant differences in the distance moved (A), velocity (B), time spent moving (C), time spent in the inner zone
(E) or latency to first inner zone entry (F), but the groups with 0.3 and 30 ppb embryonic ATZ exposure had a
significantly increased frequency of inner zone entry compared to controls (D). n = 4, 10 subsamples per gender per
treatment per replicate, error bars represent standard deviation, * = p < 0.05.
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Figure 5.6. OFT performance of male zebrafish with embryonic ATZ exposure. Male zebrafish had a trend towards
decreasing activity with increasing embryonic ATZ exposure, however, it did not reach significance for distance
moved (A), velocity (B), or time spent moving (C). There was no significant differences in the frequency of inner
zone entry (D), time spent in the inner zone (E), or the latency to the first inner zone entry (F) between treatments. n
= 4, 10 subsamples per gender per treatment per replicate, error bars represent standard deviation, * = p < 0.05.

5.4.2 Brain Transcriptome
Transcriptomic analysis of brain from 9 mpf female zebrafish with embryonic ATZ exposure
identified 128 genes with altered expression that mapped to human orthologs in the 0.3 ppb
exposure, 102 mapped genes with altered expression in the 3 ppb exposure and 95 mapped genes
with altered expression in the 30 ppb exposure. Of these genes, 43 had altered expression in all
three exposure groups (GSE112503; Figure 5.7A; Table 5.2). Transcriptomic analysis of brain

Table 5.2. List of genes changed in females common to all embryonic ATZ exposures
Name
Angiotensin I converting
enzyme

Gene Symbol
ACE

ATP/GTP binding
protein like 2
Ankyrin repeat and
SOCS box containing 2
ATCAY, caytaxin

AGBL2

Cdk5 and Abl enzyme
substrate 1
Calpain 7
Cadherin 1

CABLES1

Coatomer protein
complex subunit zeta 2
CTP synthase 1
2,4-dienoyl-CoA
reductase 1
Filamin binding LIM
protein 1
Guanylate binding
protein 1
Iroquois homeobox 1
Keratin 17
Keratin 8

COPZ2

Lipolysis stimulated
lipoprotein receptor
Mediator complex
subunit 11
Migration and invasion
enhancer 1
Matrix metallopeptidase
8

LSR

ASB2
ATCAY

CAPN7
CDH1

CTPS1
DECR1
FBLIM1
GBP1
IRX1
KRT17
KRT8

MED11
MIEN1
MMP8

Biological Function
Regulation of angiotensin metabolic process; brain development; embryo development; female pregnancy;
hormone catabolic process; negative regulation of renal sodium excretion; positive regulation of blood pressure;
positive regulation of neurogenesis; posttranscriptional regulation of gene expression; proteolysis
Protein side chain deglutamylation; proteolysis
Intracellular signal transduction; myoblast differentiation; post-translational protein modification; protein
polyubiquitination
Mitochondrion distribution; negative regulation of glutamate metabolic process; nervous system development;
neuron projection development; regulation of protein localization; transport
Cell cycle; cell division; G1/S transition of mitotic cell cycle; nervous system development; regulation of cell cycle
Positive regulation of epithelial cell migration; proteolysis; self-proteolysis
Adherens junction organization; embryonic development; negative regulation of canonical Wnt receptor signaling
pathway; pituitary gland development; regulation of neuron migration; protein localization
ER to Golgi vesicle-mediated transport; intracellular protein transport; vesicle-mediated transport
De novo CTP biosynthetic process; B cell proliferation; glutamine metabolic process; immune system process
Fatty acid beta-oxidation; fatty acid metabolic process; lipid metabolic process; oxidation-reduction process; protein
homotetramerization
Cell adhesion; cell junction assembly; mRNA processing; regulation of alternative nuclear mRNA splicing, via
spliceosome; regulation of cell shape; regulation of integrin activation
Cellular response to interferon-beta; cellular response to interferon-gamma; interferon-gamma-mediated signaling
pathway; negative regulation of ERK1 and ERK2 cascade; regulation of calcium-mediated signaling
Metanephros development; negative regulation of transcription from RNA polymerase II promoter
Cornification; epidermis development; hair follicle morphogenesis
Cell differentiation involved in placenta development; cell morphogenesis involved in differentiation; extrinsic
apoptotic signaling pathway; keratinization; tumor necrosis factor-mediated signaling pathway
Establishment of blood-brain barrier; lipoprotein transport; liver development; regulation of lipid metabolic
process
Protein ubiquitination; regulation of transcription, DNA-dependent
Negative regulation of apoptotic process; positive regulation of cell migration; positive regulation of filopodium
assembly
Collagen catabolic process; endodermal cell differentiation; extracellular matrix disassembly; neutrophil
degranulation; ossification; proteolysis
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Table 5.2. Continued.
Name
Mannose-P-dolichol
utilization defect 1
Myosin X

Gene Symbol
MPDU1

Biological Function
Dolichol-linked oligosaccharide biosynthetic process; protein folding; transport

MYO10

Myosin IE

MYO1E

NDUFA4, mitochondrial
complex associated
NADH:ubiquinone
oxidoreductase subunit
S6
Nicotinamide riboside
kinase 2
NOP2 nucleolar protein

NDUFA4

Cell motility; cytoskeleton-dependent intracellular transport; Fc-gamma receptor signaling pathway involved in
phagocytosis; positive regulation of cell-cell adhesion; regulation of cell shape; regulation of filopodium assembly;
signal transduction; transport
Actin filament-based movement; endocytosis; in utero embryonic development; kidney development; postembryonic hemopoiesis; vasculogenesis
Mitochondrial electron transport, cytochrome c to oxygen; mitochondrial electron transport, NADH to ubiquinone;
oxidation-reduction process
Cardiovascular system development; fatty acid metabolic process; mitochondrial electron transport, NADH to
ubiquinone; mitochondrial respiratory chain complex I assembly

Otoancorin
Prolyl 3-hydroxylase
family member 4 (nonenzymatic)
Periplakin
Protein phosphatase 1
regulatory subunit 3B
Pre-mRNA processing
factor 31
Protease, serine 48
Retinoic acid receptor
responder 3
Ras homolog family
member V
Sciellin

OTOA
P3H4

Serologically defined
colon cancer antigen 8
Selenium binding
protein 1

SDCCAG8

NDUFS6

NMRK2
NOP2

PPL
PPP1R3B
PRPF31
PRSS48
RARRES3
RHOV
SCEL

SELENBP1

NAD biosynthetic process; NAD metabolic process; negative regulation of myoblast differentiation; pyridine
nucleotide biosynthetic process
Maturation of LSU-rRNA; positive regulation of cell proliferation; regulation of transcription; rRNA base
methylation; rRNA processing
Cell-matrix adhesion; C-terminal protein lipidation; sensory perception of sound; transmission of nerve impulse
Bone remodeling; collagen biosynthetic process; collagen fibril organization; peptidyl-lysine hydroxylation;
synaptonemal complex assembly
Cornification; cytoskeleton organization; keratinization; response to mechanical stimulus
Carbohydrate metabolic process; glycogen metabolic process; protein dephosphorylation; regulation of catalytic
activity; regulation of glycogen biosynthetic process; regulation of glycogen catabolic process
Assembly of spliceosomal tri-snRNP; mRNA processing; nuclear mRNA splicing, via spliceosome;
ribonucleoprotein complex localization; snoRNA localization
Proteolysis
Lipid catabolic process; negative regulation of cell proliferation; phosphatidylethanolamine acyl-chain remodeling;
phospholipid metabolic process
Regulation of small GTPase mediated signal transduction
Embryo development; epidermis development; keratinocyte differentiation; positive regulation of canonical Wnt
receptor signaling pathway
Centrosome cycle; establishment of cell polarity; G2/M transition of mitotic cell cycle; microtubule organizing
center organization; neuron migration; regulation of G2/M transition of mitotic cell cycle; tube formation
Brown fat cell differentiation; protein transport; transport
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Table 5.2. Continued.
Name
Sp8 transcription factor
Steroid 5 alphareductase 2

Gene Symbol
SP8
SRD5A2

Striatin interacting
protein 1
TSC complex subunit 2

STRIP1
TSC2

Biological Function
Dorsal/ventral pattern formation; embryonic limb morphogenesis; regulation of transcription,
Androgen biosynthetic process; cell differentiation; female genitalia development; hippocampus development;
hypothalamus development; progesterone metabolic process; response to steroid hormone stimulus; sex
differentiation; steroid biosynthesis and metabolism
Cortical actin cytoskeleton organization; regulation of cell morphogenesis
Aging; cell cycle arrest; establishment of cell polarity; negative regulation of axonogenesis; negative regulation of
epithelial to mesenchymal transition; neural tube closure; positive regulation of autophagy; positive regulation of
dendritic spine development; social behavior; vesicle-mediated transport

Table 5.3. List of genes changed in males common to all embryonic ATZ exposures
Gene Symbol
AK7

Aquaporin 1
(Colton blood group)
CASK interacting protein
2
Caveolae associated
protein 4
Coiled-coil domain
containing 39
Cyclin dependent
kinase 5

AQP1

Cytochrome P450 family
26 subfamily B member
1
Dihydrolipoamide
branched chain
transacylase E2

CYP26B1

CASKIN2
CAVIN4
CCDC39
CDK5

DBT

Biological Function
Axoneme assembly; brain development; cell projection organization; epithelial cilium movement; inflammatory
response to antigenic stimulus; phosphorylation; spermatogenesis
Ammonium transport; bicarbonate transport; cellular homeostasis; cellular response to cAMP; cerebrospinal fluid
secretion; lateral ventricle development; lipid digestion; response to hormone stimulus
Protein-protein interactions
Cardiac myofibril assembly; cell differentiation; muscle organ development; regulation of gene expression;
regulation of Rho protein signal transduction; Rho protein signal transduction
Axonemal dynein complex assembly; cilium movement; determination of left/right symmetry; heart development;
sperm motility
Neuron apoptotic process; associative learning; axon extension; axonogenesis; neuron development; dendrite
morphogenesis; negative regulation of axon extension; negative regulation of cell cycle; negative regulation of
synaptic plasticity; neuron differentiation; neuron migration; neuron projection development;
oligodendrocyte differentiation; protein localization to synapse; synaptic transmission, dopaminergic; synaptic
transmission, glutamatergic; synaptic vesicle endocytosis; synaptic vesicle exocytosis; synaptic vesicle transport;
telencephalon development; visual learning
Bone morphogenesis; cell fate determination; cellular response to retinoic acid; embryonic limb morphogenesis;
oxidation-reduction process; positive regulation of gene expression; spermatogenesis; sterol metabolic process;
xenobiotic metabolic process
Branched chain family amino acid catabolic process; cellular nitrogen compound metabolic process; metabolic
process
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Name
Adenylate kinase 7

Table 5.3. Continued.
Name
Dopey family member 2
Family with sequence
similarity 169 member A
Gammaglutamylcyclotransferase
HtrA serine peptidase 2

Gene Symbol
DOPEY2
FAM169A

Biological Function
Cognition; endoplasmic reticulum organization; Golgi to endosome transport; protein transport
--

GGCT

Glutathione biosynthetic process; release of cytochrome c from mitochondria

HTRA2

Insulin like growth factor
binding protein 7

IGFBP7

Integral membrane
protein 2C
L-2-hydroxyglutarate
dehydrogenase
Macrophage stimulating
1 receptor
Ornithine decarboxylase
antizyme 2

ITM2C

Adult locomotor behavior; cellular protein catabolic process; cellular response to oxidative stress; DNA damage
response, execution phase of apoptosis; forebrain development; mitochondrion organization; negative regulation
of cell cycle; neuron development; protein auto-processing; proteolysis; response to herbicide
Cell adhesion; cellular protein metabolic process; cellular response to hormone stimulus; embryo implantation;
inner ear development; negative regulation of cell proliferation; post-translational protein modification; regulation
of cell growth; regulation of steroid biosynthetic process; response to cortisol stimulus
Negative regulation of amyloid precursor protein; negative regulation of neuron projection development;
nervous system development and differentiation; positive regulation of extrinsic apoptotic signaling pathway
2-oxoglutarate metabolic process; cellular protein metabolic process; oxidation-reduction process

Oxysterol binding protein
like 3
Protein disulfide
isomerase family A
member 6
Periostin

OSBPL3

Protein regulator of
cytokinesis 1
Peroxiredoxin 3

PRC1

Solute carrier family 25
member 15
Sulfotransferase family
2B member 1
Troponin I2, fast skeletal
type

SLC25A15

L2HGDH
MST1R
OAZ2

Cellular component movement; defense response; hepatocyte growth factor receptor signaling pathway; immune
system process
Negative regulation of catalytic activity; polyamine biosynthetic process; polyamine metabolic process; positive
regulation of intracellular protein transport; positive regulation of protein catabolic process; regulation of cellular
amino acid metabolic process
Bile acid biosynthetic process; lipid transport; sterol transport; transport

PDIA6

Apoptotic cell clearance; cell redox homeostasis; cellular protein metabolic process; platelet activation; platelet
aggregation; post-translational protein modification; protein folding; response to endoplasmic reticulum stress

POSTN

Cell adhesion; cellular response to fibroblast growth factor, transforming growth factor beta, tumor necrosis factor,
and vitamin K; extracellular matrix organization; response to estradiol stimulus
Cell cycle; cell division; cytokinesis; microtubule bundle formation; microtubule cytoskeleton organization; mitotic
spindle elongation; positive regulation of cell proliferation
Apoptotic process; cell redox homeostasis; mitochondrion organization; myeloid cell differentiation; negative
regulation of neuron apoptotic process; positive regulation of cell proliferation
Mitochondrial ornithine transport; mitochondrial transport; transport; urea cycle

PRDX3

SULT2B1
TNNI2

200

Sulfate conjugation of hormones, neurotransmitters, and xenobiotic compounds; lipid metabolic process; steroid
metabolic process; sulfate assimilation; 3'-phosphoadenosine 5'-phosphosulfate metabolic process;
Calcium-dependent regulation of muscle contraction; co-activator of estrogen receptor-related receptor alpha in
mammary gland; suppresses tumor growth in human ovarian carcinoma; positive regulation of transcription
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from 9 mpf male zebrafish with embryonic ATZ exposure identified 123 mapped genes with
altered expression in the 0.3 ppb exposure, 95 genes with altered expression in the 3 ppb
exposure, and 121 genes with altered expression in the 30 ppb exposure group. In the male brain,
25 genes were altered in all three exposure groups (GSE112504; Figure 5.7B; Table 5.3).

Figure 5.7. Venn diagrams of the number of mapped genes changed in each embryonic exposure group for each sex.
Females shared 43 mapped genes with altered expression among all three embryonic ATZ exposures (A). Males
shared 25 mapped genes with altered expression among all three embryonic ATZ exposures (B).

Gene ontology analyses identified the most enriched pathways associated with disease
and biological functions for each treatment and sex. Females with embryonic exposure to 0.3 ppb
ATZ had enrichment in pathways associated with cancer, reproductive system disease, RNA
post-transcriptional modification, and embryonic development (Table 5.4). Specifically, 61
genes were associated with genital tract cancer. The females with embryonic exposure to 3 ppb
ATZ had enrichment in pathways associated with cancer, endocrine system disorders, cell
morphology, and nervous system development and function (Table 5.5). Specifically, 92 genes
are associated with solid tumors and 5 genes are associated with axonogenesis. Females with
embryonic exposure to 30 ppb ATZ had enrichment in pathways associated with cancer, cell
death and survival, and organismal development (Table 5.6). Specifically, 49 genes were
associated with genitourinary carcinoma. Genes that were altered in all three exposures were
identified and gene ontology of the 43 mapped genes in females identified enrichment of
pathways associated with cancer, cell-to-cell signaling and interaction, and embryonic

Table 5.4. Pathways altered in females by embryonic 0.3 ppb exposure.
Top Diseases and Bio Functions
0.3 ppb Female
Diseases and Disorders
Name
p-valuea
# Moleculesb
Cancer
2.01E-02 - 4.63E-09
115
Gastrointestinal Disease
2.01E-02 - 4.63E-09
108
Organismal Injury and
2.01E-02 - 4.63E-09
117
Abnormalities
Reproductive System
1.99E-02 - 1.65E-04
67
Disease
Metabolic Disease
1.58E-02 - 2.74E-04
13
Molecular and Cellular Functions
Name
p-valuea
# Moleculesb
RNA Post-Transcriptional
1.65E-04 - 1.65E-04
2
Modification
Lipid Metabolism
1.97E-02 - 3.43E-04
20
Small Molecule
1.97E-02 - 3.43E-04
27
Biochemistry
Vitamin and Mineral
1.24E-02 - 3.43E-04
5
Metabolism
Cell-to-Cell Signaling and
1.81E-02 - 4.54E-04
20
Interaction
Physiological System Development and Function
Name
p-valuea
# Moleculesb
Embryonic Development
1.90E-02 - 2.77E-05
21
Hair and Skin Development
2.08E-02 - 2.77E-05
13
and Function
Organ Development
2.08E-02 - 2.77E-05
25
Organismal Development
2.10E-02 - 2.77E-05
34
Tissue Development
1.82E-02 - 2.77E-05
34
a

Derived from the likelihood of observing the degree of enrichment in a gene
set of a given size by chance alone.
b

Classified as being differentially expressed that relate to the specified
function category; a gene may be present in more than one category.

Table 5.5. Pathways altered in females by embryonic 3 ppb exposure.
Top Diseases and Bio Functions
3 ppb Female
Diseases and Disorders
Name
p-valuea
Cancer
1.28E-02 - 6.26E-08
Gastrointestinal Disease
1.28E-02 - 6.26E-08
Organismal Injury and
Abnormalities
1.28E-02 - 6.26E-08
Endocrine System Disorders 8.58E-03 - 1.22E-03
Tumor Morphology
9.93E-03 - 1.38E-03
Molecular and Cellular Functions

# Moleculesb
92
91
93
31
8

# Moleculesb
Name
p-valuea
Cell Morphology
1.28E-02 - 1.83E-05
20
Cellular Assembly and
34
Organization
1.28E-02 - 1.83E-05
Cellular Function and
27
Maintenance
1.28E-02 - 3.23E-05
Cellular Movement
1.28E-02 - 9.42E-05
28
Cellular Development
1.28E-02 - 2.34E-05
20
Physiological System Development and Function
Name
p-valuea
# Moleculesb
Nervous System
8
Development and Function
1.28E-02 - 1.83E-05
Connective Tissue
14
Development and Function
1.28E-02 - 9.42E-05
Tissue Development
1.28E-02 - 2.34E-04
21
Embryonic Development
1.28E-02 - 4.39E-04
26
Hair and Skin Development
9
and Function
8.58E-03 - 4.39E-04
a

Derived from the likelihood of observing the degree of enrichment in a gene
set of a given size by chance alone.
b

Classified as being differentially expressed that relate to the specified
function category; a gene may be present in more than one category.
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Table 5.6. Pathways altered in females by embryonic 30 ppb exposure.

Table 5.7. Pathways associated with common female genes

Top Diseases and Bio Functions
30 ppb Female
Diseases and Disorders
Name
p-valuea
# Moleculesb
Cancer
4.00E-03 - 2.99E-09
88
Gastrointestinal Disease
4.00E-03 - 2.99E-09
84
Organismal Injury and
89
Abnormalities
4.00E-03 - 2.99E-09
Cardiovascular Disease
4.00E-03 - 9.97E-06
30
Respiratory Disease
4.00E-03 - 1.27E-05
34
Molecular and Cellular Functions
Name
p-valuea
# Moleculesb
Cell Death and Survival
4.00E-03 - 3.40E-06
41
Cellular Movement
4.00E-03 - 3.50E-06
35
Cellular Assembly and
34
Organizaton
4.00E-03 - 6.93E-06
Cell Morphology
4.00E-03 - 1.11E-05
28
Cellular Growth and
32
Proliferation
4.00E-03 - 1.65E-05
Physiological System Development and Function
Name
p-valuea
# Moleculesb
Organismal Development
4.00E-03 - 7.04E-10
49
Renal and Urological
23
System Development and
Function
4.00E-03 - 7.04E-10
Embryonic Development
4.00E-03 - 5.56E-08
40
Organ Development
4.00E-03 - 5.56E-08
31
Tissue Development
4.00E-03 - 5.56E-08
44

Top Diseases and Bio Functions
Female Common Genes
Diseases and Disorders
Name
p-valuea
# Moleculesb
Cancer
3.47E-02 - 3.16E-04
35
Gastrointestinal Disease
3.64E-02 - 3.16E-04
35
Organismal Injury and
36
Abnormalities
3.64E-02 - 3.16E-04
Developmental Disorder
3.64E-02 - 5.08E-04
12
Renal and Urological
7
Disease
3.64E-02 - 5.08E-04
Molecular and Cellular Functions
Name
p-valuea
# Moleculesb
Cell-to-Cell Signaling and
10
Interaction
3.13E-02 - 1.65E-04
Cellular Assembly and
19
Organization
3.59E-02 - 1.65E-04
Cellular Function and
15
Maintenance
3.59E-02 - 1.65E-04
Cell Morphology
3.59E-02 - 5.08E-04
15
Cellular Movement
3.64E-02 - 5.64E-04
15
Physiological System Development and Function
Name
p-valuea
# Moleculesb
Embryonic Development
3.54E-02 - 2.25E-04
14
Hair and Skin Development
3.13E-02 - 2.25E-04
9
Organ Development
3.64E-02 - 2.25E-04
13
Organismal Development
3.58E-02 - 2.25E-04
18
Tissue Development
3.58E-02 - 2.25E-04
19

a

Derived from the likelihood of observing the degree of enrichment in a gene
set of a given size by chance alone.

a

b

b

Classified as being differentially expressed that relate to the specified
function category; a gene may be present in more than one category.

Derived from the likelihood of observing the degree of enrichment in a gene
set of a given size by chance alone.
Classified as being differentially expressed that relate to the specified
function category; a gene may be present in more than one category.
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Table 5.8. Pathways altered in males by embryonic 0.3 ppb exposure.

Table 5.9. Pathways altered in males by embryonic 3 ppb exposure.

Top Diseases and Bio Functions
0.3 ppb Male
Diseases and Disorders
Name
p-valuea
# Moleculesb
Cancer
9.23E-03 - 5.20E-09
115
Organismal Injury and
116
Abnormalities
9.78E-03 - 5.20E-09
Gastrointestinal Disease
8.24E-03 - 1.42E-08
108
Endocrine System Disease
9.14E-03 - 2.65E-06
44
Reproductive System Disease 7.47E-03 - 2.65E-06
64
Molecular and Cellular Functions
Name
p-valuea
# Moleculesb
Cell Morphology
7.96E-03 - 1.66E-05
31
Cellular Compromise
5.16E-03 - 1.66E-05
12
Cellular Development
9.11E-03 - 1.30E-04
24
Cellular Growth and
23
Proliferation
7.33E-03 - 1.30E-04
Cell Cycle
9.73E-03 - 2.20E-04
23
Physiological System Development and Function
Name
p-valuea
# Moleculesb
Organ Morphology
8.53E-03 - 2.65E-06
33
Reproductive System
22
Development and Function
7.25E-03 - 2.65E-06
Tissue Morphology
7.31E-03 - 7.02E-06
41
Connective Tissue
21
Development and Function
8.24E-03 - 3.43E-05
Organismal Development
9.78E-03 - 5.22E-05
54

Top Diseases and Bio Functions
3 ppb Male
Diseases and Disorders
Name
p-valuea
# Moleculesb
Connective Tissue Disorders
1.19E-02 - 1.12E-06
90
Organismal Injury and
88
Abnormalities
1.19E-02 - 3.15E-05
Skeletal and Muscular
30
Disorders
1.19E-02 - 7.71E-05
Reproductive System Disease 1.19E-02 - 1.15E-04
78
Endocrine System Disorders
1.19E-02 - 1.57E-04
7
Molecular and Cellular Functions
Name
p-valuea
# Moleculesb
Cellular Development
1.19E-02 - 4.83E-05
22
Molecular Transport
1.19E-02 - 9.44E-05
10
Cellular Growth and
20
Proliferation
1.19E-02 - 1.03E-04
Cellular Movement
1.08E-02 - 3.69E-04
26
Cell-to-Cell Signaling and
11
Interaction
1.19E-02 - 4.51E-04
Physiological System Development and Function
Name
p-valuea
# Moleculesb
Organismal Development
1.19E-02 - 3.89E-07
32
Embryonic Development
1.19E-02 - 4.90E-07
28
Digestive System
14
Development and Function
1.19E-02 - 1.84E-06
Nervous System
25
Development and Function
1.19E-02 - 6.55E-06
Organ Development
1.19E-02 - 6.55E-06
29

a

Derived from the likelihood of observing the degree of enrichment in a gene
set of a given size by chance alone.
a
b

Classified as being differentially expressed that relate to the specified
function category; a gene may be present in more than one category.

Derived from the likelihood of observing the degree of enrichment in a gene
set of a given size by chance alone.
b

Classified as being differentially expressed that relate to the specified
function category; a gene may be present in more than one category.
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Table 5.10. Pathways altered in males by embryonic 30 ppb exposure.

Table 5.11. Pathways associated with common male genes

Top Diseases and Bio Functions
30 ppb Male
Diseases and Disorders
Name
p-valuea
# Moleculesb
Cancer
1.48E-02 - 2.77E-07
113
Organismal Injury and
114
Abnormalities
1.48E-02 - 2.77E-07
Gastrointestinal Disease
1.03E-02 - 9.50E-06
103
Renal and Urological Disease 1.03E-02 - 9.94E-05
31
Hereditary Disorder
1.48E-02 - 3.17E-04
42
Molecular and Cellular Functions
Name
p-valuea
# Moleculesb
Amino Acid Metabolism
1.03E-02 - 2.64E-05
12
Small Molecule Biochemistry 1.25E-02 - 2.64E-05
33
Molecular Transport
1.25E-02 - 7.07E-05
20
Cell-to-Cell Signaling and
13
Interaction
1.24E-02 - 2.25E-05
Cellular Assembly and
22
Organization
1.24E-02 - 2.25E-05
Physiological System Development and Function
Name
p-valuea
# Moleculesb
Tissue Development
1.26E-02 - 1.03E-04
24
Tissue Morphology
1.35E-02 - 1.29E-04
37
Humoral Immune Response
1.48E-02 - 2.61E-04
3
Cardiovascular System
23
Development and Function
1.16E-02 - 3.15E-04
Organ Morphology
1.45E-02 - 3.91E-04
24

Top Diseases and Bio Functions
Male Common Genes
Diseases and Disorders
Name
p-valuea
# Moleculesb
Developmental Disorder
2.49E-02 - 4.74E-04
11
Hereditary Disease
2.32E-02 - 4.74E-04
15
Metabolic Disease
1.60E-02 - 4.74E-04
6
Organismal Injury and
25
Abnormalities
4.96E-02 - 4.74E-04
Cardiovascular Disease
8.57E-03 - 5.06E-04
4
Molecular and Cellular Functions
Name
p-valuea
# Moleculesb
Cellular Function and
9
Maintenance
4.83E-02 - 7.22E-04
Cellular Movement
4.93E-02 - 7.22E-04
9
Cellular Development
4.73E-02 - 8.86E-04
8
Cellular Growth and
5
Proliferation
4.73E-02 - 8.86E-04
Cell Cycle
4.17E-02 - 1.07E-03
6
Physiological System Development and Function
Name
p-valuea
# Moleculesb
Organismal Functions
2.86E-02 - 3.09E-05
5
Renal and Urological
4
System Development and
Function
3.49E-02 - 8.86E-04
Reproductive System
5
Development and Function 3.80E-02 - 9.29E-04
Embryonic Development
4.83E-02 - 9.67E-04
8
Organismal Development
4.88E-02 - 9.67E-04
8

a

Derived from the likelihood of observing the degree of enrichment in a gene
set of a given size by chance alone.
a
b

Classified as being differentially expressed that relate to the specified
function category; a gene may be present in more than one category.

Derived from the likelihood of observing the degree of enrichment in a gene
set of a given size by chance alone.
b

Classified as being differentially expressed that relate to the specified
function category; a gene may be present in more than one category.
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development (Table 5.7). Of the common genes in females, 34 genes were associated with
abdominal cancer and 25 with urogenital cancer. The top networks associated with the common
gene pathways included a cell morphology, cellular movement, and cell cycle network (Figure
5.8).

Figure 5.8. Network analysis of genes changed in all three female ATZ exposure groups. Female zebrafish with
embryonic ATZ exposure had in common altered expression of genes in a cell morphology, cellular movement, and
cell cycle network. Red indicates upregulation, green indicates down regulation.
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Figure 5.9. Network analysis of genes changed in all three male ATZ exposure groups. Male zebrafish with
embryonic ATZ exposure had in common altered expression of genes in a developmental disorder, neurological
disease, organismal injury and abnormalities network. Red indicates upregulation, green indicates down regulation

Males with embryonic exposure to 0.3 ppb ATZ had enrichment in pathways associated
with cancer, endocrine system disease, cell morphology, and reproductive system development
and function (Table 5.8). Within the endocrine pathway, 23 genes were associated with gonadal
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tumors and 45 genes were associated with tumorigenesis of the reproductive tract within that
pathway. Males with embryonic exposure to 3 ppb ATZ had enrichment in pathways associated
with organismal injury and abnormalities, reproductive and endocrine system disease, cellular
development, and nervous system development and function (Table 5.9). Within the nervous
system pathway, 17 genes were associated with central nervous system solid tumor. Males with
embryonic exposure to 30 ppb ATZ had enrichment in pathways associated with cancer, amino
acid metabolism, and tissue development (Table 5.10), with 113 genes having an association
with solid tumors. Gene ontology of the 25 genes common to all male ATZ exposure groups
indicated enrichment of developmental disorder, cellular function and maintenance, organismal
function, and reproductive system development and function pathways (Table 5.11). Of the
common genes in males, 25 genes are associated with solid tumors and 5 are associated with
abnormal morphology of the reproductive system. The top network associated with the common
gene pathways is a developmental disorder, neurological disease, and organismal injury and
abnormalities network (Figure 5.9).
We compared the lists of genes with altered expression between the sexes to determine if
there were common gene targets. Although there were no common genes that were altered in all
three embryonic exposures for both sexes, there were 7 genes with altered expression in both the
female and male 0.3 ppb ATZ exposure, 4 genes in common between females and males with 3
ppb embryonic ATZ exposure, and 4 genes with altered expression common to both females and
males with embryonic exposure to 30 ppb ATZ. Table 5.12 lists these genes and their biological
function. Notably, the expression of CDK5, a gene associated with neuron development and
synaptic vesicle exocytosis, was altered in both the 0.3 ppb and the 3 ppb exposures for both
genders.
Our laboratory had previously evaluated the alterations in the brain transcriptome of 6
mpf female and male zebrafish with embryonic ATZ exposure (Wirbisky et al., 2016b; Wirbisky
et al., 2015b). The results of the gene expression changes in the 9 mpf adult fish from this study
were compared to the results of the previous studies performed at 6 mpf to evaluate the
persistence of gene expression changes over time. We found there were 27 genes that were
altered in both the 6 mpf and 9 mpf females with embryonic exposure to 0.3 ppb ATZ, 3 genes
with altered expression at both 6 mpf and 9 mpf in females with 3 ppb ATZ exposure, and 7
genes with altered expression in both the 6 mpf and 9 mpf females with embryonic exposure to

Table 5.12. List of common genes with altered expression between males and females at each exposure
Name

Gene Symbol

Cyclin dependent kinase 5

CDK5

Fatty acid 2-hydroxylase

FA2H

Karyopherin subunit alpha 5
Ornithine decarboxylase
antizyme 2
Sp8 transcription factor

KPNA5
OAZ2

Thyroid hormone receptor
associated protein 3
Zinc finger protein 729

THRAP3

Coiled-coil domain containing
39
Cyclin dependent kinase 5

CCDC39

Ornithine decarboxylase
antizyme 2
Sp8 transcription factor

OAZ2

Activating transcription factor 7
interacting protein
Coiled-coil domain containing
39
Dopey family member 2
Nicotinamide riboside kinase 2

ATF7IP

SP8

ZNF729

CDK5

SP8

CCDC39
DOPEY2
NMRK2

Biological Function
Genes Common Between 0.3 ppb Female and Male Exposures
Neuron apoptotic process; associative learning; axon extension; axonogenesis; neuron development;
dendrite morphogenesis; negative regulation of axon extension; negative regulation of cell cycle; negative
regulation of synaptic plasticity; neuron differentiation; neuron migration; neuron projection
development; oligodendrocyte differentiation; protein localization to synapse; synaptic transmission,
dopaminergic; synaptic transmission, glutamatergic; synaptic vesicle endocytosis; synaptic vesicle
exocytosis; synaptic vesicle transport; telencephalon development; visual learning
Central nervous system myelin maintenance; fatty acid biosynthetic process; lipid modification; oxidationreduction process; peripheral nervous system myelin maintenance; regulation of cell proliferation
NLS-bearing substrate import into nucleus; protein import into nucleus
Negative regulation of catalytic activity; polyamine biosynthetic process; positive regulation of intracellular
protein transport; positive regulation of protein catabolic process
Dorsal/ventral pattern formation; embryonic limb morphogenesis; proximal/distal pattern formation;
regulation of transcription, regulation of transcription from RNA polymerase II promoter
Androgen receptor signaling pathway; circadian rhythm; intracellular steroid hormone receptor signaling
pathway; mRNA processing
Regulation of transcription
Genes Common Between 3 ppb Female and Male Exposures
Axonemal dynein complex assembly; cilium movement; determination of left/right symmetry; heart
development; sperm motility
Neuron apoptotic process; associative learning; axon extension; axonogenesis; neuron development;
dendrite morphogenesis; negative regulation of axon extension; negative regulation of cell cycle; negative
regulation of synaptic plasticity; neuron differentiation; neuron migration; neuron projection
development; oligodendrocyte differentiation; protein localization to synapse; synaptic transmission,
dopaminergic; synaptic transmission, glutamatergic; synaptic vesicle endocytosis; synaptic vesicle
exocytosis; synaptic vesicle transport; telencephalon development; visual learning
Negative regulation of catalytic activity; polyamine biosynthetic process; positive regulation of intracellular
protein transport; positive regulation of protein catabolic process
Dorsal/ventral pattern formation; embryonic limb morphogenesis; regulation of transcription,
Genes Common Between 30 ppb Female and Male Exposures
DNA methylation; negative regulation of transcription
Axonemal dynein complex assembly; cilium movement; determination of left/right symmetry; heart
development; sperm motility
Cognition; endoplasmic reticulum organization; Golgi to endosome transport; protein transport
NAD biosynthetic process; NAD metabolic process; pyridine nucleotide biosynthetic process
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Table 5.13. List of common genes with altered expression in females at 6 mpf and 9 mpf
Name

Gene Symbol

Guanylate binding protein 1

GBP1

Aladin WD repeat
nucleoporin
Angiotensin I converting
enzyme

AAAS

ATCAY, caytaxin

ATCAY

Basic leucine zipper and
W2 domains 1
Calcium voltage-gated
channel auxiliary subunit
gamma 8
Coatomer protein complex
subunit zeta 2
Copine 5
Collagen triple helix repeat
containing 1

BZW1

Forkhead box D2

FOXD2

Guanylate binding protein 1

GBP1

Iroquois homeobox 1
Keratin 17
Lipolysis stimulated
lipoprotein receptor
Melanoma associated
antigen (mutated) 1
Nicotinamide riboside
kinase 2
Phosphatase and actin
regulator 4

IRX1
KRT17
LSR

ACE

Biological Function
Genes altered in all exposures at 6 mpf and 9 mpf
Cellular response to interferon-beta; cellular response to interferon-gamma; interferon-gamma-mediated signaling
pathway; negative regulation of ERK1 and ERK2 cascade; regulation of calcium-mediated signaling
Genes altered in 0.3 ppb exposure at 6 mpf and 9 mpf
Fertilization; learning; mitotic nuclear envelope disassembly; mRNA export from nucleus; protein sumoylation;
protein transport; regulation of gene silencing by miRNA; regulation of glycolysis
Regulation of angiotensin metabolic process; brain development; embryo development; female pregnancy;
hormone catabolic process; negative regulation of renal sodium excretion; positive regulation of blood pressure;
positive regulation of neurogenesis; posttranscriptional regulation of gene expression; proteolysis;
Mitochondrion distribution; negative regulation of glutamate metabolic process; nervous system
development; neuron projection development; regulation of protein localization; transport
Regulation of transcription, DNA-dependent

CACNG8

Calcium ion transmembrane transport; calcium ion transport; cardiac conduction; regulation of alpha-amino-3hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; transmission of nerve impulse

COPZ2

ER to Golgi vesicle-mediated transport; intracellular protein transport; vesicle-mediated transport

CPNE5
CTHRC1

Cell differentiation
Cell migration; cochlea morphogenesis; establishment of planar polarity involved in neural tube closure;
negative regulation of canonical Wnt receptor signaling pathway; positive regulation of osteoblast differentiation
and proliferation; positive regulation of protein binding
Anatomical structure morphogenesis; cell differentiation; positive regulation of transcription from RNA
polymerase II promoter; transcription, DNA-dependent;
Cellular response to interferon-beta; cellular response to interferon-gamma; interferon-gamma-mediated signaling
pathway; negative regulation of ERK1 and ERK2 cascade; regulation of calcium-mediated signaling
Metanephros development; negative regulation of transcription from RNA polymerase II promoter
Cornification; epidermis development; hair follicle morphogenesis
Establishment of blood-brain barrier; lipoprotein transport; liver development; regulation of lipid metabolic
process
Chromatin organization; DNA repair; response to DNA damage stimulus

MUM1
NMRK2
PHACTR4
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NAD biosynthetic process; NAD metabolic process; negative regulation of myoblast differentiation; pyridine
nucleotide biosynthetic process
Actin cytoskeleton organization; closure of optic fissure; enteric nervous system development; regulation of
catalytic activity; negative regulation of integrin-mediated signaling pathway; nervous system development;
neural crest cell migration; neural tube closure; regulation of cell cycle; Rho protein signal transduction

Table 5.13. Continued.
Name
Pogo transposable element
derived with ZNF domain
Proopiomelanocortin

Gene Symbol
POGZ

Biological Function
Cell cycle; cell division; kinetochore assembly; mitotic sister chromatid cohesion

POMC

Protein phosphatase 1
regulatory subunit 3B
Prostaglandin D2 synthase

PPP1R3B

Protein tyrosine
phosphatase, receptor type
U
RAB42, member RAS
oncogene family
Serologically defined colon
cancer antigen 8
Selenium binding protein 1
Sestrin 2

PTPRU

Cell-cell signaling; feeding behavior; negative regulation of tumor necrosis factor production; neuropeptide
signaling pathway; peptide hormone processing; regulation of appetite; regulation of blood pressure; regulation
of corticosterone secretion; signal transduction
Carbohydrate metabolic process; glycogen metabolic process; protein dephosphorylation; regulation of catalytic
activity; regulation of glycogen biosynthetic process; regulation of glycogen catabolic process
Cyclooxygenase pathway; lipid metabolism; negative regulation of male germ cell proliferation; prostaglandin
biosynthensis and metabolism; regulation of circadian sleep/wake cycle; response to glucocorticoids
Canonical Wnt receptor signaling pathway; cell adhesion; cell differentiation; dephosphorylation; homotypic cellcell adhesion; negative regulation of cell migration and proliferation; neuron differentiation; response to
glucocorticoid stimulus
GTP binding; GTPase activity; metabolism of proteins; post-translational protein modification

Stathmin 1

STMN1

Zinc finger protein 729

ZNF729

Guanylate binding protein 1

GBP1

PDZ and LIM domain 4
Zinc finger protein 729

PDLIM4
ZNF729

ATCAY, caytaxin

ATCAY

Dopey family member 2

DOPEY2

Follistatin like 1

FSTL1

Guanylate binding protein 1

GBP1

PTGDS

RAB42
SDCCAG8
SELENBP1
SESN2
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Centrosome cycle; establishment of cell polarity; G2/M transition of mitotic cell cycle; microtubule organizing
center organization; neuron migration; regulation of G2/M transition of mitotic cell cycle; tube formation
Brown fat cell differentiation; protein transport; transport
Cellular response to starvation; cellular response to oxidative stress; DNA damage response, signal transduction
by p53 class mediator; fatty acid beta-oxidation; glucose homeostasis; positive regulation of macroautophagy;
protein kinase B signaling cascade
Axonogenesis; brain development; cytokinesis after mitosis; intracellular signal transduction; microtubule
depolymerization; mitotic spindle organization; nervous system development; neuron projection development
Regulation of transcription
Genes altered in 3 ppb exposure at 6 mpf and 9 mpf
Cellular response to interferon-beta; cellular response to interferon-gamma; interferon-gamma-mediated signaling
pathway; negative regulation of ERK1 and ERK2 cascade; regulation of calcium-mediated signaling
Actin cytoskeleton organization; positive regulation of stress fiber assembly
Regulation of transcription
Genes altered in 30 ppb exposure at 6 mpf and 9 mpf
Mitochondrion distribution; negative regulation of glutamate metabolic process; nervous system development;
neuron projection development; regulation of protein localization
Cognition; endoplasmic reticulum organization; Golgi to endosome transport; multicellular organismal
development; protein transport
BMP signaling pathway; cellular protein metabolic process; post-translational protein modification; response to
starvation
Cellular response to interferon-beta; cellular response to interferon-gamma; interferon-gamma-mediated signaling
pathway; negative regulation of ERK1 and ERK2 cascade; regulation of calcium-mediated signaling

Table 5.13. Continued.
Name
Homeobox B6

Gene Symbol
HOXB6

Iroquois homeobox 1
Zinc finger protein 729

IRX1
ZNF729

Biological Function
Anterior/posterior pattern specification; embryonic skeletal system development and morphogenesis; erythrocyte
homeostasis
Metanephros development; negative regulation of transcription from RNA polymerase II promoter
Regulation of transcription

Table 5.14. List of common genes with altered expression in males at 6 mpf and 9 mpf.
Name

Gene Symbol

Caveolae associated
protein 4
Cyclin dependent kinase 5

CAVIN4

HtrA serine peptidase 2

HTRA2

Insulin like growth factor
binding protein 7

IGFBP7

Integral membrane
protein 2C
Sulfotransferase family
2B member 1
Troponin I2, fast skeletal
type

ITM2C

Beta-1,3glucuronyltransferase 3

B3GAT3

CDK5

SULT2B1
TNNI2

Biological Function
Genes altered in all exposures at 6 mpf and 9 mpf
Cardiac myofibril assembly; cell differentiation; muscle organ development; regulation of gene expression;
regulation of Rho protein signal transduction; Rho protein signal transduction
Neuron apoptotic process; associative learning; axon extension; axonogenesis; neuron development; dendrite
morphogenesis; negative regulation of axon extension; negative regulation of cell cycle; negative regulation of
synaptic plasticity; neuron differentiation; neuron migration; neuron projection development;
oligodendrocyte differentiation; protein localization to synapse; synaptic transmission, dopaminergic; synaptic
transmission, glutamatergic; synaptic vesicle endocytosis; synaptic vesicle exocytosis; synaptic vesicle transport;
telencephalon development; visual learning
Adult locomotor behavior; cellular protein catabolic process; cellular response to oxidative stress; DNA damage
response, execution phase of apoptosis; forebrain development; mitochondrion organization; negative regulation
of cell cycle; neuron development; protein auto-processing; proteolysis; response to herbicide
Cell adhesion; cellular protein metabolic process; cellular response to hormone stimulus; embryo implantation;
inner ear development; negative regulation of cell proliferation; post-translational protein modification; regulation
of cell growth; regulation of steroid biosynthetic process; response to cortisol stimulus
Negative regulation of amyloid precursor protein; negative regulation of neuron projection development;
nervous system development and differentiation; positive regulation of extrinsic apoptotic signaling pathway
Sulfate conjugation of hormones, neurotransmitters, and xenobiotic compounds; lipid metabolic process; steroid
metabolic process; sulfate assimilation; 3'-phosphoadenosine 5'-phosphosulfate metabolic process;
Calcium-dependent regulation of striated muscle contraction; co-activator of estrogen receptor-related receptor
alpha in mammary gland; suppresses tumor growth in human ovarian carcinoma; positive regulation of transcription
Genes altered in 0.3 ppb exposure at 6 mpf and 9 mpf
Carbohydrate metabolic process; chondroitin sulfate metabolic process; dermatan sulfate proteoglycan biosynthetic
process; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; protein
glycosylation
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Table 5.14. Continued.
Name
Bruton tyrosine kinase

Gene Symbol
BTK

Caveolae associated
protein 4
Cyclin dependent kinase 5

CAVIN4

Complement factor H

CFH

Carboxypeptidase M

CPM

Cytochrome P450, family
2, subfamily ac,
polypeptide 1
Eosinophil peroxidase

Cyp2ac1

Glutamic--pyruvic
transaminase
Hypoxia inducible factor
3 alpha subunit
Hydroxysteroid 11-beta
dehydrogenase 2
HtrA serine peptidase 2

GPT

Defense response; eosinophil migration; negative regulation of interleukin-10 production; negative regulation of
interleukin-5 production;oxidation-reduction process; positive regulation of interleukin-4 production
Biosynthetic process; cellular amino acid biosynthetic process; L-alanine catabolic process

HIF3A

Angiogenesis; apoptotic process; cellular response to hypoxia; protein ubiquitination; regulation of transcription

HSD11B2

Interferon induced protein
44
Insulin like growth factor
binding protein 7

IFI44

Glucocorticoid biosynthesis and metabolism; oxidation-reduction process; response to glucocorticoid stimulus;
response to hypoxia; response to insulin stimulus; response to steroid hormone stimulus
Adult locomotor behavior; cellular protein catabolic process; cellular response to oxidative stress; DNA damage
response, execution phase of apoptosis; forebrain development; mitochondrion organization; negative regulation
of cell cycle; neuron development; protein auto-processing; proteolysis; response to herbicide
Response to virus

Integral membrane
protein 2C

ITM2C

CDK5

EPX

HTRA2

IGFBP7

Biological Function
Adaptive immune response; apoptotic process; B cell activation; B cell affinity maturation; B cell receptor signaling
pathway; calcium-mediated signaling; Fc-epsilon receptor signaling pathway; histamine secretion by mast cell; IkappaB kinase/NF-kappaB cascade; mesoderm development
Cardiac myofibril assembly; cell differentiation; muscle organ development; regulation of gene expression;
regulation of Rho protein signal transduction; Rho protein signal transduction
Neuron apoptotic process; associative learning; axon extension; axonogenesis; neuron development; dendrite
morphogenesis; negative regulation of axon extension; negative regulation of cell cycle; negative regulation of
synaptic plasticity; neuron differentiation; neuron migration; neuron projection development;
oligodendrocyte differentiation; protein localization to synapse; synaptic transmission, dopaminergic; synaptic
transmission, glutamatergic; synaptic vesicle endocytosis; synaptic vesicle exocytosis; synaptic vesicle transport;
telencephalon development; visual learning
Cellular response to hydrogen peroxide; cellular response to interferon-gamma; cellular response to
lipopolysaccharide; complement activation; immune system process; positive regulation of cytolysis
Anatomical structure morphogenesis; C-terminal protein lipidation; peptide metabolic process; protein processing;
proteolysis
--

Cell adhesion; cellular protein metabolic process; cellular response to hormone stimulus; embryo implantation;
inner ear development; negative regulation of cell proliferation; post-translational protein modification; regulation
of cell growth; regulation of steroid biosynthetic process; response to cortisol stimulus
Negative regulation of amyloid precursor protein; negative regulation of neuron projection development;
nervous system development and differentiation; positive regulation of extrinsic apoptotic signaling pathway
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Table 5.14. Continued.
Name
Kynurenine 3monooxygenase
L-2-hydroxyglutarate
dehydrogenase
Membrane palmitoylated
protein 1
Protein disulfide
isomerase family A
member 6
Protein phosphatase,
Mg2+/Mn2+ dependent
1L
Protein regulator of
cytokinesis 1
Pleckstrin and Sec7
domain containing 3
Solute carrier family 43
member 1
Sp8 transcription factor

Gene Symbol
KMO
L2HGDH

Biological Function
Kynurenine metabolic process; NAD biosynthesis and metabolism process; oxidation-reduction process; pyridine
nucleotide biosynthetic process; quinolinate biosynthetic process; tryptophan catabolic process
2-oxoglutarate metabolic process; cellular protein metabolic process; oxidation-reduction process

MPP1

GDP metabolic process; GMP metabolic process; regulation of neutrophil chemotaxis; signal transduction

PDIA6

Apoptotic cell clearance; cell redox homeostasis; cellular protein metabolic process; platelet activation; platelet
aggregation; post-translational protein modification; protein folding; response to endoplasmic reticulum stress

PPM1L

MAPK cascade; protein dephosphorylation; sphingolipid biosynthetic process; transmembrane receptor protein
serine/threonine kinase signaling pathway

PRC1

Cell cycle; cell division; cytokinesis; microtubule bundle formation; microtubule cytoskeleton organization; mitotic
spindle elongation; positive regulation of cell proliferation
ARF protein signal transduction; positive regulation of GTPase activity; regulation of ARF protein signal
transduction
Amino acid transport; L-amino acid transport; neutral amino acid transport; transmembrane transport; transport

Sulfotransferase family
2B member 1
Troponin I2, fast skeletal
type
Zinc finger protein 729

SULT2B1

Aminoacylase 1
Caveolae associated
protein 4
Cyclin dependent kinase 5

ACY1
CAVIN4

PSD3
SLC43A1
SP8

TNNI2
ZNF729

CDK5

Dorsal/ventral pattern formation; embryonic limb morphogenesis; proximal/distal pattern formation; regulation of
transcription, regulation of transcription from RNA polymerase II promoter
Sulfate conjugation of hormones, neurotransmitters, and xenobiotic compounds; lipid metabolic process; steroid
metabolic process; sulfate assimilation; 3'-phosphoadenosine 5'-phosphosulfate metabolic process;
Calcium-dependent regulation of striated muscle contraction; co-activator of estrogen receptor-related receptor
alpha in mammary gland; suppresses tumor growth in human ovarian carcinoma; positive regulation of transcription
Regulation of transcription
Genes altered in 3 ppb exposure at 6 mpf and 9 mpf
Cellular amino acid metabolic process; protein catabolic process; proteolysis; xenobiotic metabolic process
Cardiac myofibril assembly; cell differentiation; muscle organ development; regulation of gene expression;
regulation of Rho protein signal transduction; Rho protein signal transduction
Neuron apoptotic process; associative learning; axon extension; axonogenesis; neuron development; dendrite
morphogenesis; negative regulation of axon extension; negative regulation of cell cycle; negative regulation of
synaptic plasticity; neuron differentiation; neuron migration; neuron projection development;
oligodendrocyte differentiation; protein localization to synapse; synaptic transmission, dopaminergic; synaptic
transmission, glutamatergic; synaptic vesicle endocytosis; synaptic vesicle exocytosis; synaptic vesicle transport;
telencephalon development; visual learning
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Table 5.14. Continued.
Name
Cytochrome P450, family
2, subfamily ac,
polypeptide 1
Cytochrome P450 family
2 subfamily J member 2
Distal-less homeobox 2

Gene Symbol
Cyp2ac1

Biological Function
--

CYP2J2

EH domain binding
protein 1 like 1
Erb-b2 receptor tyrosine
kinase 4

Ehbp1l1

Arachidonic acid metabolic process; epoxygenase P450 pathway; icosanoid metabolic process; linoleic acid
metabolic process; negative regulation of collagen biosynthetic process; xenobiotic metabolic process
Brain development; branching morphogenesis of a nerve; cartilage development; cell differentiation; cerebral
cortex GABAergic interneuron differentiation and fate commitment; embryonic cranial skeleton
morphogenesis; forebrain neuron differentiation; hippocampus development; negative regulation of Notch
signaling pathway; negative regulation of oligodendrocyte differentiation; negative regulation of photoreceptor
cell differentiation; olfactory bulb development; proximal/distal pattern formation; subpallium development
Rab effector protein; vesicle trafficking

Coagulation factor X

F10

GSH2, GS homeobox 2

GSX2

Histidine decarboxylase

HDC

HtrA serine peptidase 2

HTRA2

Insulin like growth factor
binding protein 7

IGFBP7

Integral membrane
protein 2C
N-acetyltransferase 1

ITM2C

DLX2

ERBB4

NAT1

apoptotic process; cardiac muscle tissue regeneration; cell fate commitment; cell migration; cell proliferation;
cellular response to epidermal growth factor stimulus; central nervous system morphogenesis; embryonic pattern
specification; ERBB2 signaling pathway; negative regulation of apoptotic process; negative regulation of neuron
migration; nervous system development; neural crest cell migration; olfactory bulb interneuron differentiation;
peptidyl-tyrosine autophosphorylation; positive regulation of synaptic transmission, GABAergic; response to
progesterone stimulus; synapse maturation; telencephalon development
Blood coagulation; ER to Golgi vesicle-mediated transport; peptidyl-glutamic acid carboxylation; positive
regulation of cell migration; protein kinase B signaling cascade; proteolysis; signal peptide processing
Brain development; central nervous system development; forebrain dorsal/ventral pattern formation;
forebrain morphogenesis; hindbrain morphogenesis; neuron fate commitment; neuron fate specification;
olfactory bulb interneuron differentiation; pattern specification process; positive regulation of Notch signaling
pathway; positive regulation of oligodendrocyte differentiation; spinal cord association neuron
differentiation; subpallium development; subpallium neuron fate commitment; telencephalon regionalization
Carboxylic acid metabolic process; catecholamine biosynthetic process; cellular amino acid metabolic process;
histamine biosynthetic process; histamine metabolic process; histidine catabolic process
Adult locomotor behavior; cellular protein catabolic process; cellular response to oxidative stress; DNA damage
response, execution phase of apoptosis; forebrain development; mitochondrion organization; negative regulation
of cell cycle; neuron development; protein auto-processing; proteolysis; response to herbicide
Cell adhesion; cellular protein metabolic process; cellular response to hormone stimulus; embryo implantation;
inner ear development; negative regulation of cell proliferation; post-translational protein modification; regulation
of cell growth; regulation of steroid biosynthetic process; response to cortisol stimulus
Negative regulation of amyloid precursor protein; negative regulation of neuron projection development;
nervous system development and differentiation; positive regulation of extrinsic apoptotic signaling pathway
Digestive tract development; response to hypoxia; response to lipopolysaccharide; xenobiotic metabolic process
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Table 5.14. Continued.
Gene Symbol
PDIA6

Biological Function
Apoptotic cell clearance; cell redox homeostasis; cellular protein metabolic process; platelet activation; platelet
aggregation; post-translational protein modification; protein folding; response to endoplasmic reticulum stress

RPP21

Response to drug; rRNA processing; tRNA 5'-leader removal; tRNA processing

SLC5A1

Sulfotransferase family
2B member 1
Tryptophan 2,3dioxygenase
Troponin I2, fast skeletal
type
Zinc finger protein 385B

SULT2B1

Aminoacylase 1
Adenylate kinase 7

ACY1
AK7

ATPase Na+/K+
transporting subunit beta
1
Beta-1,3glucuronyltransferase 3
Bruton tyrosine kinase

ATP1B1

Caveolae associated
protein 4
Cyclin dependent kinase 5

CAVIN4

Carbohydrate transport; glucose transport; intestinal absorption; intestinal D-glucose absorption; ion transport;
metanephros development; sodium ion transport
Dorsal/ventral pattern formation; embryonic limb morphogenesis; proximal/distal pattern formation; regulation of
transcription, regulation of transcription from RNA polymerase II promoter
Sulfate conjugation of hormones, neurotransmitters, and xenobiotic compounds; lipid metabolic process; steroid
metabolic process; sulfate assimilation; 3'-phosphoadenosine 5'-phosphosulfate metabolic process;
Oxidation-reduction process; protein homotetramerization; tryptophan catabolic process; tryptophan catabolic
process to acetyl-CoA; tryptophan catabolic process to kynurenine
Calcium-dependent regulation of striated muscle contraction; co-activator of estrogen receptor-related receptor
alpha in mammary gland; suppresses tumor growth in human ovarian carcinoma; positive regulation of transcription
Apoptotic process; signal transduction by p53 class mediator resulting in induction of apoptosis
Genes altered in 30 ppb exposure at 6 mpf and 9 mpf
Cellular amino acid metabolic process; protein catabolic process; proteolysis; xenobiotic metabolic process
Axoneme assembly; brain development; cell projection organization; epithelial cilium movement; inflammatory
response to antigenic stimulus; nucleobase-containing compound metabolic process; phosphorylation;
spermatogenesis
ATP metabolic process; blastocyst development; cell communication by electrical coupling involved in cardiac
conduction; cellular calcium ion homeostasis; cellular potassium ion homeostasis; metal ion transport; positive
regulation of ATPase activity
Carbohydrate metabolic process; chondroitin sulfate, dermatan, and glycosaminoglycan metabolic process; heparan
sulfate proteoglycan biosynthetic process; protein glycosylation
Adaptive immune response; apoptotic process; B cell activation; B cell affinity maturation; B cell receptor signaling
pathway; calcium-mediated signaling; Fc-epsilon receptor signaling pathway; histamine secretion by mast cell; IkappaB kinase/NF-kappaB cascade; mesoderm development
Cardiac myofibril assembly; cell differentiation; muscle organ development; regulation of gene expression;
regulation of Rho protein signal transduction; Rho protein signal transduction
Neuron apoptotic process; associative learning; axon extension; axonogenesis; neuron development; dendrite
morphogenesis; negative regulation of axon extension; negative regulation of cell cycle; negative regulation of
synaptic plasticity; neuron differentiation; neuron migration; neuron projection development;
oligodendrocyte differentiation; protein localization to synapse; synaptic transmission, dopaminergic; synaptic
transmission, glutamatergic; synaptic vesicle endocytosis; synaptic vesicle exocytosis; synaptic vesicle transport;
telencephalon development; visual learning

SP8

TDO2
TNNI2
ZNF385B

B3GAT3
BTK

CDK5
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Name
Protein disulfide
isomerase family A
member 6
Ribonuclease P/MRP
subunit p21
Solute carrier family 5
member 1
Sp8 transcription factor

Table 5.14. Continued.
Name
Carboxypeptidase M

Gene Symbol
CPM

Dystrobrevin beta
Engrailed homeobox 1

DTNB
EN1

Eosinophil peroxidase

EPX

Family with sequence
similarity 43 member B
Glutamic--pyruvic
transaminase
Hemoglobin subunit
epsilon 1
Hypoxia inducible factor
3 alpha subunit
Hydroxysteroid 11-beta
dehydrogenase 2
HtrA serine peptidase 2

FAM43B

Biological Function
Anatomical structure morphogenesis; C-terminal protein lipidation; peptide metabolic process; protein processing;
proteolysis
Metal ion binding; protein binding; zinc ion binding
Adult locomotor behavior; anatomical structure morphogenesis; cerebellum development; dopaminergic
neuron differentiation; dorsal/ventral pattern formation; drinking behavior; hindbrain development; midbrain
development; midbrain-hindbrain boundary development; negative regulation of neuron apoptotic process;
neuron development; neuron differentiation; social behavior
Defense response; eosinophil migration; negative regulation of interleukin-10 production; negative regulation of
interleukin-5 production; oxidation-reduction process; positive regulation of interleukin-4 production
negative regulation of cell proliferation

GPT

Biosynthetic process; cellular amino acid biosynthetic process; L-alanine catabolic process

HBE1

Blood coagulation; oxygen transport; response to organic cyclic compound

HIF3A

Angiogenesis; apoptotic process; cellular response to hypoxia; protein ubiquitination; regulation of transcription

HSD11B2

Insulin like growth factor
binding protein 7

IGFBP7

Integral membrane
protein 2C
L-2-hydroxyglutarate
dehydrogenase
Membrane palmitoylated
protein 1
Peroxiredoxin 3

ITM2C
L2HGDH

Glucocorticoid biosynthesis and metabolism; oxidation-reduction process; response to glucocorticoid stimulus;
response to hypoxia; response to insulin stimulus; response to steroid hormone stimulus
Adult locomotor behavior; cellular protein catabolic process; cellular response to oxidative stress; DNA damage
response, execution phase of apoptosis; forebrain development; mitochondrion organization; negative regulation
of cell cycle; neuron development; protein auto-processing; proteolysis; response to herbicide
Cell adhesion; cellular protein metabolic process; cellular response to hormone stimulus; embryo implantation;
inner ear development; negative regulation of cell proliferation; post-translational protein modification; regulation
of cell growth; regulation of steroid biosynthetic process; response to cortisol stimulus
Negative regulation of amyloid precursor protein; negative regulation of neuron projection development;
nervous system development and differentiation; positive regulation of extrinsic apoptotic signaling pathway
2-oxoglutarate metabolic process; cellular protein metabolic process; oxidation-reduction process

MPP1

GDP metabolic process; GMP metabolic process; regulation of neutrophil chemotaxis; signal transduction

PRDX3

Protein kinase C delta

PRKCD

Apoptotic process; cell redox homeostasis; mitochondrion organization; myeloid cell differentiation; negative
regulation of neuron apoptotic process; positive regulation of cell proliferation
Activation of phospholipase C activity; activation of protein kinase activity; aging; cell chemotaxis; cell cycle;
execution phase of apoptosis; histone phosphorylation; interleukin-10 production; interleukin-12 production;
negative regulation of glial cell apoptotic process; regulation of mRNA stability

HTRA2
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Table 5.14. Continued.
Name
Protein kinase C epsilon

Gene Symbol
PRKCE

Solute carrier family 43
member 1
Slingshot protein
phosphatase 1

SLC43A1

Sulfotransferase family
2B member 1
Tryptophan 2,3dioxygenase
Troponin I2, fast skeletal
type

SULT2B1

SSH1

TDO2
TNNI2

Biological Function
Activation of phospholipase C activity; apoptotic process; cell cycle; cell division; cellular response to hypoxia;
intracellular signal transduction; locomotory exploration behavior; negative regulation of protein ubiquitination;
positive regulation of synaptic transmission, GABAergic
Amino acid transport; L-amino acid transport; neutral amino acid transport; transmembrane transport; transport
Actin cytoskeleton organization; cell morphogenesis; cellular response to ATP; dephosphorylation; positive
regulation of excitatory postsynaptic membrane potential; positive regulation of synaptic plasticity;
regulation of axonogenesis
Sulfate conjugation of hormones, neurotransmitters, and xenobiotic compounds; lipid metabolic process; steroid
metabolic process; sulfate assimilation; 3'-phosphoadenosine 5'-phosphosulfate metabolic process;
Oxidation-reduction process; protein homotetramerization; tryptophan catabolic process; tryptophan catabolic
process to acetyl-CoA; tryptophan catabolic process to kynurenine
Calcium-dependent regulation of striated muscle contraction; co-activator of estrogen receptor-related receptor
alpha in mammary gland; suppresses tumor growth in human ovarian carcinoma; positive regulation of transcription
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30 ppb ATZ (Table 5.13). Only 1 gene, GBP1, had altered expression in all three exposure
groups at both 6 mpf and 9 mpf. When evaluating the data sets for the male zebrafish, we found
27 genes that were altered in the 0.3 ppb exposure at 6 mpf and 9 mpf, 23 genes that were altered
at both 6 mpf and 9 mpf after embryonic exposure to 3 ppb ATZ, and 29 genes that were altered
in the 30 ppb exposure groups at 6 and 9 mpf (Table 5.14). A total of 7 genes (CAVIN4, CDK5,
HTRA2, IGFBP7, ITM2C, SULT2B1, TNNI2) had altered expression in all three embryonic
exposure groups at both 6 mpf and 9 mpf.
5.4.3 qPCR Confirmation of Microarray Data
The results of the microarray were independently confirmed by evaluating the relative expression
of a subset of genes altered in all three treatments for each sex. The relative expression of five
genes (ace, decr1, krt8, nmrk2, and strip1) was evaluated in all female ATZ exposures and
correlated to the log2 fold change determined on microarray analysis. There was a significant
strong positive correlation between qPCR and microarray results for the 0.3 ppb (R=0.94046,
p=0.0173) and the 30 ppb (R=0.88245, p=0.0475) exposures, but although the 3 ppb exposure
had a strong correlation (R=0.86770), the p-value just failed to reach significance (p=0.0566)
(Figure 5.10). The relative expression of six genes (aqp1a, cdk5, cyp26b1, ifgbp7, itm2cb, and
sult2b1) was evaluated in all male ATZ exposures and correlated to the log2 fold change
determined on microarray analysis. There was a significant strong positive correlation for all
three male exposure groups (0.3 ppb R=0.98254, p=0.0005; 3 ppb R=0.98623, p=0.0003; 30 ppb
R=0.97087, p=0.0013) (Figure 5.11).
5.4.4 Histopathology
Histopathology was performed on 9 mpf zebrafish brain to evaluate for physical brain alterations
resulting from embryonic ATZ exposure. No obvious histopathological changes such as
neoplasia, necrosis, or inflammation were observed in any section of any treatment for either sex;
Figure 5.12 is a representative image. Morphometric evaluation found no significant difference
between female zebrafish with embryonic ATZ exposure and the control group in the number of
cells per brain region area for the dorsal telencephalon (p=0.5996), posterior tuberculum
(p=0.3501), or the raphe populations (p=0.0370, control not significantly different from any
treatment) (Figure 5.13). Although there was no significant difference between male zebrafish
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Figure 5.10. Correlation between qPCR relative expression results and microarray fold change in females. There
was a strong positive correlation between the log2 relative expression determined by qPCR and the microarray log2
fold change for all treatments. The correlation was significant (p<0.05) for the females with embryonic exposure to
0.3 ppb (A), and 30 ppb ATZ (C); however, the females with embryonic exposure to 3 ppb ATZ had a correlation pvalue of 0.0566 (B). n =4, the relative expression of 5 genes was evaluated.
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Figure 5.11. Correlation between qPCR relative expression results and microarray fold change in males. There was a
strong positive correlation between the log2 relative expression determined by qPCR and the microarray log2 fold
change for all treatments. The correlation was significant for males with embryonic exposure to 0.3 (A), 3 (B), and
30 ppb (C) ATZ (p<0.05). n =4, the relative expression of 6 genes was evaluated.
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with embryonic ATZ and controls in the number of cells per µm2 in the dorsal telencephalon
(p=0.0793) or the posterior tuberculum (p=0.1525), there was a significant decrease in the cells
per µm2 in the males exposed to 30 ppb ATZ compared to the controls (p=0.0215) (Figure 5.14).
When both sexes were analyzed together, there was a significant decrease in the cells per µm 2 of
the dorsal telencephalon (p=0.0429), suggesting a lack of power in the individual sexes, but no
significant difference between treatments in the cells per µm2 in the posterior tuberculum
(p=0.0587) or the raphe populations (p=0.2095) (Figure 5.15).

Figure 5.12. Representative image of zebrafish brain. Green area outlines the dorsal telencephalon. The yellow
labels the posterior tuberculum. The red outlines a portion of the raphe populations (superior raphe does not appear
in this plane of section). Scale bar represents 600 µm.

5.4.5 Body and Brain Size
The body length, body weight, and brain weight to body weight ratio was assessed for each sex
at 14 mpf. The females with embryonic exposure to 30 ppb ATZ had a significantly increased
body length compared to controls (p=0.0030, Figure 5.16A). There was a significant difference
in body weight between females with embryonic ATZ exposure (p<0.0001), with the 3 ppb
exposure having decreased body weight and the 30 ppb exposure having increased body weight
compared to controls (Figure 5.16B). The females with exposure to 0.3 and 3 ppb ATZ had
significantly (p=0.0025) smaller brains compared to controls (Figure 5.16C), but when the brain
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Figure 5.13. Morphometric analysis of zebrafish brain regions from females with embryonic ATZ exposure. There
was no difference between female zebrafish with embryonic ATZ exposure and control zebrafish in the number of
cells per µm2 in the dorsal telencephalon (A), posterior tuberculum (B), or raphe populations (C). n = 3, 6
subsamples per gender per treatment per replicate, 2 brain sections evaluated per subsample, error bars represent
standard deviation, * = p < 0.05.
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Figure 5.14. Morphometric analysis of zebrafish brain regions from males with embryonic ATZ exposure. Male
zebrafish had no differences between treatments in the cells per µm2 of the dorsal telencephalon (A) or the posterior
tuberculum (B), but the males with embryonic exposure to 30 ppb ATZ ad significantly fewer cells per µm2
compared to controls (C). n = 3, 6 subsamples per gender per treatment per replicate, 2 brain sections evaluated per
subsample, error bars represent standard deviation, * = p < 0.05.
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Figure 5.15. Morphometric analysis of zebrafish brain regions from both sexes with embryonic ATZ exposure.
Combining the sexes resulted in a significant decrease in the number of cells per µm2 in the dorsal telencephalon for
the zebrafish with embryonic exposure to 30 ppb (A), but no significant differences between treatments for the cells
per µm2 of the posterior tuberculum (B), or the raphe populations (C). n = 3, 6 subsamples per gender per treatment
per replicate, 2 brain sections evaluated per subsample, error bars represent standard deviation, * = p < 0.05.
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Figure 5.16. Alterations in adult body length and weight, and brain weight in females after embryonic ATZ
exposure. Female zebrafish with embryonic exposure to 30 ppb ATZ had increased body length compared to
controls (A). The female 3 ppb embryonic ATZ exposure had a decreased body weight, but the 30 ppb exposure
group had an increased weight compared to controls (B). The raw brain weight was decreased in the 0.3 and 3 ppb
exposures compared to the controls. The brain weight to body weight ratio was decreased in the females with 0.3
and 30 ppb embryonic exposures (D). n = 3, with 14-69 subsamples per sex per treatment per replicate. Error bars
represent standard deviation. * = p < .05.

weight to body weight ratio was calculated, the 0.3 and 30 ppb exposures had a significantly (p=
0.0032) smaller brain per body weight (Figure 5.16D). Male zebrafish with embryonic ATZ
exposure did not have any differences in body length between treatments (p=0.8887), but the 3
ppb exposure group did have a significantly decreased body weight (p=0.0456) compared to
controls (Figure 5.17A-B). However, there was no significant difference between treatments in
brain weight (p=0.3562) or brain weight to body weight ratio (p=0.1028) (Figure 5.17C-D).
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Figure 5.17. Alterations in adult body length and weight, and brain weight in males after embryonic ATZ exposure.
There was no difference in body weight between male embryonic ATZ exposure groups (A), but the body weight
was significantly decreased in the males with embryonic exposure to 3 ppb ATZ (B). There was no difference in
brain weight (C) or brain weight to body weight ratio between the male exposures (D). n = 3, with 14-69 subsamples
per sex per treatment per replicate. Error bars represent standard deviation. * = p < .05.

5.5

Discussion

The studies presented here investigated the developmental origins of ATZ related adult
neurotoxicity. ATZ is an EDC and can disrupt intracellular signaling (Kucka et al., 2012), the
expression of steroidogenic genes (Abarikwu et al., 2011), and the epigenome through altered
expression and function of DNA methyltransferases (Wirbisky-Hershberger et al., 2017) and
microRNAs (Wirbisky et al., 2016c). Disruption of these functions has the potential to have
significant consequences for organismal growth and development. Exposure to ATZ has been
implicated in altered neurodevelopment and function by our laboratory (Weber et al., 2013;
Wirbisky et al., 2016b; Wirbisky et al., 2015b) and others (Bardullas et al., 2011; Belloni et al.,
2011; Filipov et al., 2007; Lin et al., 2014a; Sun et al., 2014). Using both female and male
zebrafish, we assessed the behavioral, transcriptomic, and pathologic changes in adult zebrafish
brain after embryonic exposure to low, environmentally relevant concentrations of ATZ with the
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aim to link embryonic ATZ exposure to both physical and functional outcomes later in life. We
hypothesized changes in anxiety-related behaviors and serotonergic pathways would be observed
based on our previous studies (Wirbisky et al., 2016b; Wirbisky et al., 2015b).
Zebrafish have well-characterized behavioral outcomes (Kalueff et al., 2013) and the
NTT, LDB, and OFT are common models used to assess zebrafish behavior and anxiety (Egan et
al., 2009; Kalueff et al., 2016; Kalueff et al., 2014). After subjecting 9 mpf female and male
zebrafish with embryonic ATZ exposure to the NTT, LDB, and OFT, we determined that
developmental ATZ exposure causes nonmonotonic, sex-specific alterations in neurobehavioral
endpoints. Female zebrafish had nonmonotonic alterations in anxiety related endpoints, such as
having decreased time spent in the upper zone of the NTT as predicted from our previous studies
(Wirbisky et al., 2016b; Wirbisky et al., 2015b). On the other hand, male zebrafish with
developmental ATZ exposure had phenotypes more suggestive of altered locomotor or
movement parameters, with decreased distance moved, velocity and time spent moving.
Although the latency to zonal entry was increased in all male exposures in the NTT and the 0.3
and 30 ppb groups on the LDB, this was attributed to the overall decrease in movement.
It should be noted that although there can be significant variation in zebrafish behavior
from clutch to clutch and between testing days (Kalueff et al., 2016), our results represent the
aggregate results of four separate clutches over multiple testing days. Even though time of day,
and testing order account for less variability (Kalueff et al., 2016), our treatments and genders
were balanced in testing order and the behavioral tests were performed in the same order at
roughly the same time each day. The nonmonotonic, sex-specific nature of our results is
consistent with the effects of low dose exposure to other EDCs (Vandenberg et al., 2012). The
NTT, LDB, and OFT are all measures of anxiety, but these tests may not be sensitive enough to
identify altered stress and anxiety behaviors in the face of altered locomotion.
Rodent studies investigating ATZ also support a developmental basis of altered behavior
later in life. Belloni et al. (2011) found that CD-1 mice with gestational exposure to 1 µg/kg/day
ATZ had altered behavior profiles, with juvenile males having feminization of behavior and
female and male mice having altered learning performance in adulthood. Lin et al. (2013a) found
alterations in activity in both sexes, time swimming on a forced swim test in males, and marble
burying in juvenile C57BL/6 mice that had developmental exposure to 3000 ppb ATZ in
maternal drinking water from gestational day 6 to postnatal day 23. In zebrafish, ATZ exposure
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has been reported to cause altered behavior in adults after chronic or subchronic exposure. Adult
zebrafish exposed to ATZ at concentrations ranging from 5 to 3125 ppb for four weeks had
altered light dark preference at all treatment concentrations (Steinberg et al., 1995) and adult
zebrafish with 14-day-exposure to 1000 ppb ATZ had altered shoaling behavior (Schmidel et al.,
2014). The effects of developmental ATZ exposure have also been studied in larval zebrafish.
Liu et al. (2016) found that 120 hpf larvae with exposure to 100 and 300 ppb ATZ up to 120 hpf
had decreased free swimming speeds and decreased locomotor activity after exposure to light
and dark stimuli. In our laboratory, we found that larvae exposed to 30 ppb ATZ from
immediately after fertilization to 72 hpf had decreased distance moved, velocity, and time spent
moving in a larval visual motor response test performed at 120 hpf (Horzmann et al, 2018Submitted). The current study is the first to use zebrafish to test the developmental origins of
adult behavioral changes after embryonic ATZ exposure. The altered behavioral outcomes in the
adult zebrafish with embryonic 0.3 and 3 ppb ATZ exposure suggests that exposure to ATZ
during development alters behavior at lower doses than what is observed in either larval
developmental or adult exposure studies. Larval behavioral tests are often used in highthroughput toxicity screening of chemicals (Reif et al., 2016; Truong et al., 2014), but larval
screening tests may not fully characterize the late life effects of embryonic toxicant exposure.
We evaluated the brain transcriptome of female and male 9 mpf zebrafish with
embryonic ATZ exposure to identify possible altered genes or pathways that could explain the
observed changes in neurobehavior and to and to determine if embryonic exposure to ATZ
causes lasting alterations in gene expression later in life. The common genes that were altered in
our 9 mpf female exposure groups were associated with cancer, cell signaling, and embryonic
development pathways. Interestingly, 22 of the genes altered in the female brain after embryonic
ATZ exposure are also altered in genital tract cancers; however, 7 of these genes, ACE, CHD1,
CTPS1, LSR, OTOA, SRD5A2, and TSC2, also have functions associated with either
neurodevelopment or neural function. In 9 mpf males, the genes common to all embryonic
exposures were associated with developmental disorders, cellular functions, and reproductive
system development and function; however, the genes are part of a larger network that influence
neurological disease. Looking closer at the genes commonly altered in male zebrafish, 5 of the
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genes (AQP1, CDK5, CYP26B1, HTRA2, and TNNI2) are associated with disease of the basal
nuclei and movement disorders, suggesting disruption of the dopaminergic system in male
zebrafish with embryonic ATZ exposure.
Although there were no genes that were altered in all exposures in both sexes, there were
common genes shared between sexes for each embryonic exposure. CDK5, a member of the
cyclin-dependent kinases family with roles in neuronal survival, synaptic plasticity, learning and
memory, and behavior had altered expression in both the female and male 0.3 and 3 ppb ATZ
exposure groups. As reviewed by Shah et al. (2014), dysreguation of CDK5 is associated with
Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. FA2H was altered in both
females and males with 0.3 ppb embryonic ATZ exposure. Mutations of FA2H are associated
with a neurodevenerative disease characterized by abnormal myelin production with symptoms
of a mixed movement disorder with spacisity (Kruer et al., 2012).
We evaluated the persistence of gene expression alterations caused by embryonic ATZ
exposure by comparing genes altered in 6 mpf female (Wirbisky et al., 2015b) and male
(Wirbisky et al., 2016b) zebrafish with embryonic ATZ exposure to the results of our analysis.
We found only one gene (GBP1) that was altered in all three exposures in females at both 6 mpf
and 9 mpf, but there were shared genes for each exposure. The females with 0.3 ppb embryonic
ATZ exposure had 27 genes with persistent altered expression, with 10 of those genes having
functions related to brain development or function (ACE, ATCAY, CACNG8, CTHRC1, LSR,
PHACTR4, POMC, PTPRU, SDCCAG8, and STMN1). With only 3 genes persistently altered in
the 3 ppb embryonic exposure and 7 with persistent expression changes in the 30 ppb exposure,
it appears that exposure to 0.3 ppb ATZ during embryogenesis causes larger disruptions in gene
expression both at the specific time points (Wirbisky et al., 2015b) and over time.
In males, we identified 7 genes (CAVIN4, CDK5, HTRA2, IGFBP7, ITM2C, SULT2B1,
and TNNI2) that were altered in all three male exposures at 6 and 9 mpf. Interestingly, CDK5,
HTRA2, ITM2C, and SULT2B1 are all related to the nervous system, neurodevelopment, or
neurotransmission while IFGBP7, SULT2B1, and TNNI2 have functions related to hormone
biosynthesis, modification, receptor action, or cellular response. Among the individual
exposures, the 3 ppb and 30 ppb embryonic exposures had a greater number of genes with
persistent changes than the 0.3 ppb exposure. The number of altered genes with functions related
to the nervous system also increased with increasing embryonic ATZ exposures. The 0.3 ppb
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embryonic exposure did not have any additional changes in genes related to neurodevelopment
or function, but the 3 ppb exposure had altered expression of 3 additional genes, DLX2, ERBB4,
and GSX2, with functions related to brain development or synaptic function. Exposure to 30 ppb
ATZ during embryogenesis altered the expression of 6 unique genes, AK7, EN1, PRDX3,
PRKCD, PRKCE, and SSH1. Although there was no additional overlap in genes between the 3
and 30 ppb exposures, the increasing number of genes with persistent altered expression could
suggest increased nervous system dysregulation which would tie into the greater behavioral
effects observed in the 30 ppb embryonic exposure group.
Microarray analysis of 72 hpf zebrafish with embryonic ATZ exposure identified changes
in genes associated with neuroendocrine system and function, reproductive system function, cell
cycle, and carcinogenesis (Weber et al., 2013). Previous brain microarray analysis of 6 mpf
female zebrafish with embryonic ATZ exposure identified altered gene expression in pathways
associated with nervous system development and function (Wirbisky et al., 2015b), and analysis
of brain from 6 mpf male zebrafish with embryonic ATZ exposure found that pathways
associated with cell development and lipid metabolism, specifically in genes involved in
synthesis and concentration of lipid and quantity of steroid hormones (Wirbisky et al., 2016b).
The number of genes in the current study linked to cancer at each exposure was surprising,
although carcinogenesis pathways were enriched in the 72 hpf transcriptomic evaluation (Weber
et al., 2013). Additionally, recent proteomic analysis of 120 hpf larval zebrafish with embryonic
(1-72 hpf) ATZ exposure identified 15 proteins with altered levels that were associated with
male and female genital tract cancers (Horzmann et al., 2018-Submitted). In our current study,
25 genes common to all three female exposures were associated with urogenital cancer,
suggesting developmental exposure to ATZ could cause persistent changes in pathways related
to these cancers. Only one protein related to genital tract cancers from Horzmann et al., (2018Submitted) had altered gene expression in our current study. The expression of KRT17, which
functions in keritinzaiton, was downregulated only in females, but in all three embryonic ATZ
exposures. The genes from our study otherwise related to genital tract cancers have functions
related to regulation of transcription and cellular metabolism.
Serotonin pathway genes were altered in both sexes in 6 mpf adult zebrafish (Wirbisky et
al., 2016b; Wirbisky et al., 2015b). Wirbisky et al. (2015b) also found that 9 mpf female
zebrafish with embryonic exposure to 0.3 and 3 ppb ATZ had decreased levels of 5-HIAA and
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decreased serotonin turnover. Based on these results, we expected to find persistent expression
changes in genes associated with the brain serotonergic system. However, we did not observe
altered expression of genes directly related to serotonin in our transcriptomic analysis in either
females or males. Rather, the gene alterations at 6 mpf appear to better predict the functional
outcomes in behavior observed at 9 mpf and the previous measured alterations in
neurotransmitter levels (Wirbisky et al., 2015b). As transcriptomic evaluation only captures a
snapshot of gene activity, it is possible that the gene expression changes later in life do not fully
capture previous alterations in physiological processes that result in altered behavior or
neurotransmission.
Other studies, though, have linked ATZ to changes in neurotransmitters. Male C57BL/6
mice with short-term (10 day) oral exposure to 5-250 mg/kg/day ATZ had changes in the plasma
metabolome in pathways that suggest disruption of α-linolenate, tryptophan, and tyrosine
metabolism (Lin et al., 2014b). Tyrosine is the precursor of dopamine and tryptophan the
precursor of serotonin and disruption of these pathways could provide one basis for altered
neurotransmission after ATZ exposure. Accordingly, adult female C57BL/6 mice that had
developmental exposure to 3000 ppb ATZ in maternal drinking water from gestational day 6 to
postnatal day 23 had decreased 5-HT in the perirhinal cortex that was associated with decreased
cognitive ability (Lin et al., 2014a).
Multiple studies have also found changes in dopamine levels or pathway functions in
rodents with either acute or developmental ATZ exposure (Bardullas et al., 2011; Coban et al.,
2007; Filipov et al., 2007; Hossain et al., 2008; Li et al., 2014a; Li et al., 2014b; Lin et al.,
2013b; Lin et al., 2014a; Rodriguez et al., 2013; Sun et al., 2014). Although our hypothesis of
altered anxiety endpoints consistent with serotonergic dysfunction was supported by the results
in female zebrafish with embryonic ATZ exposure, the decrease in locomotion observed in the
males with embryonic ATZ exposure may point to sex-specific disruptions in the dopaminergic
neurotransmission, which is supported by other studies (Coban et al., 2007; Filipov et al., 2007;
Li et al., 2014a; Lin et al., 2013b; Lin et al., 2014a; Sun et al., 2014). We did identify alterations
in genes related to movement disorders and basal nuclei disease; however, we did not find gene
expression changes in direct dopaminergic pathways and previously neurotransmitter analysis
did not identify changes in dopamine or dopamine metabolites in zebrafish brain (Wirbisky et
al., 2015b). It is also possible that the decreased activity of male zebrafish is related to a change
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in overall brain arousal state, rather than in movement related pathways, suggesting alterations in
serotonergic pathways as supported by the work of our laboratory (Wirbisky et al., 2016b;
Wirbisky et al., 2015b) and others (Lin et al., 2014a; Lin et al., 2014b; Rajkovic et al., 2011). It
is likely that both the serotonergic and dopaminergic systems have altered function and it is
possible that some of the cellular dysfunction occurs in non-neuronal populations.
We evaluated sections of brain from 9 mpf female and male zebrafish with embryonic
ATZ exposure for physical or pathological alterations. There were no obvious differences
between treatments and no evidence of pathological processes such as neoplasia, necrosis, or
inflammation in any section. Morphometric analysis was performed on three brain regions to
semi-quantitatively evaluate for subtle differences in tissue morphology, namely the number of
cells per µm2 area (Shackelford et al., 2002). The utility of using morphometric histopathologic
techniques in the evaluation of EDCs has previously been recognized (van der Ven et al., 2003)
and the dorsal telencephalon, posterior tuberculum, and raphe populations were identified as
regions of interest based on suspected functional homology of these areas and their potential link
to neurological diseases and disorders in humans (Kozol et al., 2016). The dorsal telencephalon
consists of the medial dorsal telencephalon (sometimes called medial dorsal pallium) and the
lateral dorsal telencephalon (sometimes called lateral dorsal pallium). The medial dorsal
telencephalon is suggested to have a function homologous to the amygdala while the lateral
dorsal telencephalon is suggested to be similar to the hippocampus (Ganz et al., 2014; Maximino
et al., 2013; Northcutt, 2006). Due to planar limitations associated with paraffin embedding and
sectioning of multiple zebrafish heads in a single block, the two regions of the dorsal
telencephalon were considered together. Although there were no significant differences in the
cells per µm2 in the dorsal telencephalon between exposure groups when genders were
considered separately, when the genders were combined, there was a significant decrease in the
number of cells per µm2. The posterior tuberculum in teleost fish is considered to have features
suggestive of an ancient basal ganglion, mainly the presence of dopaminergic cells that project to
the striatum (Wullimann, 2014). In our analysis, there was no significant differences in the
number of cells per area between exposures. Finally, the raphe populations are classically
considered populations of serotonergic neurons with projections that extend to the telencephalon,
cerebellum, and spinal cord (Herculano et al., 2014; Lillesaar, 2011). The superior (dorsal) and
inferior (caudal) populations were considered together, again due to limitations related to plane
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of section. Dopaminergic neurons can also be identified in raphe populations and have been
linked to phenotypes of social isolation in mice (Matthews et al., 2016). The sections from males
with 30 ppb embryonic ATZ exposure had significantly fewer cells per µm2 of raphe area. If
these cells represent alterations in serotonergic neuron numbers, then behavioral alterations
observed in males with embryonic ATZ exposure may be related to an altered state of arousal.
However, in the determination of cells per µm2, the number of nuclei were counted in each brain
region, including all neuronal populations, glial cells, and microglia. Nucleated fish red blood
cells were excluded. We could not determine if the decrease in cells per µm2 were attributed to
decreased numbers of neurons, glia, or microglia in the H&E sections evaluated, but a decrease
in number of any of those subpopulations could disrupt normal brain function and would require
further investigation.
Evaluation of the body and brain size of female and male 14 mpf zebrafish with
embryonic ATZ exposure indicated that the females with embryonic exposure to 30 ppb ATZ
had increased body size (length and weight), but proportionally smaller brains. In a previous
study (Wirbisky et al., 2016d), female zebrafish with embryonic exposure to 30 ppb ATZ had a
bloated abdomen that was related to significantly heavier ovaries with increased numbers of
atretic ovarian follicles. Although we did not see a similar bloated abdomen phenotype in the
female fish of this study, it is possible that increased body weight in females is due to increased
ovarian weight. The raw brain weight for the 30 ppb exposed females was not significantly
different from controls, and it must be considered that the decrease in brain to body weight ratio
is due to increased body weight rather than decreased brain weight. The female 0.3 ppb exposure
group had a significant decrease in brain to body weight ratio that cannot be explained by
changes in body size, suggesting true decrease in brain size. In 72 hpf larval zebrafish,
embryonic exposure to 0.3, 3, and 30 ppb ATZ was associated with increased head length
(Weber et al., 2013) and a larger brain length was observed only in larvae with exposure to 0.3
ppb ATZ (Horzmann et al., 2018-Submitted). Although the relationship between early brain
length increase and later life brain weight decrease is uncertain, it is possible that early disruption
of neurodevelopment results in physical changes that persist through life course, or that the
smaller brains later in life represent an age related pathologic atrophy of tissue consistent with
degenerative neurological diseases (Romanowski et al., 2011).
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Conclusions
In this study we investigated the developmental origins of ATZ related neurotoxicity. In

summary, we identified sex-specific, nonmonotonic alterations in behavioral outcomes in adult
zebrafish after embryonic ATZ exposure, with female zebrafish having altered anxiety related
endpoints and male zebrafish having decreased measures of movement. Although we
hypothesized persistent alterations in neurotransmission-related genes would be observed, female
zebrafish with embryonic ATZ exposure had gene expression changes enriched in pathways
related to cancer, cellular signaling, and embryonic development and male zebrafish with
embryonic ATZ exposure had expression changes in genes related to developmental disorders,
cell function, and the reproductive system. Interestingly, genes with persistently altered
expression in females and males have functions related to the nervous system and hormone
action in males. Furthermore, we observed alterations in body and brain size after embryonic
ATZ exposure and identified areas of the brain that appear to have altered cellular density
resulting from the early exposure. Further characterization is needed to better understand the
physiological implication of the morphometric changes and to identify how the altered genes
interact to alter neurobehavior.

236
5.7

References

Abarikwu, S. O., Farombi, E. O., Kashyap, M. P., and Pant, A. B. (2011). Atrazine induces
transcriptional changes in marker genes associated with steroidogenesis in primary
cultures of rat Leydig cells. Toxicol. Vitro 25(8), 1588-1595.
Bailey, J., Oliveri, A., and Levin, E. D. (2013). Zebrafish model systems for developmental
neurobehavioral toxicology. Birth Defects Res C Embryo Today 99(1), 14-23.
Bardullas, U., Giordano, M., and Rodriguez, V. M. (2011). Chronic atrazine exposure causes
disruption of the spontaneous locomotor activity and alters the striatal dopaminergic
system of the male Sprague-Dawley rat. Neurotoxicology and teratology 33(2), 263-72.
Barker, D. J. P., Godfrey, K. M., Gluckman, P. D., Harding, J. E., Owens, J. A., and Robinson, J.
S. (1993). Fetal nutrition and cardiovascular disease in adult life. The Lancet 341(8850),
938-941.
Barker, D. J. P., and Osmond, C. (1986). Infant mortality, childhood nutrition, and ischaemic
heart disease in England and Wales. Lancet i(8489), 1077-1081.
Barouki, R., Gluckman, P. D., Grandjean, P., Hanson, M., and Heindel, J. J. (2012).
Developmental origins of non-communicable disease: implications for research and
public health. Environ Health 11, 42.
Battaglin, W. A., Furlong, E. T., Burkhardt, M. R., and Peter, C. J. (2000). Occurrence of
sulfonylurea, sulfonamide, imidazolinone, and other herbicides in rivers, reservoirs and
ground water in the Midwestern United States, 1998. Sci. Total Environ. 248(2-3), 123133.
Belloni, V., Dessi-Fulgheri, F., Zaccaroni, M., Di Consiglio, E., De Angelis, G., Testai, E.,
Santochirico, M., Alleva, E., and Santucci, D. (2011). Early exposure to low doses of
atrazine affects behavior in juvenile and adult CD1 mice. Toxicology 279(1-3), 19-26.
Bern, H. (1992). The Fragile Fetus. In Chemically-Induced Alterations in Sexual and Functional
Development: The Wildlife/Human Connection (T. Colborn, and C. Clement, Eds.), pp. 915. Princeton Scientific Publishing Co., Inc., Princeton, N.J. USA.
Birnbaum, L. S., and Fenton, S. E. (2003). Cancer and developmental exposure to endocrine
disruptors. Environ. Health Perspect. 111(4), 389-394.

237
Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J.,
Ansorge, W., Ball, C. A., Causton, H. C. et al. (2001). Minimum information about a
microarray experiment (MIAME)-toward standards for microarray data. Nature genetics
29(4), 365-71.
Brodeur, J. C., Sassone, A., Hermida, G. N., and Codugnello, N. (2013). Environmentallyrelevant concentrations of atrazine induce nonmonotonic acceleration of developmental
rate and increased size at metamorphosis in Rhinella arenarum tadpoles. Ecotoxicology
and environmental safety 92, 10-7.
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R.,
Nolan, T., Pfaffl, M. W., Shipley, G. L. et al. (2009). The MIQE Guidelines: Minimum
Information for Publication of Quantitative Real-Time PCR Experiments. Clin. Chem.
55(4), 611-622.
Coban, A., and Filipov, N. M. (2007). Dopaminergic toxicity associated with oral exposure to
the herbicide atrazine in juvenile male C57BL/6 mice. Journal of neurochemistry 100(5),
1177-87.
Cooper, R. L., Stoker, T. E., Goldman, J. M., Parrish, M. B., and Tyrey, L. (1996). Effect of
atrazine on ovarian function in the rat. Reprod. Toxicol. 10(4), 257-264.
Cragin, L. A., Kesner, J. S., Bachand, A. M., Barr, D. B., Meadows, J. W., Krieg, E. F., and Reif,
J. S. (2011). Menstrual cycle characteristics and reproductive hormone levels in women
exposed to atrazine in drinking water. Environmental research 111(8), 1293-301.
Dao, T., Lavy, T., and Sorensen, R. (1979). Atrazine degradation and residue distribution in soil.
Soil Science Society of America Journal 43(6), 1129-1134.
de Esch, C., Slieker, R., Wolterbeek, A., Woutersen, R., and de Groot, D. (2012). Zebrafish as
potential model for developmental neurotoxicity testing: A mini review. Neurotoxicology
and teratology 34(6), 545-553.
Diamanti-Kandarakis, E., Bourguignon, J. P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A.
M., Zoeller, R. T., and Gore, A. C. (2009). Endocrine-Disrupting Chemicals: An
Endocrine Society Scientific Statement. Endocr. Rev. 30(4), 293-342.
Dickerson, S. M., and Gore, A. C. (2007). Estrogenic environmental endocrine-disrupting
chemical effects on reproductive neuroendocrine function and dysfunction across the life
cycle. Reviews in Endocrine and Metabolic Disorders 8(2), 143-159.

238
Dolinoy, D. C., and Jirtle, R. L. (2008). Environmental epigenomics in human health and
disease. Environ. Mol. Mutagen. 49(1), 4-8.
Egan, R. J., Bergner, C. L., Hart, P. C., Cachat, J. M., Canavello, P. R., Elegante, M. F.,
Elkhayat, S. I., Bartels, B. K., Tien, A. K., Tien, D. H. et al. (2009). Understanding
behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain
Res 205(1), 38-44.
European Commission (2003). Review report for the active substance atrazine; European
Commission Health and Consumer Protection Directorate-General. SANCO/10496/2003final.
Filipov, N. M., Stewart, M. A., Carr, R. L., and Sistrunk, S. C. (2007). Dopaminergic toxicity of
the herbicide atrazine in rat striatal slices. Toxicology 232(1-2), 68-78.
Foradori, C. D., Hinds, L. R., Quihuis, A. M., Lacagnina, A. F., Breckenridge, C. B., and Handa,
R. J. (2011). The Differential Effect of Atrazine on Luteinizing Hormone Release in
Adrenalectomized Adult Female Wistar Rats. Biol. Reprod. 85(4), 684-689.
Foradori, C. D., Zimmerman, A. D., Hinds, L. R., Zuloaga, K. L., Breckenridge, C. B., and
Handa, R. J. (2013). Atrazine Inhibits Pulsatile Gonadotropin-Releasing Hormone
(GnRH) Release Without Altering GnRH Messenger RNA or Protein Levels in the
Female Rat. Biol. Reprod. 88(1), 7.
Freeman, J. L., Beccue, N., and Rayburn, A. L. (2005). Differential metamorphosis alters the
endocrine response in anuran larvae exposed to T-3 and atrazine. Aquatic toxicology
75(3), 263-276.
Freeman, J. L., Weber, G. J., Peterson, S. M., and Nie, L. H. (2014). Embryonic ionizing
radiation exposure results in expression alterations of genes associated with
cardiovascular and neurological development, function, and disease and modified
cardiovascular function in zebrafish. Frontiers in Genetics 5, 268.
Friedmann, A. S. (2002). Atrazine inhibition of testosterone production in rat males following
peripubertal exposure. Reprod. Toxicol. 16(3), 275-279.
Ganz, J., Kroehne, V., Freudenreich, D., Machate, A., Geffarth, M., Braasch, I., Kaslin, J., and
Brand, M. (2014). Subdivisions of the adult zebrafish pallium based on molecular marker
analysis. F1000Research 3, 308.

239
Gilliom, R., Barbash, J., Crawford, C., Hamilton, P., Martin, J., Nakagaki, N., Nowell, L., Scott,
J., Stackelberg, P., Thelin, G. et al. (2006). The Quality of Our Nation’s Waters—
Pesticides in the Nation’s Streams and Ground Water, 1992–2001: U.S. Geological
Survey Circular 1291,172.
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., and
Zoeller, R. T. (2015). EDC-2: The Endocrine Society's Second Scientific Statement on
Endocrine-Disrupting Chemicals. Endocr. Rev. 36(6), E1-E150.
Graeff, F. G., Guimaraes, F. S., DeAndrade, T., and Deakin, J. F. W. (1996). Role of 5-HT in
stress, anxiety, and depression. Pharmacology Biochemistry and Behavior 54(1), 129141.
Haugen, A. C., Schug, T. T., Collman, G., and Heindel, J. J. (2015). Evolution of DOHaD: the
impact of environmental health sciences. Journal of developmental origins of health and
disease 6(2), 55-64.
Hayes, T. B., Collins, A., Lee, M., Mendoza, M., Noriega, N., Stuart, A. A., and Vonk, A.
(2002). Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at
low ecologically relevant doses. Proc. Natl. Acad. Sci. U. S. A. 99(8), 5476-5480.
Heindel, J. J., Balbus, J., Birnbaum, L., Brune-Drisse, M. N., Grandjean, P., Gray, K., Landrigan,
P. J., Sly, P. D., Suk, W., Cory Slechta, D. et al. (2015). Developmental Origins of Health
and Disease: Integrating Environmental Influences. Endocrinology 156(10), 3416-3421.
Herculano, A. M., and Maximino, C. (2014). Serotonergic modulation of zebrafish behavior:
Towards a paradox. Progress in Neuro-Psychopharmacology and Biological Psychiatry
55(0), 50-66.
Hill, A. J., Teraoka, H., Heideman, W., and Peterson, R. E. (2005). Zebrafish as a model
vertebrate for investigating chemical toxicity. Toxicological sciences 86(1), 6-19.
Horzmann, K. A., Reidenbach, L. S., Thanki, D. H., Winchester, A. E., Qualizza, B. A., Ryan, G.
A., Egan, K. E., Hedrick, V. E., Sobreira, T. J. P., Peterson, S. M. et al. (2018).
Embryonic atrazine exposure elicits proteomic, behavioral, and brain abnormalities with
developmental time specific gene expression signatures. Journal of Proteomics
Submitted. .

240
Hossain, M. M., and Filipov, N. M. (2008). Alteration of dopamine uptake into rat striatal
vesicles and synaptosomes caused by an in vitro exposure to atrazine and some of its
metabolites. Toxicology 248(1), 52-8.
Howe, K., Clark, M. D., Torroja, C. F., Torrance, J., Berthelot, C., Muffato, M., Collins, J. E.,
Humphray, S., McLaren, K., Matthews, L. et al. (2013). The zebrafish reference genome
sequence and its relationship to the human genome. Nature 496(7446), 498-503.
Janesick, A., and Blumberg, B. (2011). Endocrine disrupting chemicals and the developmental
programming of adipogenesis and obesity. Birth Defects Research Part C: Embryo
Today: Reviews 93(1), 34-50.
Jin, Y., Chen, R., Liu, W., and Fu, Z. (2010). Effect of endocrine disrupting chemicals on the
transcription of genes related to the innate immune system in the early developmental
stage of zebrafish (Danio rerio). Fish & Shellfish Immunology 28(5), 854-861.
Kalueff, A. V., Echevarria, D. J., Homechaudhuri, S., Stewart, A. M., Collier, A. D., Kaluyeva,
A. A., Li, S., Liu, Y., Chen, P., Wang, J. et al. (2016). Zebrafish neurobehavioral
phenomics for aquatic neuropharmacology and toxicology research. Aquatic toxicology
170, 297-309.
Kalueff, A. V., Gebhardt, M., Stewart, A. M., Cachat, J. M., Brimmer, M., Chawla, J. S.,
Craddock, C., Kyzar, E. J., Roth, A., Landsman, S. et al. (2013). Towards a
comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 10(1), 70-86.
Kalueff, A. V., Stewart, A. M., and Gerlai, R. (2014). Zebrafish as an emerging model for
studying complex brain disorders. Trends in Pharmacological Sciences 35(2), 63-75.
Kettles, M. A., Browning, S. R., Prince, T. S., and Horstman, S. W. (1997). Triazine herbicide
exposure and breast cancer incidence: An ecologic study of Kentucky counties. Environ.
Health Perspect. 105(11), 1222-1227.
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B., and Schilling, T. F. (1995). Stages
of embryonic development of the zebrafish. Developmental 203(3), 253-310.
Kozol, R. A., Abrams, A. J., James, D. M., Buglo, E., Yan, Q., and Dallman, J. E. (2016).
Function Over Form: Modeling Groups of Inherited Neurological Conditions in
Zebrafish. Frontiers in Molecular Neuroscience 9, 55.

241
Kruer, M. C., Gregory, A., and Hayflick, S. J. (2012). Fatty Acid Hydroxylase-Associated
Neurodegeneration. In GeneReviews((R)) (M. P. Adam, H. H. Ardinger, R. A. Pagon, S.
E. Wallace, L. J. H. Bean, K. Stephens, and A. Amemiya, Eds.). University of
Washington, Seattle. Seattle, WA, USA.
Kucka, M., Pogrmic-Majkic, K., Fa, S., Stojilkovic, S. S., and Kovacevic, R. (2012). Atrazine
acts as an endocrine disrupter by inhibiting cAMP-specific phosphodiesterase-4.
Toxicology and applied pharmacology 265(1), 19-26.
Li, Y., Sun, Y., Yang, J., Wu, Y., Yu, J., and Li, B. (2014a). Age-dependent dopaminergic
dysfunction following fetal exposure to atrazine in SD rats. Environmental toxicology
and pharmacology 37(3), 1275-82.
Li, Y., Sun, Y., Yang, J., Wu, Y., Yu, J., and Li, B. (2014b). The long-term effects of the
herbicide atrazine on the dopaminergic system following exposure during pubertal
development. Mutation research. Genetic toxicology and environmental mutagenesis
763, 23-9.
Lillesaar, C. (2011). The serotonergic system in fish. Journal of Chemical Neuroanatomy 41(4),
294-308.
Lin, Z., Dodd, C. A., and Filipov, N. M. (2013a). Differentiation state-dependent effects of in
vitro exposure to atrazine or its metabolite diaminochlorotriazine in a dopaminergic cell
line. Life sciences 92(1), 81-90.
Lin, Z., Dodd, C. A., and Filipov, N. M. (2013b). Short-term atrazine exposure causes behavioral
deficits and disrupts monoaminergic systems in male C57BL/6 mice. Neurotoxicology
and teratology 39, 26-35.
Lin, Z., Dodd, C. A., Xiao, S., Krishna, S., Ye, X., and Filipov, N. M. (2014a). Gestational and
lactational exposure to atrazine via the drinking water causes specific behavioral deficits
and selectively alters monoaminergic systems in C57BL/6 mouse dams, juvenile and
adult offspring. Toxicological sciences 141(1), 90-102.
Lin, Z., Roede, J. R., He, C., Jones, D. P., and Filipov, N. M. (2014b). Short-term oral atrazine
exposure alters the plasma metabolome of male C57BL/6 mice and disrupts alphalinolenate, tryptophan, tyrosine and other major metabolic pathways. Toxicology 326,
130-41.

242
Liu, Z., Wang, Y., Zhu, Z., Yang, E., Feng, X., Fu, Z., and Jin, Y. (2016). Atrazine and its main
metabolites alter the locomotor activity of larval zebrafish (Danio rerio). Chemosphere
148, 163-70.
Matthews, G. A., Nieh, E. H., Vander Weele, C. M., Halbert, S. A., Pradhan, R. V., Yosafat, A.
S., Glober, G. F., Izadmehr, E. M., Thomas, R. E., Lacy, G. D. et al. (2016). Dorsal
Raphe Dopamine Neurons Represent the Experience of Social Isolation. Cell 164(4),
617-31.
Maximino, C., Lima, M. G., Oliveira, K. R., Batista Ede, J., and Herculano, A. M. (2013).
"Limbic associative" and "autonomic" amygdala in teleosts: a review of the evidence. J
Chem Neuroanat 48-49, 1-13.
Mostafalou, S., and Abdollahi, M. (2017). Pesticides: an update of human exposure and toxicity.
Archives of Toxicology 91(2), 549-599.
Northcutt, R. G. (2006). Connections of the lateral and medial divisions of the goldfish
telencephalic pallium. J Comp Neurol 494(6), 903-43.
Ochoa-Acuna, H., Frankenberger, J., Hahn, L., and Carbajo, C. (2009). Drinking-Water
Herbicide Exposure in Indiana and Prevalence of Small-for-Gestational-Age and Preterm
Delivery. Environ. Health Perspect. 117(10), 1619-1624.
Peterson, S. M., and Freeman, J. L. (2009). RNA isolation from embryonic zebrafish and cDNA
synthesis for gene expression analysis. Journal of Visualized Experiments 30, 1470.
Peterson, S. M., Zhang, J., Weber, G., and Freeman, J. L. (2011). Global Gene Expression
Analysis Reveals Dynamic and Developmental Stage-Dependent Enrichment of LeadInduced Neurological Gene Alterations. Environ. Health Perspect. 119(5), 615-621.
Plaznik, A., Kostowski, W., and Archer, T. (1989). Serotonin and depression: Old problems and
new data. Progress in Neuro-Psychopharmacology and Biological Psychiatry 13(5), 623633.
Rajkovic, V., Djolai, M., and Matavulj, M. (2011). Alterations in jejunal morphology and
serotonin-containing enteroendocrine cells in peripubertal male rats associated with
subchronic atrazine exposure. Ecotoxicology and environmental safety 74(8), 2304-9.
Reif, D. M., Truong, L., Mandrell, D., Marvel, S., Zhang, G., and Tanguay, R. L. (2016). Highthroughput characterization of chemical-associated embryonic behavioral changes
predicts teratogenic outcomes. Arch Toxicol 90(6), 1459-70.

243
Ressler, K. J., and Nemeroff, C. B. (2000). Role of serotonergic and noradrenergic systems in the
pathophysiology of depression and anxiety disorders. Depression and Anxiety 12, 2-19.
Roberge, M., Hakk, H., and Larsen, G. (2004). Atrazine is a competitive inhibitor of
phosphodiesterase but does not affect the estrogen receptor. Toxicol. Lett. 154(1-2), 6168.
Rodriguez, V. M., Limon-Pacheco, J. H., Mendoza-Trejo, M. S., Gonzalez-Gallardo, A.,
Hernandez-Plata, I., and Giordano, M. (2013). Repeated exposure to the herbicide
atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino
rat. Neurotoxicology 34, 82-94.
Romanowski, C. A. J., and Wilkinson, I. D. (2011). Atrophy: When too much atrophy is too little
brain. Neuroradiology 53(1), 133.
Sanderson, J. T., Boerma, J., Lansbergen, G. W. A., and van den Berg, M. (2002). Induction and
inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R
human adrenocortical carcinoma cells. Toxicology and applied pharmacology 182(1), 4454.
Schantz, S. L., and Widholm, J. J. (2001). Cognitive effects of endocrine-disrupting chemicals in
animals. Environ. Health Perspect. 109(12), 1197-1206.
Schmidel, A. J., Assmann, K. L., Werlang, C. C., Bertoncello, K. T., Francescon, F., Rambo, C.
L., Beltrame, G. M., Calegari, D., Batista, C. B., Blaser, R. E. et al. (2014). Subchronic
atrazine

exposure

changes

defensive

behaviour

profile

and

disrupts

brain

acetylcholinesterase activity of zebrafish. Neurotoxicology and teratology 44, 62-69.
Schug, T. T., Barouki, R., Gluckman, P. D., Grandjean, P., Hanson, M., and Heindel, J. J.
(2013). PPTOX III: environmental stressors in the developmental origins of disease-evidence and mechanisms. Toxicological sciences 131(2), 343-50.
Schwab, A. P., Splichal, P. A., and Banks, M. K. (2006). Persistence of Atrazine and Alachlor in
Ground Water Aquifers and Soil. Water, Air, & Soil Pollution 171(1), 203-235.
Shackelford, C., Long, G., Wolf, J., Okerberg, C., and Herbert, R. (2002). Qualitative and
quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol 30(1),
93-6.
Shah, K., and Lahiri, D. K. (2014). Cdk5 activity in the brain - multiple paths of regulation.
Journal of cell science 127(Pt 11), 2391-400.

244
Song, Y., Jia, Z. C., Chen, J. Y., Hu, J. X., and Zhang, L. S. (2014). Toxic Effects of Atrazine on
Reproductive System of Male Rats. Biomed. Environ. Sci. 27(4), 281-288.
Steinberg, C. E. W., Lorenz, R., and Spieser, O. H. (1995). Effects of atrazine on swimming
behavior of zebrafish, Brachydanio rerio. Water Res. 29(3), 981-985.
Sun, Y., Li, Y. S., Yang, J. W., Yu, J., Wu, Y. P., and Li, B. X. (2014). Exposure to atrazine
during gestation and lactation periods: toxicity effects on dopaminergic neurons in
offspring by downregulation of Nurr1 and VMAT2. International journal of molecular
sciences 15(2), 2811-25.
Tennant, M. K., Hill, D. S., Eldridge, J. C., Wetzel, L. T., Breckenridge, C. B., and Stevens, J. T.
(1994). Chloro-s-triazine antagonism of estrogen action: limited interaction with estrogen
receptor binding. J Toxicol Environ Health 43(2), 197-211.
Thurman, E. M., Goolsby, D. A., Meyer, M. T., and Kolpin, D. W. (1991). Herbicides in Surface
Waters of the Midwestern United-States - the Effect of Spring Flush. Environ. Sci.
Technol. 25(10), 1794-1796.
Truong, L., Reif, D. M., St Mary, L., Geier, M. C., Truong, H. D., and Tanguay, R. L. (2014).
Multidimensional in vivo hazard assessment using zebrafish. Toxicological sciences : an
official journal of the Society of Toxicology 137(1), 212-33.
U.S. Environmental Protection Agency (2006). Decision documents for atrazine. Available at:
http://www.epa.gov/oppsrrd1/reregistration/REDs/atrazine_combined_docs.pdf/.
Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B. C., Remm, M., and Rozen, S.
G. (2012). Primer3--new capabilities and interfaces. Nucleic Acids Res 40(15), e115.
van der Ven, L. T. M., Wester, P. W., and Vos, J. G. (2003). Histopathology as a tool for the
evaluation of endocrine disruption in zebrafish (Danio rerio). Environ. Toxicol. Chem.
22(4), 908-913.
Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Lee, D. H., Shioda,
T., Soto, A. M., vom Saal, F. S., Welshons, W. V. et al. (2012). Hormones and
Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses.
Endocr. Rev. 33(3), 378-455.
Victor-Costa, A. B., Bandeira, S. M. C., Oliveira, A. G., Mahecha, G. A. B., and Oliveira, C. A.
(2010). Changes in testicular morphology and steroidogenesis in adult rats exposed to
Atrazine. Reprod. Toxicol. 29(3), 323-331.

245
Vonberg, D., Hofmann, D., Vanderborght, J., Lelickens, A., Köppchen, S., Pütz, T., Burauel, P.,
and Vereecken, H. (2014). Atrazine Soil Core Residue Analysis from an Agricultural
Field 21 Years after Its Ban. J. Environ. Qual. 43(4), 1450-1459.
Weber, G. J., Sepulveda, M. S., Peterson, S. M., Lewis, S. S., and Freeman, J. L. (2013).
Transcriptome Alterations Following Developmental Atrazine Exposure in Zebrafish Are
Associated with Disruption of Neuroendocrine and Reproductive System Function, Cell
Cycle, and Carcinogenesis. Toxicol. Sci. 132(2), 458-466.
Welshons, W. V., Thayer, K. A., Judy, B. M., Taylor, J. A., Curran, E. M., and vom Saal, F. S.
(2003). Large effects from small exposures. I. Mechanisms for endocrine-disrupting
chemicals with estrogenic activity. Environ. Health Perspect. 111(8), 994-1006.
Westerfield, M. (2007). The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish
(Danio rerio), 5th ed. University of Oregon Press, Eugene, Oregon, USA.
Wirbisky-Hershberger, S. E., Sanchez, O. F., Horzmann, K. A., Thanki, D., Yuan, C., and
Freeman, J. L. (2017). Atrazine exposure decreases the activity of DNMTs, global DNA
methylation levels, and dnmt expression. Food Chem Toxicol 109(Pt 1), 727-734.
Wirbisky, S. E., Damayanti, N. P., Mahapatra, C. T., Sepulveda, M. S., Irudayaraj, J., and
Freeman,

J.

L.

(2016a).

Mitochondrial

Dysfunction,

Disruption

of

F-Actin

Polymerization, and Transcriptomic Alterations in Zebrafish Larvae Exposed to
Trichloroethylene. Chem Res Toxicol 29(2), 169-79.
Wirbisky, S. E., and Freeman, J. L. (2015a). Atrazine Exposure and Reproductive Dysfunction
through the Hypothalamus-Pituitary-Gonadal (HPG) Axis. Toxics 3(4), 414-450.
Wirbisky, S. E., Sepulveda, M. S., Weber, G. J., Jannasch, A. S., Horzmann, K. A., and
Freeman, J. L. (2016b). Embryonic Atrazine Exposure Elicits Alterations in Genes
Associated with Neuroendocrine Function in Adult Male Zebrafish. Toxicological
sciences 153(1), 149-64.
Wirbisky, S. E., Weber, G. J., Schlotman, K. E., Sepulveda, M. S., and Freeman, J. L. (2016c).
Embryonic atrazine exposure alters zebrafish and human miRNAs associated with
angiogenesis, cancer, and neurodevelopment. Food Chem. Toxicol. 98, 25-33.
Wirbisky, S. E., Weber, G. J., Sepúlveda, M. S., Lin, T.-L., Jannasch, A. S., and Freeman, J. L.
(2016d). An embryonic atrazine exposure results in reproductive dysfunction in adult
zebrafish and morphological alterations in their offspring. Scientific Reports 6, 21337.

246
Wirbisky, S. E., Weber, G. J., Sepulveda, M. S., Xiao, C., Cannon, J. R., and Freeman, J. L.
(2015b). Developmental origins of neurotransmitter and transcriptome alterations in adult
female zebrafish exposed to atrazine during embryogenesis. Toxicology 333, 156-167.
Wullimann, M. F. (2014). Ancestry of basal ganglia circuits: New evidence in teleosts. J. Comp.
Neurol. 522(9), 2013-2018.
Zhang, J., Peterson, S. M., Weber, G. J., Zhu, X. Q., Zheng, W., and Freeman, J. L. (2011).
Decreased axonal density and altered expression profiles of axonal guidance genes
underlying lead (Pb) neurodevelopmental toxicity at early embryonic stages in the
zebrafish. Neurotoxicology and teratology 33(6), 715-720.

247

CHAPTER 6.

CONCLUSIONS AND FUTURE
DIRECTIONS

The studies presented in this dissertation use the zebrafish model to investigate the
developmental

toxicity

of

three

environmental

toxicants:

trichloroethylene

(TCE),

methylcyclohexanemethanol (MCHM) mixtures, and atrazine (ATZ). In particular, the studies
focused on the effects of embryonic exposure on developmental neurotoxicity and the later life
effects of embryonic exposure, according to the Developmental Origins of Health and Disease
(DOHaD) hypothesis. Techniques ranging from basic toxicity assays, evaluations of
neurobehavior, and ‘-omics’ level interrogation of gene expression and protein level changes
were used to determine these effects. The results of these studies help characterize possible
human health risks of developmental exposure to these possible drinking water contaminants.
The first chemical investigated was TCE. Embryonic exposure to the legacy
environmental contaminant TCE did cause developmental toxicity. Exposure to 500 ppb
increased the percent hatch while also altering the development of the larval head and brain.
Although no changes were observed on behavioral analysis, we were able to confirm the utility
of the behavioral test with a positive control, apomorphine. The expression of four cytochrome
p450 enzymes (cyps) was evaluated and although there was no change in relative expression for
the cyps most similar to the enzyme responsible for the majority of TCE metabolism in humans,
there was decreased expression of cyp24a1, the enzyme that metabolizes the active form of
vitamin D. This study establishes that TCE does cause developmental neurotoxicity at
environmentally relevant concentrations and suggests altered vitamin D metabolism as a possible
mechanism. Further investigation into the toxicokinetics of TCE in zebrafish is needed. The
metabolites of TCE are thought to mediate cancer related and non-cancer related health effects
and the metabolites and the relative amounts of the metabolites produced by zebrafish are
currently unknown. Further study is also needed into the role of vitamin D in TCE related
toxicity. It is unknown if the levels of vitamin D are altered or if further down-stream effects of
decreased vitamin D metabolism occur.
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The second study investigated the acute developmental toxicity of 4-MCHM and two
MCHM mixtures. The crude MCHM mixtures emerged as compounds of concern after a mixture
of crude MCHM leaked into the Elk River in early 2014 and contaminated the drinking water of
Charleston, West Virginia. This study identified the chemical compositions of crude MCHM and
the proprietary mixture from the tank that leaked. Acute toxicity assays with larval zebrafish
were performed for the parent compound, 4-MCHM, crude MCHM, and the tank mixture. As the
acute developmental toxicity increased with the complexity of the chemical mixture, but 4MCHM appeared to have the largest effect on zebrafish larval growth. All three chemicals or
mixtures caused nonmonotonic alterations in larval zebrafish behavior at the 1 ppm short term
screening level set by the Centers of Disease Control and Prevention. This study confirms the
need to acquire basic toxicity information on chemicals that have the potential to enter the
environment and also highlights the need to adequately characterize the components of mixtures
but also consider the mixture as the components may have synergic effects on toxicity. Further
study into mechanism of MCHM toxicity, molecular changes associated with developmental
MCHM exposure, and the long term effects of developmental MCHM exposure are needed to
better characterize the effects of the Elk River incident.
The third and fourth studies investigate the effects of developmental exposure to ATZ, a
commonly used herbicide linked to endocrine disruption, cancer, and altered neurochemistry.
The third study evaluates changes in gene expression, brain morphology, behavior, and protein
levels in larval zebrafish with embryonic ATZ exposure. Two genes, ttc3 and tpd53l1, had
altered expression prior to 72 hours post fertilization (hpf), suggesting that some of the gene
targets of ATZ toxicity are sensitive during critical periods in embryogenesis. Developmental
neurotoxicity was suggested by altered brain length in larvae with 0.3 ppb embryonic ATZ
exposure and hypoactivity observed on a behavioral assay in larvae with embryonic exposure to
30 ppb ATZ. Proteomic analysis identified altered levels of 28 proteins related to ATZ exposure.
These proteins were associated with organismal development, intracellular signaling, protein
metabolism, epigenetic gene regulation, and genital tract cancer pathways. The results add to the
body of evidence on ATZ toxicity and provide additional support for neurobehavioral outcomes
and epigenetic mechanisms of toxicity. Further work is needed to characterize the toxicokinetics
of ATZ in zebrafish and better correlate zebrafish embryonic exposures to human in utero
exposures.
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The fourth study follows the DOHaD hypothesis and investigates the embryonic
exposure of later life ATZ neurotoxicity. ATZ causes nonmonotonic, sex-specific alterations in
behavior, the brain transcriptome, and brain pathology. Females with embryonic exposure to
ATZ had a more anxious phenotype while males with embryonic exposure had trending to
significant decreases in activity endpoints. Additional tests of learning or social behavior may
provide additional information to better describe the phenotypic outcome of embryonic ATZ
exposure. Transcriptomic analysis also identified sex-specific changes in gene expression in
females and males after embryonic ATZ exposure in pathways related to cancer, cellular
signaling, organismal injury, and the reproductive system. Genes with persistent changes in
expression were related to steroid hormone action and nervous system development and
function. Although changes in cellular density was observed within the raphe populations of the
male zebrafish brain and the dorsal telencephalon when the sexes are combined, the
pathophysiology of the observation needs further investigation. The characterization of cell type
within these areas may provide additional information as to the cellular targets of ATZ toxicity
within the central nervous system. Finally, there were nonmonotonic changes in body size and
brain weight in zebrafish with embryonic ATZ exposure, though further investigation into
pathologic alterations of other organs, such as the gonads, at this time point may offer new
insights into the developmental origins of ATZ related toxicity.
Collectively, these results demonstrate the usefulness of the zebrafish biomedical model
in investigating both acute and delayed toxicity resulting from developmental exposure to a
variety of environmental toxicants.
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